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Summary 
The opportunistic pathogen Pseudomonas aeruginosa is an increasing threat in human health 
care, since multi-resistant strains are on the rise. One protein family that was found to par-
ticipate in a variety of resistance mechanisms is the βαβββ-module-containing protein family. 
They have a highly conserved fold but a diverse set of functions. P. aeruginosa contains 22 of 
these proteins. Conserved active site residues subdivide them into three classes. Class I con-
tains at least three conserved metal-complexing residues, and most characterized members 
catalyze the breakdown of toxic compounds. In class II, two aromatic side chains complex 
toxic aromatics to mediate resistance. The remaining proteins lack the conserved residues 
and were assigned to class III.  
In this study, the physiological roles of class III proteins PA1358, PA1672, PA2721, PA4183 and 
PA4518 were investigated with microbiological, biophysical and X-ray crystallography meth-
ods. This revealed that PA1672 has a low affinity to chlorpromazine and promethazine. At the 
same time, PA1672 seems to play a role during swarming motility and biofilm formation. A 
ligand structure of PA2721 revealed the binding with N-benzyloxycarbonyl-L-proline and that 
a proposed active site cysteine residue is covalently modified by the antimicrobial compounds 
dichlofluanid and captan. P. aeruginosa mutants of PA1358, PA4183 and PA4518 revealed an 
altered sensitivity to a variety of distinct antimicrobial compounds.  
Furthermore, a high-resolution crystal structure of the class III protein PA418316-155 was de-
termined, as well as structures of the proteins PA1359, PA2722 and PA2723, which are en-
coded in the same operon as class III proteins. The structures showed that the C-terminal 
domain of PA1359 has a cupin-like and that PA2722 has a Gfa/CENP-V-like fold. PA2723 was 
the first protein that solely consists of an R3H-like domain. However, no functional annota-
tions could be derived from these structures.  
Overall, this study identified undetermined protein structures and gave specific starting 
points for the functional characterization of PA2721 and PA1672. The results from the chem-
ical sensitivity assays seem to support the assumption that at least some class III βαβββ-mod-
ule proteins participate in resistance mechanisms. 
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1 Introduction 
1.1 Pseudomonas aeruginosa 
Pseudomonas aeruginosa is a versatile Gram-negative γ-proteobacterium. The soil-dwelling 
bacterium has simple growth requirements, which allows it to adopt to a variety of environ-
mental conditions (Silby et al., 2011). For example it was found to survive in distilled water 
(Favero et al., 1971) and to be able to degrade “non-biodegradable” synthetic plastics such 
as low density polythene (Kyaw et al., 2012). Pathogenic strains infect several organisms in-
cluding plants or mammals (Silby et al., 2011). In humans, they can cause fatal chronic and 
acute, nosocomial infections, for example in the urinary tract, on burn wounds or in the res-
piratory system of immunocompromised patients. In cystic fibrosis (CF) patients, the human 
pathogen causes severe pneumonia and is the main cause for morbidity and mortality (Figure 
1A) (Moradali et al., 2017). Increasing levels of antimicrobial resistant strains raise the need 
for new cures to overcome an upcoming public health crisis and prevent the prophesies of a 
post-antibiotic future, in which infectious diseases will be responsible for millions of deaths 
(Pendleton et al., 2013).  
 
Figure 1: Pseudomonas aeruginosa. A) Biofilm in the lungs from a CF patient. Reprinted from Alhede et al., 2014, Copyright 
(2014), with permission from Elsevier Inc. B) Phenazine production by P. aeruginosa PAO1 strain. The figure was reprinted 
from Mavrodi et al., 2001. C) Monoflagellated bacterial cell with a magnification of the cell pole (right square). The figure 
was reprinted from van Ditmarsch et al., 2013.  
 Virulence factors  
The pathogenicity is based on various virulence factors that are produced and secreted in the 
extracellular environment or directly injected into the host cell via distinct secretion systems, 
of which P. aeruginosa encodes at least six different types (Bleves et al., 2010). Virulence fac-
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tors can either be recognized by receptors of the immune cells and modulate the immune 
response or they are cytotoxic compounds, proteins or enzymes that induce apoptosis of host 
or bacterial cells. This triggers inflammation, weakens host antibacterial mechanisms or kills 
competing bacterial species to gain a growth advantage (Hall et al., 2016; Michalska and Wolf, 
2015). One well-studied example is the redox-active, organic phenazine compound pyocya-
nin. It is one of the most abundant secondary metabolites from P. aeruginosa and is, among 
others, responsible for the characteristic greenish pigmentation of the bacterial colonies, be-
cause it has a blue color in the oxidized state (Figure 1 A/B) (Mavrodi et al., 2006; Pierson & 
Pierson, 2010). It is secreted via the type II secretion system machinery into the extracellular 
space (Hall et al., 2016). Based on its redox properties it is able to induce the emergence of 
highly reactive superoxide and H2O2, which cause unspecific oxidative damage (Mavrodi et 
al., 2006). The most toxic, enzymatically active virulence factor is exotoxin A, which is also 
secreted through the type II secretion system. It induces its phagocytic uptake and release 
into the host cell cytosol, where it enzymatically alters a specific translation elongation factor 
on the ribosome, causing the inactivation of the host cell protein biosynthesis and the induc-
tion of apoptosis (Michalska & Wolf, 2015). The cell appendices of P. aeruginosa that are cru-
cial for the bacterial motility, such as the polar flagellum and type IV pili, are also considered 
as virulence factors (Josenhans & Suerbaum, 2002). Non-motile cells are unable to cause a 
successful infection (Feldman et al., 1998) and besides, the flagellum proteins are recognized 
by the host immune cells and also influence the immune response (Haiko & Westerlund-Wik-
ström, 2013).  
 Motility and acute infections 
Highly motile lifestyle forms initiate the acute infection (Klockgether & Tümmler, 2017). Dif-
ferent motility types, such as swimming, swarming or twitching, allow the bacteria to spread 
and colonize larger surface areas in the host and further enable the chemotactic movement 
away from toxic environments or towards favorable substrates (Josenhans & Suerbaum, 
2002). The main motor for swimming and swarming is the single polar flagellum. The rotation 
of this organelle alone allows the bacteria to swim through liquid and low viscosity media 
(Jarrell & McBride, 2008). Swarming describes the movement over high viscosity, semisolid 
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surfaces. In contrast to swimming, which is performed by individual bacteria, swarming is a 
multicellular behavior that further requires the secretion of surface-active agents (surfac-
tants) that are amphiphilic wetting agents to decrease the surface tension between the bac-
teria and the environment and allow them to move. Swarming further requires the presence 
of type IV pili. Type IV pili are appendages that are distributed at the bacterial surface. They 
have adhesive function that allow the attachment to and the sensing of other cells (Kearns, 
2010). The suggested role of type IV pili during swarming is to mediate the interaction be-
tween the bacterial cells to control their collective movement (Anyan et al., 2014). Type IV 
pili alone are responsible for twitching. In this case, the retractability of the pili filaments plays 
an important role. They are elongated, adhere and are retracted, which drags the cell towards 
the side of adherence (Kearns, 2010). The pili and the flagellum are also crucial for initial 
adherence to biotic or abiotic surfaces for switching to the sessile lifestyle, since non-motile 
mutants are not able to form a biofilm (O’Toole & Kolter, 1998).   
 Biofilms and persistence 
Biofilms consist of cellular aggregates of non-motile cells that are embedded in a hydrated 
matrix of extracellular polymeric substances such as exopolysaccharides, extracellular DNA 
or polypeptides (Figure 2 A) (Rasamiravaka et al., 2015). The biofilm builds a barrier that 
shields the bacterial cells from being attacked by the immune system of the host and by an-
timicrobial compounds. This limits the effective eradication of the bacterial population inde-
pendently of specific antibiotic resistance mechanism and enables the establishment of 
chronic infections (Rybtke et al., 2011). Distinct subpopulations with various metabolic activ-
ity within the biofilm further complicate the total elimination of bacterial cells, especially if 
persister cells are among them. During persistence, the cell enters a dormant lifestyle in 
which cellular processes such as proliferation or metabolism are arrested. The arrest is trig-
gered by the stringent response upon all kinds of stressful conditions such as in the presence 
of toxic compounds, by oxidative stress and under nutrient starvation. The transformation 
towards persister cells is driven by genetically encoded, bicistronic toxin-antitoxin (TA) sys-
tems (Moradali et al., 2017). They are widely distributed among bacteria and archaea and six 
distinct types of TA systems are identified at present that are distinguished by the identity of 
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the labile antitoxin, which can be a protein or RNA, while stabile toxins are always proteins 
(Page & Peti, 2016; Unterholzner et al., 2013). So far, only type I and especially type II TA-
system were discovered to influence persister cell formation (Figure 2 B). 
 
Figure 2: Biofilms and persistence of P. aeruginosa. A) P. aeruginosa Biofilm. Reprinted from Alhede et al., 2014, Copyright 
(2014), with permission from Elsevier Inc. B) Mechanisms of type I (a) and type II (b) toxin-antitoxin systems. Reprinted from 
Wen, Y., Behiels, E. & Devreese, B., Toxin-Antitoxin systems: their role in persistence, biofilm formation, and pathogenicity, 
(2014). Pathog. Dis. 70, 240–249, Copyright (2014), with permission of Federation of European Microbiological Societies. 
In the type I TA system, the antitoxin is a small RNA that is complementary to a portion of the 
mRNA that codes for the toxin and therefore inhibits the translation of the toxin. In type II 
systems, the antitoxin is a protein that detoxifies the toxin by protein-protein interaction (Un-
terholzner et al., 2013). Under favorable conditions, toxin and antitoxin are present at com-
parable level and the antitoxin prevents the toxic effect. Under stress conditions, the strin-
gent response also triggers the expression of specific proteases or RNases that degrade the 
respective antitoxin. This liberates the toxins, which inhibit basic cellular processes such as 
DNA replication or protein translation resulting in growth arrest (Page & Peti, 2016). Func-
tionally characterized TA systems from P. aeruginosa include the type II HigB/HigA and 
HicA/HicB systems. HigB and HicA are the respective toxins with RNase activity. Both systems 
are widely distributed among clinical P. aeruginosa isolates and it is suggested that persister 
cells are one reason that make it difficult to eradicate chronic infections with antibiotics, since 
the persisters reawaken after the treatment is finished and transform back into normal grow-
ing cells that can reestablish the infection (Moradali et al., 2017). 
 Antibiotic resistance 
Single bacterial cells can combat antibiotic treatment by different intrinsic resistance mecha-
nisms. They express several enzymes that are able to catalyze the breakdown and inactiva-
tion of antibiotics, such as β-lactam or fosfomycin, which actively target dividing bacteria by 
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inhibiting cell wall synthesis enzymes (Kong et al., 2010; Silver, 2017). Enzymes that target β-
lactam antibiotics are called β-lactamases. 120 of them were identified in different clinical 
isolates that detoxify all types of β-lactam antibiotics, such as cephalosporins, which are de-
toxified by AmpC-like enzymes, or like carbapanems, which are degraded by carbapenemases 
(Zhao & Hu, 2010). Fosfomycin is hydrolyzed by the enzyme FosA, which belongs to the 
βαβββ-module-containing protein family (Bernat et al., 1997; Rife et al., 2002). Indirect mech-
anisms involve the reduced permeability of the membrane for antimicrobials (Moradali et al., 
2017). The membrane is semipermeable to supply the cell with nutrient molecules. Molecules 
up to a size of 500 Da can pass the membranes by passive diffusion through porins (Nikaido, 
2003). The expression of porins such as the outer membrane protein F (OprF) or OprD is re-
duced if the bacterium is exposed to antimicrobials so that their uptake is limited and the 
bacterium becomes resistant (Pendleton et al., 2013). Harmful effects of antibiotics that have 
nevertheless reached the interior of the cell can be avoided by actively exporting them out 
of the cytoplasm again. This is achieved by increased levels of multidrug efflux pumps (Mex) 
with distinct substrate specificity. MexXY pumps, for example, transport several antibiotics, 
like fluoroquinolones, aminoglycosides, tetracycline or chloramphenicol (Lister et al., 2009). 
The MexAB-OprM pump is further able to export other toxic compounds, such as biocides or 
detergents, in addition to the classic antibiotics such as β-lactams or sulfonamides (Lister et 
al., 2009). Other resistance mechanisms are based on mutations in the antimicrobial target. 
Fluoroquinolone antibiotics, for instance, target DNA gyrase and topoisomerase IV and there-
fore prevent replication and inhibit bacterial growth (Drlica, 1999). Mutational changes in the 
respective targets render the antibiotic ineffective and mediate resistance (Lee et al., 2005).  
 Genome  
The wide spectrum of mechanisms that were developed by P. aeruginosa to optimize the 
survival under all kinds of adverse circumstances is reflected by the large genome size, which, 
with more than 6 Mbp, encodes roughly 6000 open reading frames (ORFs) (Moradali et al., 
2017; Valot et al., 2015). Albeit a large amount of genes were functionally annotated in the 
past there are still around 35 % of hypothetical and unknown proteins that are without func-
tional predictions (Winsor et al., 2016).  
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1.2 βαβββ-module-containing proteins  
22 genes of one large protein family were recently discovered in the genome of P. aeruginosa 
PAO1. They are predicted to encode members of the functionally diverse βαβββ-module-
containing protein family (Vit, 2015). βαβββ-module proteins are abundant in all kingdoms 
of life and participate in the detoxification of compounds with antimicrobial functions, but 
only eight members of the 22 βαβββ-module proteins from P. aeruginosa were functionally 
characterized (Bernat et al., 1997; Kalawy-Fansa, 2010; Sukdeo et al., 2004; Vit, 2015; Yu, 
2009). Since the functionally unknown proteins are assumed to mediate resistance mecha-
nisms like their relatives, shedding light on those unrevealed functions might identify new 
and interesting mechanisms.         
 Overview of βαβββ-module-containing proteins  
The βαβββ-module-containing protein family is also termed glyoxalase I/bleomycin re-
sistance protein family and vicinal oxygen chelate (VOC) domain superfamily. The distinct de-
nominations are attributed to the diverse functions that are me-
diated by the members of this protein family. Albeit sequence 
similarities are low the core fold of these proteins is highly con-
served. The fold originates in the βαβββ-module. One module 
has four β-strands that form a β-sheet. The strands have the or-
der and polarity of β1↑ β4↑ β3↓ β2↑. One α-helix connects β1 and 
β2 (Figure 3) (Bergdoll et al., 1998). Four of these modules assem-
ble to the stable and fully functional βαβββ-module containing 
protein (Figure 4). In this assembly, the α-helices from two mod-
ules, which interact with each other via so-called back-to-back contacts. The β-sheets of two 
modules are connected via edge-to-edge contacts and form one big, eight-stranded U-shaped 
or half barrel-like β-sheet (Figure 4). 
Figure 3: Structure of a βαβββ-
module colored from white to 
black (N- to C-terminus). 
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Figure 4: Assembly of βαβββ-module-containing proteins DHBD from B. cepacia LB400 (PDB-ID: 1HAN, Han et al., 1995), 
glyoxalase 1 (Glx1) from Zea mays (PDB-ID: 5D7Z, Turra et al., 2015), human glyoxalase 1 (Glo1) (PDB-ID: 1FRO, Cameron et 
al., 1997) and the hypothetical protein MM_3218 from Methanosarcina mazei (PDB-ID: 3R6A, Eswaramoorthy et al. to be 
published). The upper panel shows the crystal structures. Secondary structure elements that are not part of the core βαβββ-
fold are yellow. The lower panel shows the schematic arrangement of βαβββ-modules in the distinct monomeric and ho-
modimeric βαβββ-module proteins. Homodimers can be established via edge-to-edge (teal) or back-to-back (red) contacts. 
The circles represent α-helices and the rectangles β-sheets. They are numbered from N- to C-terminus. The connections 
between the secondary elements are indicated by arrows and may contain additional secondary elements besides the core 
fold. The schematic representation is adapted from Bergdoll et al., 1998. The βαβββ-modules that belong to one protein 
chain have different shades of the same color. The U-shapes indicate the location of the conserved active or binding sites. 
Dashed lines represent the homodimer interfaces. 
The arrangement of the tertiary structure is dependent on how many βαβββ-modules are 
encoded in one protein chain. On the one hand, there are monomeric proteins that encode 
four modules, which can assemble in two distinct ways as depicted in Figure 4. On the other, 
there are proteins that encode two βαβββ-modules per chain and form homodimers in two 
different ways. The dimerization can either be mediated by edge-to-edge contacts, where the 
half barrel is formed between two protein chains or by back-to-back contacts, where each of 
the half barrels is made up by one protein chain (Figure 4) (Bergdoll et al., 1998). Since the 
half-barrel is the conserved location for the active site, the homodimers contain two identical 
sites, while the monomeric βαβββ-module-containing proteins can have two distinct sites 
(Figure 4). Further, βαβββ-module-containing proteins also exist as higher order oligomers, 
like the 2,3-dihydroxybiphenyl 1,2-dioxygenase (DHBD) from Burkholderia cepacia LB400 
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(Han et al., 1995), which encodes four βαβββ-modules per protein chain (Figure 4) and as-
sembles into an octamer (Figure 5). Another example is the tetrameric homoprotocatechuate 
2,3-dioxygenase (HPCD) from Brevibacterium fuscum (Figure 5) (Oberthuer et al., 2017). 
There are also multidomain proteins such as the bleomycin N-acetyltransferase (BAT) from 
Streptomyces verticillus (Oda et al., 2010). This enzyme consists of an N-terminal acetyltrans-
ferase domain that mediates the catalytic activity and a C-terminal βαβββ-module domain 
with two modules that mediate the dimerization of the protein (Figure 5).   
 
Figure 5: Examples for higher order oligomers and multidomain βαβββ-module-containing proteins. Octamer assembly of 
DHBD monomers (differently colored) from B. cepacia LB400 (PDB-ID: 1HAN, Han et al., 1995). Tetrameric assembly of HPCD 
monomers (differently colored) from B. fuscum (PDB-ID: 5TRX, Oberthuer et al., 2017). Multidomain bleomycin N-acetyl-
transferase (BAT) from S. verticillus (PDB-ID: 2ZW7, Oda et al., 2010) in complex with bleomycin (white) and coenzyme A 
(grey). Each protein chain (different shades of teal or red) contains an N-terminal acetyltransferase domain and two C-ter-
minal βαβββ-modules. The homodimer of BAT is formed by edge-to-edge dimerization of the C-terminal βαβββ-module 
domains. 
The structural diversity is reflected in different functions that βαβββ-module-containing pro-
teins fulfill. The VOC family of βαβββ-module-containing proteins share three to four amino 
acid residues in the active site that complex a divalent metal ion. The metal ion bidentate 
coordinates substrates and reaction intermediates with vicinal oxygen atoms and serves as 
catalytic center in different reaction mechanisms (He & Moran, 2011). Two general enzyme 
groups can be distinguished, namely the dioxygenase and the non-dioxygenase groups. The 
later catalyzes non-redox active reactions. In this group, the divalent metal center is im-
portant for electrophilic activation of the substrate and/or for stabilization of a transition 
state or an intermediate to catalyze isomerization reactions or to open oxirane rings by nu-
cleophilic addition. Isomerizations are carried out in similar fashion by glyoxalase I (GlxI) and 
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methylmalonyl-CoA epimerases (MMCE), which coordinate several divalent metal ions by 
four active site residues and are widely distributed in all kingdoms of life (Figure 6). MMCE 
catalyzes the epimerization of (2R)-methylmalonyl-CoA to (2S)-methylmalonyl-CoA, which is 
an essential reaction during the breakdown of odd-chain fatty and branched amino acids. GlxI 
are lactoylglutathione lyases that catalyze a step during the detoxification pathway of the 
toxic side-product methylglyoxal. Methylglyoxal spontaneously reacts with glutathione (GSH) 
to a hemithioacetal product that serves as substrate for GlxI and is converted to S-D-lac-
toylglutathione (Figure 6) (He & Moran, 2011; Silva et al., 2013). Nucleophilic additions were 
discovered in fosfomycin resistance proteins, which complex Mn2+ or Mg2+ ions by three 
amino acid side chains in the active site (Figure 6 B). Fosfomycin is an epoxide antibiotic that 
inhibits bacterial cell wall synthesis by inactivation of the UDP-N-acetylglucosamine-enolpy-
ruvyltransferase MurA, which catalyzes the first step in peptidoglycan synthesis (Silver, 2017). 
Three classes of fosfomycin resistance proteins have been discovered by now. FosA and FosB 
catalyze the addition of respectively GSH or cysteine to fosfomycin, while FosX hydrolyses the 
antibiotic. These reactions result in the opening of the epoxide ring and thus inactivate 
fosfomycin. Fosfomycin binding is exemplified for FosA from P. aeruginosa, which addition-
ally uses the monovalent ion K+ not present in FosB and FosX (Figure 6 B). The general reaction 
mechanism is displayed in Figure 6 A. The dioxygenase group of VOC enzymes catalyzes the 
oxidative cleavage of carbon-carbon bonds using molecular O2 as substrate. Most of them 
complex Fe2+, but also Mn2+-dependent enzymes were discovered (Armstrong, 2000; Fenwick 
et al., 2011). All discovered βαβββ-fold dioxygenases are monomeric with two distinct sites 
of whom only one is occupied by a metal, complexed by three residues (Figure 6 B). Distinct 
substrate specificities and O2 activation mechanisms distinguish type I aromatic ring-cleaving 
extradiol dioxygenases, two-substrate α-keto acid dependent oxygenases (2S-αKGO) and 
toxoflavin lyases. Extradiol dioxygenases, such as HPCD from B. fuscum (Figure 6 B), catalyze 
the O2 transfer to single or double ring aromatic compounds with a benzene-1,2-diol moiety 
to yield the respective 2-hydroxymuconic semialdehyde derivatives (Figure 6 A). 2S-αKGOs 
are 4-hydroxyphenylpyruvate dioxygenases (HPPD) and hydroxymandelate synthases (HMS), 
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which catalyze the oxidative decarboxylation of 4-hydroxyphenylpyruvate to 2,5-dihydroxy-
phenylacetate or to hydroxymandelate as intermediate steps during tyrosine catabolism, re-
spectively (Armstrong, 2000; He & Moran, 2009, 2011). Toxoflavin lyases, such as TflA from 
Paenibacillus polymyxa, catalyze the Mn2+-dependent oxidative detoxification of toxoflavin 
(Fenwick et al., 2011), which is produced by several bacteria (Jeong et al., 2003; Levenberg & 
Linton, 1966), to yield peroxytoxoflavin (Philmus et al., 2012) (Figure 6).  
 
Figure 6: VOC family of βαβββ-module-containing proteins. A) Reactions catalyzed by distinct VOC family members. B) Ex-
amples for enzymes from the VOC family. Protein chains are colored differently. The boxes are magnifications of the active 
sites with the metal-complexing residues and the substrate (fosfomycin, toxoflavin), substrate analogue (4-nitrochatechol) 
or reaction product (4-hydroxmandelate) (white). The spheres represent Zn2+ (purple), Mn2+ (yellow), K+ (orange), Co2+ (pink) 
and H2O (blue). Glo1: human isomerase (PDB-ID: 1FRO, Cameron et al., 1997). FosA: fosfomycin resistance protein from 
P. aeruginosa PAO1 (PDB-ID: 1LQP, Rife et al., 2002). HPCD: extradiol dioxygenase from B. fuscum (PDB-ID: 3OJK, Fielding et 
al., 2011). HMS: 2S-αKGO from Amycolatopsis orientalis (PDB-ID: 2R5V, Fielding et al., 2011). TflA: toxoflavin lyase from 
P. polymyxa (PDB-ID: 3PXK, Fenwick et al., 2011).  
There are also various metal-independent βαβββ-module-containing proteins. All the metal-
independent proteins that have been characterized until now do not catalyze an enzymatic 
reaction. Many of them have two opposing aromatic amino acid residues in the conserved 
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βαβββ-module protein binding site, which mediate the complexation of small aromatic, het-
erocyclic compounds. Examples are the mitomycin C resistance protein MRD from Strepto-
myces lavendulae, which complexes mitomycin C, EhpR from Pantoea agglomerans, which 
binds the phenazine griseoluteic acid, and PA0803 from P. aeruginosa, which binds the self-
produced pyocyanin (Figure 7). A more complex binding mode has been identified in bleomy-
cin resistance proteins, which is a consequence of the relatively large size of their ligands. 
One example is the bleomycin resistance determinant (BLMT) from Klebsiella pneumoniae 
(Figure 7), where many residues stabilize the compounds in the binding site via salt bridges 
and H-bonds. Two aromatic side chains (W35, W99) in the binding site interact with an aro-
matic moiety of bleomycin in a similar fashion as seen in MRD, EhpR and PA0803 in complex 
with their respective ligands (Figure 7). 
 
Figure 7: Metal-independent βαβββ-module-containing ligand binding proteins. The top panel shows the overall structure 
of the homodimeric binding proteins (chain A in grey, chain B in teal). The lower panel highlights the ligand-binding site and 
the ligand (white). Dashed lines represent H-bonds with a maximum distance of 3.2 Å. MRD from S. lavendulae in complex 
with mitomycin C (PDB-ID: 1KLL, Martin et al., 2002), EhpR from P. agglomerans with griseoluteic acid (PDB-ID: 3SK2, Yu et 
al., 2011), PA0803 from P. aeruginosa PAO1 (Vit, 2015), BLMT from K. pneumoniae (PDB-ID: 1EWJ, Maruyama et al., 2001). 
These binding proteins render the bacteria self-resistant to cope with the cytotoxic activity 
of endogenous secondary metabolites, such as mitomycin C, phenazines or bleomycin. This 
way, it is hypothesized that the respective compound is safely transported through the cell 
until it is exported to the environment and that the βαβββ-module protein might directly 
interact with a respective exporter (Martin et al., 2002; Vit, 2015; Yu et al., 2011).  
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Besides, another βαβββ-module-containing protein Rv0577 from Mycobacterium tuberculo-
sis was recently structurally characterized. It is monomeric with different binding sites that 
are both metal-independent. One site, however, has two opposing tryptophan residues, sim-
ilar to BLMT and other aromatic compound binding βαβββ-module proteins (Figure 7), that 
are not present in the second site (Buchko et al., 2017). It is overexpressed and secreted into 
the host during infection (Huard et al., 2003; Rosenkrands et al., 2000) and was shown to 
interact with human Toll-like receptor 2 (TLR2), thereby interfering with the human immune 
response (Byun et al., 2012). The molecular function is not clear, but it seems to be a virulence 
factor of this pathogenic bacterium and is therefore considered as a potential new drug target 
(Buchko et al., 2012). The structurally undefined protein KbpA from Streptomyces coelicolor 
is homologous to Rv0577 (Buchko et al., 2017). KbpA was shown to participate in the negative 
regulation of actinorhodin production, which is a secondary metabolite with antibiotic func-
tion. KbpA directly interacts with the serine/threonine kinase AfsK, which inhibits its auto-
phosphorylation and thus the signal transduction pathway that would lead to the transcrip-
tion of the actinorhodin synthesis genes (Umeyama & Horinouchi, 2001).   
 βαβββ-module-containing proteins of P. aeruginosa 
The overall sequence similarity between the 22 βαβββ-module-containing proteins that are 
encoded in the genome of P. aeruginosa PAO1 is very low, but some distinct conserved resi-
dues enabled the identification of different protein classes (Figure 8) (Vit, 2015). Class I 
βαβββ-module proteins all possess three conserved metal-complexing residues in the binding 
site (HIS, HIS, GLU) that coordinate divalent metal cations as exemplified for FosA (Figure 6 B) 
(Bernat et al., 1997; Rife et al., 2002). Further functionally characterized representatives are 
the glyoxalases GloA1 (PA3524), GloA2 (PA0710) and GloA3 (PA5111), which all contain the 
fourth metal-complexing glutamate that is conserved among glyoxalases (Figure 6 B, Figure 
8) (Sukdeo et al., 2004). The two proteins with four βαβββ-modules per protein chain, 
PA0242 and PA0856 also contain the conserved metal-complexing residues and are therefore 
assigned to class I.      
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Figure 8: Excerpt from the structure-based sequence alignment of βαβββ-module-containing proteins from P. aeruginosa 
performed with PROMALS3D (Pei et al., 2008) and colored with ESPript 3.0 (Robert & Gouet, 2014). The figure was adapted 
from Vit, 2015. Conserved metal-complexing residues among all class I βαβββ-module proteins are highlighted in teal and 
additional conserved metal-complexing residues in glyoxalases are highlighted in light teal. Conserved aromatic compound 
binding residues from class II βαβββ-module proteins are highlighted in green.  
Proteins that have two conserved aromatic residues in their binding pocket are assigned to 
class II βαβββ-module-containing proteins (Vit, 2015). PA0803, PA1353 and PA4641 are cat-
alytically inactive, unspecific phenazine binding proteins and suspected to mediate resistance 
to self-produced compounds like pyocyanin (Figure 7) (Kalawy-Fansa, 2010; Vit, 2015; Yu, 
2009). PA3127 is suggested to be a two domain bleomycin N-acetyltransferase that catalyzes 
the detoxification of bleomycin (Vit, 2015). The enzymatic reaction is catalyzed by the C-ter-
minal acetyltransferase domain (Vit, 2015). The N-terminal βαβββ-module domain probably 
assists in the proper binding of an aromatic moiety of bleomycin, mediated by the two con-
served aromatic side chains also found in the other class II βαβββ-module proteins (Popp, 
2013; Vit, 2015). The class III βαβββ-module-containing protein family comprises six proteins 
that lack both the conserved metal complexing and aromatic residues in the binding pocket 
(Vit, 2015). 
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 Class III βαβββ-module-containing proteins in P. aeruginosa  
Class III βαβββ-module-containing proteins from P. aeruginosa are PA0880, PA1358, PA1672, 
PA2721, PA4183 and PA4518 (Vit, 2015). They are conserved among several P. aeruginosa 
strains, such as PAO1 and PA14 (Valot et al., 2015). Except for PA4183, the crystal structures 
of all class III βαβββ-module proteins have been determined (Figure 9).  
 
Figure 9: Crystal structures of class III βαβββ-module-containing proteins. The distinct protein chains of the homodimeric 
proteins are colored in grey and teal. PA0880, PA1672, PA4518 (Vit, 2015). PA1358 (PDB-ID: 1U7I, Osipiuk et al., to be pub-
lished). PA2721 (PDB-ID: 1U69, Nocek et al., 2006). 
They are homodimers that are formed via edge-to-edge contacts (Vit, 2015; Nocek et al., 
2006; Osipiuk et al., to be published). Besides the core βαβββ-module-containing protein fold 
and a lack of the conserved residues of class I and class II βαβββ-proteins, they only have little 
similarity. They have sequence identities below 30 % and do not share conserved residues in 
their active sites indicating that they are not functionally homologous to each other (Sievers 
et al., 2011). Based on the available structures of class III proteins, no functional predictions 
were possible, because the sequence identities with functionally characterized βαβββ-family 
members are very low (Nocek et al., 2006; Vit, 2015) or the structures have not been further 
analyzed as in the case of PA1358 (PDB-ID: 1U7I, Osipiuk et al., to be published). Only PA0880 
is suspected to participate in itaconate metabolism, since it is encoded in the same operon 
as genes that code for itaconate degradation enzymes (Sasikaran et al., 2014). However, even 
for this protein, an actual substrate could not be identified until now (Vit, 2015).     
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2 Research Objectives 
Pseudomonas aeruginosa is an opportunistic human pathogen, which causes infections that 
are difficult to treat with current antibiotics. For better understanding of P. aeruginosa infec-
tions, its virulence, resistance mechanisms and regulatory pathways, it is crucial to character-
ize previously unknown proteins to support the identification of new drug targets and the 
development of effective antimicrobial strategies.  
P. aeruginosa encodes 22 members of the βαβββ-module-containing protein family. These 
proteins are abundant in all kingdoms of life and all so far functionally characterized proteins 
mediate resistance towards toxic compounds. The 22 βαβββ-module proteins from P. aeru-
ginosa are distinguished in metal-binding (class I), aromatic compound-binding (class II) and 
functionally uncharacterized proteins (class III) (Vit, 2015). Since aromatic compound-binding 
proteins mediate resistance against small aromatic compounds, such as the self-produced 
pyocyanin (Kalawy-Fansa, 2010; Vit, 2015; Yu, 2009) and most of the metal-binding repre-
sentatives mediate resistance towards extrinsic antibiotics such as fosfomycin (Bernat et al., 
1997), class III proteins are also assumed to participate in resistance mechanisms.  
Therefore, the structural and functional characterization of the class III βαβββ-module-con-
taining proteins PA1358, PA1672, PA2721, PA4183 and PA4518 was in the focus of this study. 
The physiological and molecular functions of class III βαβββ-module proteins were supposed 
to by characterized. The physiological roles were investigated using comparative microbio-
logical assays with P. aeruginosa wild type strains and transposon insertion mutants of the 
respective genes to identify conditions that caused altered phenotypes in the mutants. For 
this, the bacteria were exposed to distinct antibiotics, incubated on different carbon sources 
and they were grown on solid and liquid media. Besides, the genomic background of class III 
genes was investigated to find further evidence towards a potential function of proteins that 
are encoded in the same operon as the class III βαβββ-module-containing proteins. Detailed 
information on molecular level were gained with biophysical methods and protein X-ray crys-
tallography using the recombinant proteins.  
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3 Materials and Methods 
3.1 Materials 
 Chemicals, media, buffer and solutions 
All chemicals were purchased from Acros Organics (Geel, Belgium), Alfa Aeser (Haverhill, Mas-
sachusetts (MA), USA), AppliChem GmbH (Darmstadt, Germany), Becton Dickinson and Com-
pany (Franklin Lakes, New Jersey, USA), Biolog (Hayward, CA, USA), Carl Roth GmbH & Co. 
(Karlsruhe, Germany), Cayman Chemicals (Ann Arbor, Michigan, USA), Merck KGaA (Darm-
stadt, Germany), MP Biomedicals, LLC (Santa Ana, California, USA), Thermo Fisher Scientific 
(Waltham, MA, USA) and Sigma-Aldrich (St. Louis, Missouri, USA). The QIAquick® PCR Purifi-
cation and Gel Extraction Kit as well as the QIAprep® Spin Miniprep Kit were purchased from 
Qiagen (Hilden, Germany).  
Media, buffers and buffer stock solutions were prepared in MilliQ®-H2O. Buffers and stock-
solutions were sterilized by filtration, while media were autoclaved. Buffers for protein puri-
fication and ITC experiments were also degassed. Antibiotic stock solutions were dissolved in 
MilliQ®-H2O (ampicillin, gentamicin) or 70 % Ethanol (chloramphenicol, tetracycline). Final 
antibiotic concentrations were 100 µg/ml ampicillin (Amp) and 34 µg/ml chloramphenicol 
(Cm) for E. coli strains, 20 µg/ml Amp for P. aeruginosa PA14 and PAO1 wild type strains and 
20 µg/ml gentamicin (Gm) or 60 µg/ml tetracycline (Tet) for P. aeruginosa transposon mu-
tants. 50 µg/ml Gm were used for PA14 wt strains transformed with pHERD30T plasmids.  
Media 
Lysogeny broth (LB)  10 g/l tryptone, 7 g/l NaCl 5 g/l yeast extract 
LB agar  10 g/l tryptone, 7 g/l NaCl, 5 g/l yeast extract, 15 g/l agar 
Terrific broth (TB)  12 g/l tryptone, 24 g/l yeast extract, 4 % (v/v) glycerol, 
17 mM KH2PO4, 72 mM K2HPO4 
Super optimal broth with 20 g/l trypton, 5 g/l yeast extract, 10 mM NaCl, 2.5 mM KCl,  
catabolite repression (SOC) 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose   
M9-medium 6 g/l Na2HPO4, 3 g/l KH2PO4, 0.5 g/l NaCl, 1 g/l NH4Cl, 1 mM 
MgSO4, 0.1 mM CaCl2, 0.4 % (w/v) glucose 
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Swarming agar 0.5 % (w/v) agar, 6 g/l Na2HPO4, 3 g/l KH2PO4, 0.5 g/l NaCl, 2 mM 
MgSO4, 0.2% (w/v) glucose, 0.5 % (w/v) casamino acids 
Swimming agar 0.3 % (w/v) agar, 6 g/l Na2HPO4, 3 g/l KH2PO4, 0.5 g/l NaCl, 1 mM 
MgSO4, 0.2% (w/v) glucose, 0.5 % (w/v) casamino acids 
Buffers for protein purification 
Buffer A   50 mM Na2HPO4/NaH2PO4 pH 8.0, 300 mM NaCl  
Buffer B   Buffer A with 500 mM imidazole, pH 8.0  
Protease cleavage buffer 20 mM Tris/HCl pH 8.0, 150 ml NaCl, 4 mM β-mercaptoethanol 
(BME) or 2 mM dithiothreitol (DTT) 
SEC buffer   20 mM Tris/HCl pH 8.0, 150 ml NaCl 
Low salt buffer  20 mM Tris/HCl pH 8.0, 20 mM NaCl 
High salt buffer  20 mM Tris/HCl pH 8.0, 1 M NaCl 
Solutions for Phenotype MicroArraysTM  
IF-0a GN/GP Base inoculating fluid (1.2x)  Biolog, Inc., Hayward, California, USA 
IF-10a GN Base inoculating fluid (1.2x)  Biolog, Inc., Hayward, CA, USA 
Biolog Redox Dye mix A (100x)   Biolog, Inc., Hayward, CA, USA 
Other solutions 
TAE buffer (1x)  40 mM Tris pH 8.0, 20 mM acetic acid, 1 mM EDTA  
0.8 % (w/v) agarose gel 0.8 g agarose in 100 ml 1xTAE buffer, 5 µl Roti®-GelStain (Carl 
Roth, Karlsruhe, Germany) 
DNA gel loading dye (6x)  30% (v/v) glycerol, 0.25% (w/v) bromophenol blue 
DNA ladder GeneRuler DNA Ladder Mix, #SM0333 (Thermo Fisher Scien-
tific, Waltham, MA, USA) 
Amino acid mix   0.1 g/l Lys, Phe, Thr, 0.05 g/l Ile, Leu, Val 
Stacking gel buffer (4x) 0.5 M Tris/HCl pH 6.8, 0.4 % (w/v) SDS 
Stacking gel (5 %)  1x stacking gel buffer, 5 % (w/v) acrylamide (stock: 30 % (w/v) 
    37.5:1), 0.1 % (w/v) ammonium persulfate (APS), 0.001 % (v/v) 
    tetramethylethylenediamine (TEMED) 
Resolving gel buffer (4x) 1.5 M Tris/HCl pH 8.8, 0.4 % (w/v) SDS 
Resolving gel (15 %)  1x resolving gel buffer, 15 % (w/v) acrylamide (stock: 30 % (w/v) 
    37.5:1), 0.1 % (w/v) APS, 0.001 % (v/v) TEMED  
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Resolving gel (18 %)  1x resolving gel buffer, 18 % (w/v) acrylamide (stock: 30 % (w/v) 
    37.5:1), 0.1 % (w/v) APS, 0.001 % (v/v) TEMED 
SDS-loading buffer (5x) 50 mM Tris/HCl pH 6.8, 500 mM BME, 50 % (v/v) glycerol, 10 % 
    (w/v) SDS, 0.05 % (w/v) bromophenol blue  
Protein standard PageRulerTM Plus Prestained Protein Ladder, #26620 (Thermo 
Fisher Scientific, Waltham, MA, USA) 
SDS-running buffer (10x) Rotiphorese® 10x SDS-PAGE (Carl Roth, Karlsruhe, Germany) 
Staining Solution  InstantBlueTM Protein Stain (expedeon, Cambridge, UK) 
 Enzymes 
All restriction endonucleases used in this study (NdeI, XhoI, BamHI, DpnI, NcoI, HindIII), 
Phusion® High-Fidelity DNA-Polymerase, T4 DNA Ligase and Antarctic Phosphatase were pur-
chased from New England Biolabs (NEB, Ipswich, MA, USA). KAPA HiFi polymerase was from 
Kapa Biosystems (Wilminton, MA, USA). Taq DNA polymerase was purchased as 2x VWR Red 
Taq DNA-polymerase Master Mix from VWR (VWR International, Haasrode, Belgium). Prote-
ases for the cleavage of purification-tags (Tobacco etch virus (TEV)- and SUMO-protease) 
were purified by Claudia Hanko, Petra Büssig, Tobias Bock, Ute Widow or Vanessa Hering. All 
proteases were expressed with at least a hexa-histidine tag (His6) and purified by Ni(II)-im-
mobilized metal ion affinity chromatography (Ni-IMAC) followed by size exclusion chroma-
tography (SEC).  
  Oligonucleotides, plasmids and bacterial strains 
Oligonucleotides for the amplification of open reading frames (ORF) of interest were designed 
using OligoCalc (Kibbe, 2007) and are displayed in Table 1. For this, DNA-sequences of P. ae-
ruginosa strain PAO1 were taken from the Pseudomonas Genome Database (Winsor et al., 
2016). Oligonucleotides for cloning were created with 5’ overhangs containing recognition 
sites for restriction endonucleases. Oligonucleotides were ordered from Eurofins MWG Op-
eron LLC (Ebersberg, Germany). 
Table 1: Oligonucleotides 
Oligonucleotide name# sequence 5’→ 3’ ¥ source 
1358_NdeI_s AAGACACATATGAGCGCACGCGTACGACC this study 
1358_XhoI_as ATATTCTCGAGTCAGGCCAGATTGAGCTGC this study 
1358_SLIC_NcoI_s AAGAAGGAGATATACATACCCATGAGCGCACGCGTACGACCC this study 
1358_SLIC_HindIII_as TAAAACGACGGCCAGTGCCAAGCTTTCAGGCCAGATTGAGCTGCCAGG this study 
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1359-CTD_NdeI_s AATGTCCATATGGCCACCGACCGCTCGC this study 
1359-CTD_XhoI_as ATATTCTCGAGCTAGCTCACCACGTTGCGG Vit, 2015 
1359_SLIC_ NcoI_s AAGAAGGAGATATACATACCCATGGAAGAGGTCCGGCAGTGGGAAG this study 
1359_SLIC_ HindIII_as TAAAACGACGGCCAGTGCCAAGCTTCTAGCTCACCACGTTGCGGGTG this study 
1672_NdeI_s AATGTCCATATGAACCTGATCGCGCACGTG Vit, 2015 
1672_XhoI_as ATATACTCGAGTCACGGCCGCTCTCCGCA Vit, 2015 
2721_NdeI_s AATGTCCATATGAACAGCAAGAACACCATC Vit, 2015 
2721_XhoI_as ATGTCCTCGAGTCATCAGCCCTTGAAG Vit, 2015 
2722_NdeI_s AATGTCCATATGGATCGATTCACCGGCG this study 
2722_XhoI_as ATAACACTCGAGTCACTCTTCGCTGCG this study 
2723_NdeI_s AATATACATATGGACGAACTGTTCGAAGAG this study 
2723_XhoI_as ATAACACTCGAGTCAGAGCAGTACGG this study 
#Oligonucleotide names contain the name of the respective restriction endonuclease in italics. ¥Recognition sites for the respective re-
striction endonucleases are underlined. 
The plasmids for recombinant protein expression in E. coli as well as for protein expression in 
P. aeruginosa that were used and generated in this study are listed in Table 2. The plasmids 
generated during this study were sequenced at Eurofins MWG Operon LLC (Ebersberg, Ger-
many) or at the Genome Analytics Facility (GMAK) of the HZI to verify the insertion of the 
correct DNA sequence in comparison to the sequence from the Pseudomonas Genome Data-
base (Winsor et al., 2016).  
Table 2: Plasmids¥  
plasmid description source 
pET19m Vector for expression of N-term. His6-tagged protein with TEV-
protease cleavage site 
MPI Dortmund 
pET-SUMO Vector for expression of N-term. His6-SUMO-tagged protein 
with SUMO-protease cleavage site 
MPI Dortmund 
pHERD30T E. coli/Pseudomonas shuttle vector for protein expression in    
P. aeruginosa 
Qiu et al., 2008 
pET19m_PA1358 pET19m containing full-length PA1358  Vit, 2015 
pET19m_PA1359 pET19m containing full-length PA1359  Vit, 2015 
pET19m_PA1359-CTD pET19m containing a PA1359 construct, coding for the C-ter-
minal domain (CTD, aa108-218) of PA1359  
this study 
pET19m_PA2721 pET19m containing full-length PA2721  this study 
pET19m_PA2722 pET19m containing full-length PA2722  this study 
pET19m_PA2723 pET19m containing full-length PA2723  this study 
pET19m_PA4183 16-155 pET19m containing a PA4183 construct, coding for N-term. 
truncated (aa 16-155) PA4183 
Vit, 2015 
pET19m_PA4518 pET19m containing full-length PA4518 Vit, 2015 
pET-SUMO_PA1358 pET-SUMO containing full-length PA1358  this study 
pET-SUMO_PA1672 pET-SUMO containing full-length PA1672 this study 
pHERD30T_PA1358 pHERD30T containing the full-length PA1358 this study 
pHERD30T_PA1359 pHERD30T containing the full-length PA1359 this study 
¥ pET19m and pETSUMO are vectors for IPTG inducible protein expression in E. coli with Ampr, pHERD30T is a vector for 
arabinose inducible protein expression in P. aeruginosa with Gmr. 
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E. coli strains (Table 3) were used for plasmid amplification and recombinant protein expres-
sion. P. aeruginosa PA14 transposon insertion mutants from the non-redundant mutant li-
brary (Liberati et al., 2006) or PAO1 transposon mutants from the two-allele library (Held et 
al., 2012) were used for microbiological experiments (Table 3). The bacteria were stored at     
-80 °C in 20 % (v/v) glycerol. To confirm the presence of the transposon insertions, the re-
spective gene was amplified by PCR (3.2.1.2) and the PCR product was sequenced at Eurofins 
MWG Operon LLC (Ebersberg, Germany).    
Table 3: Bacterial strains 
Strain Genotype or description† source 
E. coli   
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 
(rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
Invitrogen 
Top10 F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara leu) 7697 galU galK rpsL (Strr) endA1 nupG 
Invitrogen 
XL1blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB 
lacIq Z∆M15 Tn10 (Tetr)] 
Stratagene 
OmniMAXTM 2 F´ [proAB lacIq lacZΔM15 Tn10 (Tetr) Δ(ccdAB)] mcrA Δ(mrr- 
hsdRMS-mcrBC) Φ80(lacZ)ΔM15 Δ(lacZYA-argF)U169 endA1 
recA1 supE44 thi-1 gyrA96 relA1 tonA panD 
Invitrogen 
BL21(DE3) F– ompT hsdSB(rB- mB-) gal dcm (DE3) Novagen 
Rosetta (DE3) pLysS F– ompT hsdSB(rB- mB-) gal dcm (DE3) pLysSRARE (Cmr) Novagen 
Rosetta2 (DE3) F– ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE2 (Cmr) Novagen 
P. aeruginosa*   
PAO1 wt wild type  
PAO1 PA1359::Tn PA1359::ISphoA/hah; Tetr, PAO1 transposon mutant 41250 Held et al., 2012 
PAO1 PA2721::Tn PA2721::ISlacZ/hah; Tetr, PAO1 transposon mutant 21211 Held et al., 2012 
PAO1 flgK::Tn flgK::ISlacZ/hah; Tetr, PAO1 transposon mutant 17288 Held et al., 2012 
PA14 wt wild type Liberati et al., 2006 
PA14 PA1358::Tn PA14_46720::MAR2xT7; Gmr, PA14 transposon mutant 43400# Liberati et al., 2006 
PA14 PA1672::Tn PA14_42870::MAR2xT7; Gmr, PA14 transposon mutant 27951 Liberati et al., 2006 
PA14 PA4183::Tn PA14_09780::MAR2xT7; Gmr,PA14 transposon mutant 36793 Liberati et al., 2006 
PA14 PA4518::Tn PA14_58620::MAR2xT7; Gmr, PA14 transposon mutant 31441 Liberati et al., 2006 
PA14 flgK::Tn  flgK::MAR2xT7; Gmr, PA14 transposon mutant 56704 Liberati et al., 2006 
PA14 rhlR::Tn rhlR::MAR2xT7; Gmr,PA14 transposon mutant 37943 Liberati et al., 2006 
PA14 wt pHERD30T PA14 wt transformed with the empty pHERD30T vector, Gmr this study 
PA14 wt 
pHERD30T_PA1358 
PA14 wt transformed with the pHERD30T plasmid containing 
the ORF of PA1358, Gmr 
this study 
PA14 wt 
pHERD30T_PA1359 
PA14 wt transformed with the pHERD30T plasmid containing 
the ORF of PA1358, Gmr 
this study 
†Antibiotic resistance genes are highlighted in bold (Str: streptomycin, Cm: chloramphenicol, Tet: tetracycline, Gm: gen-
tamicin). * P. aeruginosa strains were provided by the collaborator S. Häußler (HZI). ¥PAO1 transposon mutants are num-
bered according to the two-allele library (Held et al., 2012). #PA14 transposon mutants are numbered according to the 
non-redundant mutant library (Liberati et al., 2006). 
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 Chromatography columns 
HisTrapTM HP 5 ml      GE Healthcare, Munich, Germany 
HiTrapTM Q HP 5 ml     GE Healthcare, Munich, Germany 
HiLoadTM 75 16/600 SuperdexTM prep grade (pg) GE Healthcare, Munich, Germany 
HiLoadTM 75 26/600 SuperdexTM pg   GE Healthcare, Munich, Germany 
SuperdexTM 75 10/300 GL    GE Healthcare, Munich, Germany 
 Screens and Phenotype MicroArraysTM (PM) 
The Phenotype MicroArraysTM (PM) PM1 and PM2 MicroPlateTM for screening carbon sources 
and the plates for testing chemical sensitivity PM11C, PM12B, PM13B, PM14A, PM15B, 
PM16A, PM17A, PM18C, PM19 and PM20B were purchased from Biolog, Inc. (Hayward, CA, 
USA). The Helmholtz-Zentrum Berlin (HZB, Berlin, Germany) provided the HZB immobilized 
fragment-screen version 2. Crystallization screens were purchased from Hampton Research 
(Aliso Viejo, CA, USA), Molecular Dimensions (Newmarket, Suffolk, UK) and Qiagen (Hilden, 
Germany). Silver BulletsTM and Silver Bullets BioTM additive screens are from Hampton Re-
search. 
3.2 Methods 
 Molecular biology 
3.2.1.1 Isolation of genomic P. aeruginosa DNA 
The genomic DNA (gDNA) from P. aeruginosa strain PAO1 for cloning was isolated by A. Vit 
(Vit, 2015). The gDNA from P. aeruginosa PAO1 and PA14 transposon insertion mutants for 
verifying the transposon insertion was either isolated by chloroform/phenol extraction as de-
scribed in Vit, 2015 or by the protocol “Procedure for sequencing the transposon insertion 
site” (Filloux and Ramos, 2014).  
3.2.1.2 Polymerase chain reaction (PCR) 
Polymerase chain reactions (PCR) were performed to amplify the DNA sequences of the genes 
of interest (GOI). gDNA from P. aeruginosa (Table 3) or plasmid DNA (Table 2) served as DNA 
templates. For colony PCR (cPCR) single bacterial colonies were suspended in 5 µl ddH2O and 
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1 µl of the cell suspension was used as template in PCR reactions with a total volume of 50 µl. 
The Phusion polymerase was used for DNA amplification and the Taq polymerase Master Mix 
(MM) was used for cPCR. The Taq polymerase MM and the KAPAHiFi were used to verify the 
transposon insertions. PCR reactions were prepared as described in Table 4. The optimal an-
nealing temperature for the KAPAHiFi polymerase was determined by gradient PCR. PCR cy-
cling programs were performed as described in Table 4.  
Table 4: Composition of PCR reactions and PCR cycling programs 
PCR reactions 
Component Phusion KAPAHiFi Taq Master Mix Final conc. 
Buffer 
Phusion GC (5x) 
10 µl 
KAPAHiFi GC (5x) 
10µl 
Taq Master Mix (2x) 
25 µl 
1x 
dNTPs (10 mM) 1 µl 0.75 µl included in MM 0.2 – 0.3 mM 
Primer fw (10 µM) 2.5 µl 0.75 µl 2.5 µl 0.3 - 0.5 µM 
Primer rv (10 µM) 2.5 µl 0.75 µl 2.5 µl 0.3 - 0.5 µM 
Template  
gDNA 
Plasmid  
50 – 250 ng 
1 pg – 10 ng 
10 – 100 ng 
0.1 – 1 ng 
10 – 500 ng 
0.1 – 1 ng 
As required 
DMSO (100 %) 2 µl 0-1 µl 1 µl 0-4 % 
Polymerase 0.5 µl 1 µl included in MM 1 – 5 U 
PCR grade H2O ad 50 µl ad 25 µl ad 50 µl  
PCR cycling programs 
Step Cycle 
Phusion KAPAHiFi Taq Master Mix 
T [°C] T [s] T [°C] T [s] T [°C] T [s] 
Initial denaturation 1 98 60 95 300 95 120 
Denaturation 
30 
98 20 98 20 95 20 
Annealing¥ Tm -5 20 Tm +/- 5 15 Tm -5 20 
Extension 72 30/kb 72 30/kb 72 60/kb 
Final extension 1 72 600 72 60/kb 72 600 
¥ Annealing temperatures for Phusion and Taq polymerase were set 5 K below the melting temperature (Tm) of the primer 
with the lower Tm. The most efficient annealing temperature for KAPAHiFi polymerase was determined with temperature 
gradient PCR. 
3.2.1.3 Agarose gel electrophoresis and DNA extraction 
Agarose gel electrophoresis was performed in agarose gels (0.8 % (w/v)) supplemented with 
Roti®-GelStain to visualize nucleotides under UV light. The PCR reactions were supplemented 
with DNA loading dye (6x), loaded on the gel and separated by size in comparison to the 
GeneRuler DNA Ladder Mix by applying a voltage of 80 V. The DNA fragments with the ex-
pected size were cut out under UV light and purified with the QIAquick® Gel Extraction Kit 
(Qiagen) according to the manufacturer’s manual.   
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3.2.1.4 Determination of nucleic acid concentrations 
Nucleic acid concentrations were determined with a NanoDrop2000 spectrophotometer 
(Thermo Scientific) by measuring the UV absorption at the maximum absorption wavelength 
of nucleic acids at 260 nm. An absorption value of 1 corresponds to a double stranded DNA 
(dsDNA) concentration of 50 µg/ml.  
3.2.1.5 Restriction digest of DNA and purification of linear DNA 
To generate single stranded 3’ overhangs in the PCR products and in the plasmid DNA, both 
were treated with specific restriction endonucleases (NEB, Table 1). PCR products for se-
quence and ligation independent cloning (SLIC, 3.2.1.7) were only digested with DpnI to re-
move the template DNA. Plasmids were simultaneously dephosphorylated at the 5’-DNA ends 
with Antarctic Phosphatase (NEB) to limit the probability for relegation. Double digestion re-
actions were prepared with plasmid DNA (> 1µg) and PCR product (500 - 600 ng). The reaction 
with the plasmid DNA contained the respective endonuclease (1 µl), Cut Smart buffer (10x, 
4 µl), Antarctic Phosphatase (1 µl, NEB) and Antarctic Phosphatase reaction buffer (10x, 4 µl). 
The total reaction volume (40 µl) was reached by adding ddH2O. The reaction with the PCR 
product contained Cut Smart buffer (10x, 4 µl) and the respective endonucleases (1 µl). The 
reactions were incubated at 37 °C for 30 min, followed by heat inactivation of the enzymes 
at 65 °C for 20 min. The linear DNA was purified with the QIAquick PCR Purification Kit (Qi-
agen) according to the manufacturer’s manual.  
3.2.1.6 Ligation 
The ligation of PCR fragments with linearized plasmids was performed with T4 DNA Ligase. 
The reactions were prepared in a total volume of 10 µl by combining 6 µl of insert DNA, 2 µl 
of plasmid DNA, 1 µl of T4 DNA Ligase buffer (10x) and 1 µl T4 DNA Ligase. The reactions were 
incubated overnight at 16 °C followed by heat inactivation for 20 min at 65 °C and directly 
used for transformation of E. coli cells (4.2.1.7). 
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3.2.1.7 Sequence and ligation independent cloning (SLIC) 
SLIC (Li and Elledge, 2007) was performed to insert the PA1358 and PA1359 genes into the 
pHERD30T plasmid. The genes were amplified as described in section 3.2.1.2 with the respec-
tive SLIC primers (Table 1), digested and purified as described in section 3.2.1.5. The 
pHERD30T plasmid was linearized with HindIII and NcoI and purified as described in section 
3.2.1.5. SLIC was performed with the Quick-Fusion Cloning Kit (Biotool) according to the ven-
dor’s protocol. Afterwards the SLIC reaction was transformed into E. coli cells (4.2.1.7).  
3.2.1.8 Preparation of competent bacterial cells 
Ca2+-competent E. coli cells for heat shock transformation were produced by Claudia Hanko 
at the Helmholtz Centre for Infection Research. Electrocompetent P. aeruginosa PA14 cells 
were prepared according to the protocol “Gene Transfer: Transformation/Electroporation” 
(Filloux and Ramos, 2014). 
3.2.1.9 Transformation of competent bacterial cells  
Plasmids were transformed into competent bacterial cells (Table 3) for plasmid amplification 
or protein production. For heat shock transformation, up to 100 ng of DNA were mixed with 
50 µl of chemically competent E. coli cells and incubated on ice for 30 min. The heat shock 
was performed for 90 s at 42 °C. After 10 min incubation on ice, the cells were supplemented 
with 1 ml LB or SOC medium and incubated at 37 °C for 30 min. The cells were pelleted for 
1 min at 15700 g, plated on LB agar that was supplemented with appropriate antibiotics and 
incubated at 37 °C overnight. Electrocompetent P. aeruginosa cells were transformed by elec-
troporation as described in the protocol “Gene Transfer: Transformation/Electroporation” 
(Filloux & Ramos, 2014).  
 Protein expression 
3.2.2.1 Recombinant expression of target proteins 
Proteins were recombinantly expressed in different E. coli strains (Table 3/4). The cells were 
transformed with the expression plasmids (Table 5) and a single colony was used for inocula-
tion of LB media supplemented with the respective antibiotics. The cell density of bacterial 
liquid cultures was determined by measuring the absorption at a wavelength of 600 nm 
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(OD600). LB cultures were incubated for 16 h at 37 °C while shaking at 130 rpm. The 
precultures were used to inoculate fresh medium, supplemented with the respective antibi-
otics, to an OD600 of 0.05. After the main cultures were grown to an OD600 of 0.6 at 37 °C, the 
incubation temperature was reduced to 20 °C and the cells were supplemented with 0.5 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) to induce the expression of the target protein. 
After incubation of 16-18 h at 20 °C, the cells were harvested at 6774 g and 10 °C for 10 min. 
The cell pellet was either directly used for protein purification or shock frozen in liquid nitro-
gen (LN2) and stored at -80 °C until usage.  
                  Table 5: Recombinant protein expression conditions.  
Protein Plasmid Bacterial strain Medium# 
His6-SUMO-PA1358 pETSUMO_PA1358 Rosetta (DE3)pLysS TB 
His6-PA1359-CTD¥ pET19m_PA1359-CTD Rosetta 2(DE3) TB 
His6-SUMO-PA1672 pETSUMO_PA1672 Rosetta (DE3)pLysS TB 
His6-PA2721 pET19m_PA2721 Rosetta (DE3)pLysS TB 
His6-PA2722 pET19m_PA2722 Rosetta 2(DE3) TB 
His6-PA2723 pET19m_PA2723 BL21 (DE3) LB 
His6-PA418316-155 pET19m_PA418316-155 BL21 (DE3) TB 
¥CTD: C-terminal domain. #TB: terrific broth; LB: lysogeny broth. 
3.2.2.2  Expression of selenomethionine-labelled protein  
For experimental phasing of PA418316-155 the two MET residues of the protein were replaced 
with selenomethionine (SEM). The pET19m_PA418316-155 plasmid was transformed into 
BL21 (DE3) cells. A single colony of the transformed cells was used to inoculate 100 ml LB 
medium. The preculture was incubated overnight at 37 °C under vigorous shaking (130 rpm) 
before cells were harvested and resuspended in 100 ml prewarmed M9-minimal medium. 
The cells were incubated for 1 h at 37 °C under vigorous shaking, while M9-minimal medium 
for the main culture was prewarmed to 37 °C and aerated under vigorous shaking (130 rpm). 
The main culture was inoculated to an OD600 of 0.05 and grown at 37 °C until the OD600 
reached 0.5. Then the amino acid mix (0.1 g/l Lys, Phe, Thr, 0.05 g/l Ile, Leu, Val) was added 
to inhibit the natural methionine biosynthesis while the incubation temperature was lowered 
to 20 °C. After 30 min of further incubation, 60 mg/l L-selenomethionine and 0.5 mM IPTG 
were added to induce protein expression. After 16 h of incubation at 20 °C under vigorous 
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shaking (130 rpm), the cells were harvested at 6774 g and 10 °C for 10 min. The cell pellet 
was directly used for protein purification (3.2.3). 
 Protein purification 
All proteins in this study were purified at 4-10 °C using the ÄKTA purifier FPLC-system (GE 
Healthcare) for all chromatography steps described below. The untagged and unlabelled pro-
tein PA418316-155 was purified by Allegra Vit in a previous study (Vit, 2015). PA4518 used in 
this study was purified by Vanessa Hering according to the protocol described by Vit, 2015. 
The purification of PA1672 and PA2721 was described before (Nocek et al., 2006; Vit, 2015; 
Weber, 2011). Purification of the other proteins (PA2722, PA2723, PA1359-CTD) was de-
scribed first in this study.   
3.2.3.1 Cell disruption  
Bacterial cell pellets (3.2.2) were resuspended in buffer A containing BME (2 mM), MgSO4 
(2 mM), DNase (0.8 mg/l, Roche Life Science) and a cOmpleteTM mini EDTA-free protease in-
hibitor cocktail tablet (Roche Life Science). Cells were disrupted with an Emulsiflex-C3 homog-
enizer (Avestin) or by sonification (Bandelin Electronic™ SONOPLUS HD3200) at 4 °C and cen-
trifuged at 37000 g for 45 min at 4°C to remove insoluble cell debris, while the supernatant 
was used to isolate the target protein (3.2.3.2).  
3.2.3.2 Ni2+-immobilized metal ion affinity chromatography (Ni2+-IMAC) 
Since all proteins were expressed with a His6-tag, the first purification step was a Ni2+-IMAC. 
The supernatant of the cell lysate (3.2.3.1) was loaded onto a 5 ml HisTrapTM HP column (GE 
Healthcare Life Sciences) charged with Ni2+ to separate the tagged protein of interest (POI) 
from E. coli proteins. The column was washed with buffer A and 2 % of buffer B to elute un-
specifically bound proteins. The His6-tagged protein was eluted with an imidazole gradient 
from 2-50 % buffer B in 2 ml fractions. The total protein amount was monitored by recording 
the absorption at 280 nm (A280) to analyze the purification process. The protein-containing 
fractions were analyzed by SDS-PAGE (3.2.3.6). Fractions that contained the POI were united 
for dialysis and protease cleavage if required (3.2.3.3).  
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After protease cleavage, a second Ni2+-IMAC was performed to remove the His6-tag, the pro-
tease and undigested protein. The Ni2+-charged HisTrapTM HP column (GE Healthcare Life Sci-
ences) was equilibrated with SEC buffer before loading the protein sample. The protein was 
collected in 2 ml fractions and analyzed by SDS-PAGE (3.2.3.6). The fractions containing the 
isolated target protein were combined, concentrated by ultrafiltration with Vivaspin® centrif-
ugal concentrators (PES membrane with 3 or 10 kDa MWCO, Sartorius AG, Göttingen) and 
used for size exclusion chromatography (3.2.3.5). 
3.2.3.3 Dialysis and protease cleavage  
The combined fractions from the Ni2+-IMAC were dialyzed in SnakeSkinTM dialysis membrane 
with a 3.5 kDa cutoff (Thermo Scientific) to remove the imidazole. The dialysis was performed 
overnight at 4 °C under stirring conditions against a buffer volume that was 50x exceeding 
the volume in the dialysis membrane. Since the His6-tagged version of PA418316-155 was not 
pure after Ni2+-IMAC it was dialyzed against a low salt buffer to prepare it for anion exchange 
chromatography (AIEX, 3.2.3.4). The other proteins were dialyzed against SEC buffer. To re-
move the purification tags during dialysis, the POI was incubated with the respective protease 
and the buffer was supplemented with a reducing agent (Table 6). After dialysis the protein 
was further purified by AIEX (3.2.3.4), size exclusion chromatography (3.2.3.5) or a second 
Ni2+-IMAC (3.2.3.2).  
Table 6: Protease cleavage conditions of expressed proteins to yield the final protein after cleavage. ¥ 
Expressed           
protein 
MW          
[kDa] 
ε280            
[M-1 cm-1] 
Reducing 
agent 
Protease# Final protein 
MW 
[kDa] 
ε280             
[M-1 cm-1] 
His6-SUMO-
PA1358 
28.28 18450 1 mM DTT SUMO PA1358 14.84 15470 
His6-PA1359-
CTD 
14.44 27960 4 mM BME TEV PA1359-CTD 12.87 26470 
His6-SUMO-
PA1672 
26.89 7450 1 mM DTT SUMO PA1672 13.55 4470 
His6-PA2721 19.43 33460 2 mM DTT TEV PA2721 17.55 31970 
His6-PA2722 16.71 18450 4 mM BME TEV PA2722 14.84 16960 
His6-PA2723 12.41 12950 4 mM BME TEV PA2723 10.54 11460 
His6-PA418316-155 
MSE 
17.46 11460 4 mM BME TEV PA418316-155 MSE 15.58 9970 
His6-PA418316-155 17.46 11460 - - His6-PA418316-155 17.46 11460 
His6-PA4518 17.22 32430 4 mM BME TEV PA4518 15.35 30940 
¥The molecular weight (MW) and the extinction coefficient at A280 (ε280) were calculated with the ExPASy program Prot-
Param (Gasteiger et al., 2005). #Proteases were applied to the cleavage reaction in molar ratios of 1:100 protein to SUMO- 
and 1:25 protein to TEV-protease. 
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3.2.3.4 Ion exchange chromatography (IEX) 
Ion exchange chromatography (IEX) was performed to separate proteins by their total charge. 
This was required for His6-PA418316-155, as it was not pure after Ni2+-IMAC. The theoretical 
isoelectric point (pI) of His6-PA418316-155 is 5.8 according to ProtParam (Gasteiger et al., 2005), 
such that the protein is negatively charged at pH 8. Therefore, an anion exchange chroma-
tography (AIEX) was performed with a 5 ml HiTrapTM Q HP column (GE Healthcare, Munich). 
The protein in low salt buffer (3.2.3.3) was loaded on the column that was equilibrated with 
the same buffer. The column was washed with low salt buffer to remove unspecific proteins, 
before the target protein was eluted with a flat NaCl gradient by increasing the concentration 
of the high salt buffer (20 mM Tris/HCl pH 8, 1 M NaCl) from 0 to 50 %. The eluate was col-
lected in 2 ml fractions, while the elution of the protein was visualized by monitoring the 
change in A280. The protein-containing fractions were analyzed by SDS-PAGE (3.2.3.6) and 
pure target protein fractions were combined and concentrated by ultrafiltration with Vi-
vaspin® centrifugal concentrators (PES membrane with 3 or 10 kDa MWCO, Sartorius AG, 
Göttingen) for size exclusion chromatography (3.2.3.5). 
3.2.3.5 Preparative size exclusion chromatography 
The final purification step was size exclusion chromatography (SEC) to separate aggregates, 
oligomerization states and further impurities. Depending on the amount of protein, the pro-
tein solutions were either loaded onto a HiLoadTM 75 16/600 SuperdexTM pg or onto a Hi-
LoadTM 75 26/600 SuperdexTM pg (GE Healthcare, Munich) column equilibrated with the re-
spective SEC buffer (Table 7). The final purity of the protein fractions (1-2 ml) was analyzed 
by SDS-PAGE (3.2.3.6). The pure and homogenous protein fractions were combined, concen-
trated by ultrafiltration with Vivaspin® centrifugal concentrators (PES membrane with 3 or 
10 kDa MWCO, Sartorius AG, Göttingen), flash frozen in LN2 and stored at -80 °C. A summary 
of the protein purification steps, storage buffers and the final yields is displayed in Table 7. 
The identity of the proteins was confirmed by mass spectrometry (MS) (3.2.4.6). 
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        Table 7: Protein purification summary. 
Final protein Purification steps# Storage buffer Yield¥ (mg/l) 
PA1358 1st Ni, 2nd Ni, SEC SEC 16 
PA1359-CTD 1st Ni, 2nd Ni, SEC SEC 24 
PA1672 1st Ni, 2nd Ni, SEC SEC 20 
PA2721 1st Ni, 2nd Ni, SEC SEC 21 
PA2722 1st Ni, 2nd Ni, SEC SEC 11 
PA2723 1st Ni, 2nd Ni, SEC SEC 8 
SEM-PA418316-155 1st Ni, 2nd Ni, SEC SEC, 2 mM DTT 19 
His6-PA418316-155 1st Ni, AIEX, SEC SEC 15 
#Ni: Ni2+-IMAC, SEC: size exclusion chromatography, AIEX: aion exchange chromatog-
raphy. ¥The yield refers to the amount of protein in mg after SEC that was purified from 
1 l of cell culture. 
3.2.3.6 SDS-PAGE 
SDS-PAGE was performed to identify and characterize the purity of the POI (Laemmli, 1970). 
Protein samples were mixed with SDS-loading buffer (5x), denatured for 5 min at 95 °C and 
electrophoretically separated by their size on polyacrylamide gels (stacking gel: 5 % acryla-
mide, resolving gel: 15 or 18 % acrylamide) in SDS running buffer (1x). Proteins were visual-
ized with InstantBlueTM protein staining solution (expedeon, Cambridge).  
3.2.3.7 Determination of protein concentrations 
Protein concentrations were determined at the NanoDropTM 2000 spectrophotometer 
(Thermo Scientific) by measuring the UV absorption at a wavelength of 280 nm (A280) based 
on Lambert-Beer’s law (1). Based on the protein sequence, the MW and ε280 (Table 6) were 
calculated with the ExPASy program ProtParam (Gasteiger et al., 2005). 
	  		 ∙ 			 ∙ 	 
																																																																															1	 
A280 – UV absorption at a wavelength of 280 nm, c – protein concentration (M), d – path length (cm), ε280 – ex-
tinction coefficient at A280 (M-1 cm-1) 
 Biochemical methods 
3.2.4.1 Dynamic light scattering (DLS) 
The oligomerization state of proteins was determined with dynamic light scattering (DLS) ex-
periments using a DynaPro Titan DLS device (Wyatt Technology Corp.). The solutions of 
PA2722 (1 mg/ml), PA2723 (1 mg/ml), PA418316-155 (2 mg/ml) and PA1359-CTD (2 mg/ml) in 
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SEC buffer were centrifuged at 17000 g at 4 °C for 15 min prior to the measurements. Inten-
sities of the scattered light were collected 100 times for 20 s at 25 °C. The DYNAMICS program 
(Wyatt Technology Corp.) calculated the MW of each protein.   
3.2.4.2 Analytical size exclusion chromatography 
Analytical SEC was used as another method to identify the oligomerization state of proteins. 
The MW of proteins can be derived from a calibration curve, which is obtained by plotting 
the partition coefficients (Kav) of known calibration standard proteins against the logarithm 
of their molecular weight. The Kav can be calculated after equation (2).  
 	  −	 −																																																																							2 
Kav –  partition coefficient, Ve – elution volume, V0 – void volume, Vc – column volume 
The SuperdexTM 75 10/300 GL column (Vc: 24 ml, GE Healthcare) was equilibrated with SEC 
buffer before the samples were loaded onto the column. The elution volume Ve of all proteins 
was determined at the peak absorption monitored at A280. The calibration standard from the 
LMW Gel Filtration Calibration Kit (GE Healthcare), which contained aprotinin, ribonucle-
ase A, carbonic anhydrase and conalbumin (100 µl 3 mg/ml each), was applied onto the col-
umn. The void volume V0 was determined with Blue Dextran 2000 (100 µl, 1 mg/ml). The Ve 
of PA2723 (100 µl, 300 µM) was determined to identify its oligomerization state. To identify 
a possible complex formation between PA1358 and PA1359-CTD, an equimolar mixture of 
both proteins (100 µl, 100:100 µM) was incubated for 10 min at RT and loaded onto the col-
umn. As reference, two independent runs with PA1358 and PA1359-CTD (100 µl, 100 µM) 
were performed.  
3.2.4.3 Thermal shift assay (TSA) 
Fluorescence-based thermal shift assays (TSA) were performed to characterize the melting 
temperature (Tm) of proteins. The technique was mainly applied to screen for molecules that 
cause a shift in thermal stability upon protein binding. The principle of TSA is based on a flu-
orescent SYPROTM Orange dye (Invitrogen) whose fluorescence is quenched in aqueous solu-
tions. Upon temperature dependent protein denaturation, hydrophobic patches of the pro-
tein core are exposed, generating a nonpolar environment in which the fluorescence of the 
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dye is enhanced. Therefore, the increase in fluorescence serves as measure for protein un-
folding. By plotting the fluorescence intensity against the temperature, a sigmoidal curve is 
obtained before the signal decreases again, caused by protein precipitation and aggregation 
(Figure 10 A). The Tm at the inflection point of this unfolding curve is defined as 50 % of dena-
tured protein. It can be calculated by fitting the non-linear part of the sigmoidal curve with 
the Boltzmann equation (Niesen et al., 2007; Huynh & Partch, 2015, Figure 10 A): 
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y – fluorescence intensity, x – temperature, a – slope, Imin and Imax – minimum and maximum fluorescence in-
tensity, Tm – melting temperature 
Alternatively the Tm can be derived from the minimum of the first derivative of the fluores-
cence emission as a function of the temperature (-dF/dT) (Niesen et al., 2007; Huynh & 
Partch, 2015) (Figure 10 B).   
 
Figure 10: Determination of the protein melting temperature (Tm) by a thermal shift assay (TSA). A) Fluorescence emission 
upon protein unfolding. Tm is determined at the inflection point of the unfolding transition by non-linear fitting (red line) of 
the sigmoidal part of the unfolding curve with the Boltzmann equation (3). B) Tm determination at the minimum of the first 
derivative of the fluorescence emission as a function of the temperature (-dF/dT) (Huynh & Partch, 2015).  
The assay was performed in a CFX96 real time PCR system connected to a C1000 thermal 
cycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The solutions were pipetted in a 96-
well PCR MultiplateTM (Bio-Rad) and sealed with optically clear sealing film (Bio-Rad). A tem-
perature was applied from 4 to 95 °C, with increments of 1 K, with 15 s hold at each temper-
ature, while the fluorescence signal was monitored (excitation: 492 nm, emission: 610 nm). 
Tm-values were calculated with the CFX ManagerTM 2.0 software (Bio-Rad). TSA to determine 
the thermal stability of proteins were set up with SYPROTM Orange (50x, 5 µl), the respective 
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protein (2 mg/ml, 5 µl) and SEC buffer (40 µl). The TSA compound screens were set up with 
SYPROTM Orange (50x, 5 µl), the respective protein (2 mg/ml, 5 µl), buffer (35 µl) and the re-
spective compound (Table 8, 5 µl). The measurement of chlorpromazine and promethazine 
with PA1672 was performed in 50 mM HEPES pH 7, 150 mM NaCl. All other experiments were 
conducted in SEC buffer. Control samples contained no ligands but the same buffer and DMSO 
concentration (Table 8). Three independent experiments were performed for each condition.  
Table 8: Final compound and DMSO concentrations in TSA compound screens.  
Compound 
c[compound] 
(µM) 
c[DMSO]            
(% (v/v)) 
Protein* 
2-nitroimidazole 130 1 PA1672 
2-phenylpenol 130 1 PA1358, PA1672, PA418316-155 
8-hydroxyquinoline 130 1 PA1672, PA2721 
Acetic acid 150 - PA1672 
Adenosine 150 - PA1672 
Azlocillin 130 - PA1358, PA1672, PA418316-155, PA4518 
Captan 100 2.5 PA2721 
CdCl2 130 - PA2721 
Cefsoludin 130 - PA1672 
Chlorodinitrobenzene 130 1 PA1672, PA2721, PA418316-155, PA4518 
Chloroxylenol 130 1 PA1358, PA1672, PA418316-155, PA4518 
Chlorpromazine 150 - PA1672 
CoCl2 130 - PA2721 
Dichlofluanid 100, 130, 130 2.5, 1, 1 PA2721, PA1672, PA4518 
Domiphen bromide 120 - PA2721 
Enoxacin 130 1 PA1358, PA1672, PA418316-155 
Gallic acid 120 1 PA2721 
Glycerol 150 - PA1672 
L-Arginine 150 - PA1672 
L-Aspartic acid 150 - PA1672 
Lauryl sulfobetaine 130 - PA1358, PA1672 
L-Lactic acid 150 - PA1672 
L-Valine 150 - PA1672 
Malonic acid 150 - PA1672 
Sodium caprylate 130 - PA1672 
Nafcillin 130 - PA1672, PA418316-155 
Oxacillin 130 - PA1358 
Patulin 120 1 PA2721 
Procaine 130 - PA1672 
Proflavin 130 - PA2721 
Promethazine 150 - PA1672 
Semicarbazide HCl 130 - PA1672, PA2721 
Succinic acid 150 - PA1672 
Sulfanilamide 130 1 PA1672 
Tobramycin 130 - PA1358, PA1672, PA418316-155, PA4518 
* Final protein concentrations: PA1358: 13.4 µM, PA1672: 14.8 µM, PA2721: 11.2 µM, PA418316-155: 12.8 µM 
PA4518: 13 µM  
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3.2.4.4 Microscale thermophoresis (MST) 
3.2.4.4.1 Principles of MST 
Thermophoresis describes the movement of particles in a temperature gradient. It is used to 
determine the interaction of molecules, because the movement in the temperature gradient 
is dependent on different properties of the molecules, such as the hydration shell, size or 
charge. These properties vary between the bound and the unbound state of a protein, which 
leads to an altered movement in the temperature gradient (Figure 11 B/C, Jerabek-Willemsen 
et al., 2014). Figure 11 A/B shows the experimental set up of a microscale thermophoresis 
(MST) experiment in which up to 16 capillaries are filled with a serial dilution of the ligand 
and a constant concentration of the labelled molecule. The fluorescence of the labelled mol-
ecule is detected, while an infrared (IR) laser induces a local temperature gradient. Changes 
in fluorescence are recorded as a measure of the molecule movement and plotted against 
the time (Figure 11 B). The thermophoresis of the fluorescent molecule changes upon ligand 
binding, which results in altered time traces. The experiment is evaluated by plotting the 
change in normalized fluorescence (ΔFnorm) against the ligand concentration. ΔFnorm is defined 
as 1000x Fcold/Fhot (Figure 11 C). Fcold is an average value of the initial fluorescence measured 
between defined areas. Fhot corresponds to an average value of the fluorescence after the 
steady state is established in the temperature gradient measured between defined areas. By 
plotting ΔFnorm against the ligand concentration a sigmoidal binding curve is obtained that can 
be fitted to derive the binding constant (KD) based on the law of mass action in equation (4) 
(Figure 11 D).  
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U – response value of the unbound state, B – response value of the bound state, cprot – concentration of the flu-
orescent molecule, clig – concentration of the titrated ligand, KD – dissociation constant 
 
Response curves for a cooperative binding event were fitted with the Hill-equation (5). The 
EC50 describes the effective ligand concentration that gives 50 % of the maximum response. 
The Hill coefficient depends on the steepness of the curve and is a measure for the coopera-
tivity.      
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U – response value of the unbound state, B – response value of the bound state, clig – concentration of the ti-
trated ligand 
 
 
Figure 11: Principles of MST. Figures A/B are reprinted from Alexander et al., 2014, Copyright (2014), with permission from 
Elsevier B.V. Figures C/D are reprinted from Jerabek-Willemsen et al., 2014. A) MST experimental set up. Capillaries are filled 
with a serial dilution of the potential binding partner and a fixed concentration of the fluorescent protein. The IR-laser cre-
ates a local temperature gradient. The movement of the fluorophore in the gradient is followed by measuring the emittance 
of the fluorophore after its excitation. B) The movement of the fluorescent molecule (yellow dots) is detected over time until 
a steady state is reached. C) Altered thermophoretic movement of molecules upon ligand binding. Fcold and Fhot correspond 
to the average values measured between the areas that are defined by the blue respective red lines. D) Response curve 
which can be fitted to obtain the KD- or EC50- value after equation 4 or 5. (Jerabek-Willemsen et al., 2011, 2014; Seidel et 
al., 2012). 
Initial fluorescence for KD determination 
Besides using thermophoresis as a measure for ligand binding, in some cases the initial fluo-
rescence signal can be used directly for KD determination. This is possible if the ligand specif-
ically quenches or enhances the signal of the fluorescent dye, which might be caused by 
changing the electrostatic surrounding of the dye (Jerabek-Willemsen et al., 2011). In this 
case the initial fluorescence signal can be plotted against the ligand concentration. The ob-
tained binding curve can be fitted with equation (4) for KD determination.    
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To make sure that the fluorescence change is caused by specific protein-ligand binding and 
not by an unspecific interaction between the dye and the protein or by a loss of the fluores-
cent molecule due to aggregation, a SDS denaturation (SD)-test has to be performed. In this 
test, the difference in fluorescence of the labelled molecule in bound form (with a high ligand 
concentration) and in unbound form (with a low or zero ligand concentration) is compared to 
the fluorescence of the denatured labelled molecule with a high and a low ligand concentra-
tion. If the change in fluorescence is caused by the binding event, the fluorescence intensities 
of the bound and unbound sample should be the same after the protein is denatured. If the 
change in fluorescence has other reasons, the difference in fluorescence intensity remains 
after denaturation. 
3.2.4.4.2 Experimental set up 
MST experiments were performed with a NanoTemper Monolith NT.115 (NanoTemper Tech-
nologies, Munich, Germany) at 20 °C using the standard glass capillaries and evaluated with 
the MO.Affinity Analysis software v2.15 (NanoTemper Technologies GmbH). Proteins with 
primary amines (PA1672, PA2721, PA2722 and PA4518) were labeled with AmershamTM-
CyTM5 Mono NHS Ester dye (GE Healthcare) according to the manual of the Monolith Protein 
Labeling Kit RED-NHS (NanoTemper Technologies GmbH). In the case of PA418316-155, the 
His6-tagged protein was labelled with the Monolith His-Tag Labeling Kit RED-tris-NTA (Nano-
Temper Technologies). 
MST screens were performed to identify possible binding partners. Two capillaries were filled 
with the same sample, containing the protein (Table 9) and a high concentration of ligand 
(>1 mM) to ensure that the protein is saturated in case of binding (bound state). Two other 
capillaries were filled with the protein in identical buffer but without the ligand as a reference 
(unbound state). ΔFnorm was measured and the amplitude between the reference (unbound 
state) and the sample containing the ligand (bound state) was determined (Figure 11 D). La-
belled PA1672 was excited with 20 % LED-power, while the other fluorescent molecules were 
excited with 30 % LED-power.  
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Table 9: Reaction conditions for screening of potential binding partners by MST. 
Ligands c[ligand] (mM) c[DMSO] (% (v/v)) 
PA1672   
100 nM NHS-labelled in SEC buffer, 0.5 mg/ml BSA 
nafcillin, azlocillin, procaine 4 - 
tobramycin, lauryl sulfobetaine 1 - 
dichlofluanid 1 25 
chloroxylenol 1.5 10 
8-hydroxyquinoline 1.7 10 
gallic acid 1 2.5 
PA2721  
100 nM NHS-labelled in SEC buffer, 0.5 mg/ml BSA  
patulin 4 10 
8-hydroxyquinoline 3.4 10 
gallic acid 1 2.5 
dichlofluanid, captan 1 25 
PA4518  
100 nM NHS-labelled in SEC buffer, 0.5 mg/ml BSA 
dichlofluanid 1 25 
His6-PA4183  
50 nM His-labelled in SEC buffer 
cholin, DMG, sarcosine, glyphosate, betaine aldehyde, 
GB, GLY, SER, pyruvate, tobramycin, nafcillin, azlocillin 
5 - 
Tetrahydrofolate (THF) 2.3 50 
enoxacin, chloroxylenol, chlorodinitrobenzene,                   
2-phenylphenol 
2.5 25 
Actual MST experiments were performed to determine the binding constant of potential lig-
ands. For this purpose, the ligands were titrated in 1:1 serial dilutions against the proteins 
(Table 10). Serial dilutions of ligands that were soluble in aqueous solutions were prepared 
with the respective buffers (Table 10). Other ligands were dissolved in 100 % (v/v) DMSO. 
Serial dilutions were prepared in 100 % (v/v) DMSO and then diluted in the respective reac-
tion buffers to reach the final concentrations given in Table 10. The mixtures were incubated 
for 10 min before they were transferred into the capillaries. All reactions were performed 
with 20 and 40 % MST power. LED power for fluorescence excitation was 20 % for labelled 
PA1672 and 30 % for the other proteins. 
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Table 10: Final conditions for MST experiments. 
Ligands c[ligand] (mM)* c[DMSO] (% (v/v)) 
PA1672  
100 nM NHS-labelled in SEC buffer, 0.5 mg/ml BSA 
nafcillin, procaine 1 - 
chloroxylenol 2 20 
8-hydroxyquinoline 1 10 
gallic acid 1 2.5 
PA2721  
100 nM NHS-labelled in SEC buffer, 0.5 mg/ml BSA 
patulin 4 10 
8-hydroxyquinoline 3.4 10 
gallic acid 1 2.5 
dichlofluanid, captan 1 25, 10 
CdCl3, CoCl2 1 - 
PA2721 
200 nM NHS-labelled in 50 mM Tris/HCl. pH 7.4, 150 mM NaCl, 0.5 mg/ml BSA 
N-benzyloxycarbonyl-L-proline  0.05 & 5 10 
PA2722  
250 nM NHS-labelled in SEC buffer, 0.05 % (v/v) Tween20  
GSH 2 - 
Formaldehyde 1 & 10 - 
PA4518  
100 nM NHS-labelled in SEC buffer, 0.5 mg/ml BSA 
dichlofluanid 1 25 
His6-PA4183  
50 nM His-labelled in SEC buffer 
cholin, glyphosate, GLY, SER, tobramycin 1 - 
sarcosine 1 & 25 - 
2-phenylphenol 1 10 
enoxacin 1 & 50 10 & 50 
*c[ligand] (mM): highest ligand concentration of the dilution series 
During MST-screening with chlorpromazine and promethazine, the fluorescence intensity of 
NHS-labelled PA1672 was significantly quenched. An SD-test was performed to find out if the 
quenching is specifically caused by the ligands binding to the protein. The labelled protein 
was mixed with 0, 1 and 20 mM of both compounds in HEPES pH 7, 150 mM NaCl, 0.5 mg/ml 
BSA. For each concentration, two independent mixtures were centrifuged for 10 min at 
17000 g to remove precipitated protein and mixed 1:1 with 2x SD-mix (4 % SDS, 40 mM DTT) 
and denatured at 95 °C for 5 min. The fluorescence signal was detected after excitation with 
40 % LED-power. The fluorescence signal was restored for the mixture containing 1 mM lig-
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and, the fluorescence difference persisted in the mixture containing 20 mM ligand. This indi-
cated that the fluorescence is specifically quenched upon ligand binding to the protein but 
only until a certain ligand concentration is exceeded. To identify the critical concentration at 
which promethazine and chlorpromazine start to interact unspecifically with the dye, a meas-
urement was conducted that contained 100 nM free dye titrated against both ligands in a 1:1 
dilution series with a highest concentration of 20 mM. For this, a buffer without BSA (125 mM 
HEPES, pH 7, 150 mM NaCl) was used to prevent the reaction of the free dye with the primary 
amines of BSA. For determining the binding constant of chlorpromazine and promethazine, 
three independent measurements were conducted. The ligands were titrated in a 1:1 dilution 
series (highest concentration: 20 mM) against 300 nM of the NHS-labelled PA1672 in 125 mM 
HEPES, pH 7, 150 mM NaCl, 0.5 mg/ml BSA. The fluorescence was excited with 40 % LED-
power at a temperature of 25 °C.  
3.2.4.5 Isothermal titration calorimetry (ITC) 
3.2.4.5.1 Principles of ITC 
Isothermal titration calorimetry (ITC) is a method to characterize interactions between mol-
ecules by detecting changes in enthalpy that occur during formation of complexes such as 
between two proteins or between small molecules and proteins. An ITC calorimeter contains 
a reference cell filled with water and the sample cell in an adiabatic jacket (Figure 12 A). The 
sample cell is filled with the macromolecule in the desired buffer, while its interaction partner 
(titrant) is filled in a syringe in the same buffer and titrated into the sample chamber under 
constant stirring. The reference and sample cells are connected to heaters that establish the 
desired reaction temperature. A sensor connecting both chambers detects if heat is gener-
ated (exothermal binding) or absorbed (endothermal binding) upon interaction of the titrant 
and the macromolecule. The heat change in the sample cell is compensated by the heaters 
through applying the necessary differential thermal power (DP in µcal/sec) until the temper-
ature balance is restored. The DP is measured throughout the titration experiment, in which 
the protein is increasingly saturated as the molar ratio between the protein and the titrant is 
gradually elevated. When the saturation increases, less binding events occur.  
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Therefore, the DP decreases until the protein is saturated (Figure 12 B). The DP is integrated 
and plotted against the molar ratio between the titrant and the protein (Figure 12 C), which 
gives a sigmoidal curve. The association constant Ka and the stoichiometry n can be derived 
from the inflection point of the curve and the enthalpy ΔH (kcal/mol) corresponds to the am-
plitude. The entropy ΔS (kcal/mol) can be calculated after equation (6).  
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ΔG – Gibbs free energy (kcal/mol), R – ideal gas constant (8.3144598 J/(mol∙K)), Ka – association constant, ΔH – 
enthalpy (kcal/mol), T – temperature (K), ΔS – entropy (kcal/mol) 
To derive reliable thermodynamic data from the ITC curve it is important to utilize appropri-
ate concentrations of the binding partners. They can be determined by calculating the C-value 
(equation (7)) that ideally ranges between 10 and 1000 (Buurma & Haq, 2007; Jelesarov & 
Bosshard, 1999).  
Figure 12: Principles of isothermal titration calorimetry (ITC). A) Schematic representation of an isothermal titration calo-
rimeter. It consists of an adiabatic jacket that encloses the reference cell, filled with water and the sample cell, filled with 
the macromolecule. A syringe is filled with the ligand and titrated to the sample under constant stirring. The heat change 
(ΔT) between sample and reference cell, upon a binding event is detected by a sensor. The sensor gives feedback to a heater 
that compensates the heat change by applying a certain differential power (DP). B) ITC raw data. The DP in µcal sec-1 that is 
necessary to keep the cells at equal temperatures is plotted over time. C) Evaluation of ITC data. The integral of the DP
(kcal/mole injectant) is plotted against the molar ratio of titrant and macromolecule. By fitting the experimental sigmoidal 
curve, the association constant Ka and the stoichiometry n can be derived from the inflection point and the enthalpy ΔH 
(kcal/mol) corresponds to the amplitude. B) and C) are reprinted from Buurma & Haq, 2007, Copyright (2007), with permis-
sion from Elsevier Inc. 
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cprot – protein concentration, KD – dissociation constant (Ka-1) 
3.2.4.5.2 Experimental set up 
ITC experiments were performed with a MicroCalTM VP-ITC System (GE Healthcare). Titration 
experiments were performed at 25 °C with a stirring speed of 307 rpm. An ITC experiment 
was conducted to verify a possible interaction of PA1358 with PA1359-CTD, which were both 
diluted in SEC buffer. PA1359-CTD was provided in the sample cell at a concentration of 
0.1 mM, while 1 mM of PA1358 was injected with a volume of 8 µl at 0.5 µl/s with spacing 
times of 240 s between injections. The reference power was 10 µCal/s.   
The interaction of PA1672 with promethazine and chlorpromazine was also analyzed with 
ITC. The sample cell was filled with 0.1 mM PA1672 in 50 mM HEPES pH 7, 150 mM NaCl. 
2 mM of each compound that was diluted in the identical buffer was injected with a volume 
of 4 µl at 0.5 µl/s with spacing times of 240 s. The reference power was 3 µCal/s. The buffer 
reference was measured by titrating the compounds with identical parameters, into the sam-
ple cell containing the protein-free buffer. ITC data were analyzed and plotted in Origin® v7.0 
(OriginLab, Northampton, MA, USA). 
3.2.4.6 Mass spectrometry (MS) analysis  
Mass spectrometry (MS) analysis was performed by the staff of the HZI mass analysis facility 
in the CPRO department. MALDI-TOF experiments of protein bands digested with trypsin, 
which were isolated from SDS gels after SDS-PAGE (3.2.3.6), were done to approve the iden-
tity of the POI. To analyze a potential covalent modification of PA2722 with glutathione, a 
MALDI analysis with the undigested protein was performed. For this, 10 µl of a 2 mM PA2722 
solution in SEC buffer were incubated with 4 mM GSH or GSSG for 30 min at room tempera-
ture. The sample was stored overnight in the fridge before the MS measurement was con-
ducted. A control sample that contained no ligands was treated equally.      
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 Microbiological methods 
Several microbiological assays were performed to identify the physiological function of the 
class III βαβββ-proteins. The phenotypes of P. aeruginosa strains with transposon insertions 
in the respective GOI were compared to the wild type (wt) reference strain (Table 3).   
3.2.5.1 Planktonic growth assays of P. aeruginosa 
For planktonic growth assays of the transposon mutants (Table 3) bacteria from glycerol 
stocks were streaked on LB agar plates supplemented with the respective antibiotics and 
were incubated overnight at 37 °C. LB media (5 ml) without antibiotics were inoculated and 
incubated at 37 °C for at least 18 h under vigorous shaking. Fresh LB medium (40 ml) was 
inoculated with the overnight culture to an OD600 of 0.05. The culture was incubated at 37 °C 
under vigorous shaking while the OD600 was measured regularly.  
The expression of PA1358 and PA1359 from pHERD30T plasmids in the PA14 wt background, 
together with an empty vector control, was performed with the respective PA14 strains, listed 
in Table 3. They were handled as described for the transposon mutants above but the LB 
medium (50 ml) for the main cultures was supplemented with gentamycin (50 mg/ml). After 
inoculation, the cultures were incubated for 180 min at 37 °C under vigorous shaking. After 
180 min they were split into subcultures (25 ml). Of each culture one subculture was induced 
with arabinose (0.1 % (w/v)) and one not. All subcultures were further incubated at 37 °C and 
the OD600 was measured regularly. 
3.2.5.2 Motility assays 
In plate-based assays, the swimming and swarming motility of PAO1 and PA14 transposon 
insertion mutants were compared with the behavior of the wt and swimming and swarming 
deficient negative control strains (Table 3). For both assays, the bacteria were streaked from 
glycerol stocks on LB agar supplied with appropriate antibiotics and incubated overnight. LB 
medium (5 ml) was inoculated with a single colony and grown overnight at 37°C under vigor-
ous shaking (200 rpm). The next day the overnight bacterial cultures were normalized to an 
OD600 of 1 by dilution with fresh LB medium and subsequently used for the inoculation of the 
swimming and swarming agar plates.  
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The swimming assay was performed as described in the protocol “Plate-Based Assay for 
Swimming Motility in Pseudomonas aeruginosa” (Filloux & Ramos, 2014). For this assay, the 
0.3 % agar swimming plates were dried under the clean bench for ~ 3h. The inoculated plates 
were incubated at 37°C for 19 h. The swarming assay was conducted on 0.5 % agar swarming 
plates according to the protocol “Plate-Based Assay for Swarming Motility in Pseudomonas 
aeruginosa” (Filloux & Ramos, 2014) apart from the following changes. After the plates were 
dried under the clean bench for 3-4 h, they were inoculated by pipetting 1 µl of the normal-
ized cell culture on the center of the plate. The plates were then incubated at 37°C for 18 h.   
3.2.5.3 Phenotype MicroArraysTM (PM) 
High-throughput phenotyping of P. aeruginosa transposon insertion mutants was performed 
with the commercially available OmniLog® Phenotype MicroArrayTM system (Biolog, Inc., Hay-
ward, CA, USA). It enables to simultaneously monitor and compare phenotypic changes be-
tween several strains that were cultured under different conditions. It provides preconfigured 
96-well microtiter plates that contain different compounds in dehydrated form. In this study, 
the PM plates PM1 and PM2 for measuring the respiration activity on different carbon 
sources and the PM11-20 plates for testing the sensitivity of cells towards different chemicals 
were used. A reporter system that is based on the redox properties of a tetrazolium dye was 
used to follow the phenotypic changes. If cell respiration is possible in a condition, NADH is 
produced. NADH induces the reduction of the tetrazolium salt to a purple formazan dye, 
whose absorption can be followed over time serving as a reporter for cell respiration 
(Bochner, 1989, 2009). 
Phenotypic changes were studied in P. aeruginosa strains carrying transposon insertions in 
the genes that are coding for class III βαβββ-module proteins PA1358, PA1672, PA2721, 
PA4183 and PA4518 (Table 3). For PA2721 the PAO1 mutant strain (PAO1 PA2721::Tn) was 
compared with the respective PAO1 wild type as a reference. For all others the PA14 mutants 
(PA14 PA1358::Tn, PA14 PA1672::Tn, PA14 PA4183::Tn, PA14 PA4518::Tn) were compared 
with the respective PA14 wild type reference. All strains were streaked from frozen glycerol 
stocks and grown overnight at 37°C on LB agar supplied with appropriate antibiotics. Single 
bacterial colonies were transferred onto antibiotic-free LB agar plates and grown overnight 
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at 37°C. Following the manufactures protocol “PM procedures for E. coli and other GN bacte-
ria” (Biolog, Inc., Hayward, CA, USA), all cells were suspended in IF-0a minima medium. The 
cell suspensions were either diluted with IF-0a medium supplemented with dye mix A (PM1 
and PM2 plates) or with IF-10a medium plus dye mix A (PM11-20 plates). Each well was inoc-
ulated with 100 µl of cell suspension. For achieving the highest possible comparability, same 
plate types were directly inoculated with cell suspensions of the different strains after each 
other. The PM plates were incubated in the OmniLog® at 37°C and increasing levels of purple 
dye were automatically monitored with the OmniLog® PM Software by measuring its absorb-
ance (490 nm) every 15 min over a period of 48 h. The phenomic data were extracted and 
plotted with the DuctApe software suite (Galardini et al., 2014)  by comparing the respiration 
curve of each mutant with the respective reference. Plates PM1 and PM2 each contained a 
negative control well. Their absorption was subtracted from the remaining 95 wells. The prep-
aration of cell suspensions and the OmniLog® PM measurements were carried out under as-
sistance of Elisabeth Majer in the department of Prof. Dr. Dietmar Schomburg, who granted 
access to the OmniLog® PM system at Braunschweig Integrated Centre of Systems Biology 
(BRICS).    
 Protein X-ray crystallography 
3.2.6.1 Principals of protein X-ray crystallography 
X-ray crystallography is a high-resolution technique that indirectly images protein structures 
at molecular level, which is crucial for understanding their function. To localize the positions 
of single atoms, distances of at least 0.15 nm (length of a C-C bond) have to be resolved. The 
optical resolution limit is dependent on the wavelength (λ) used for imaging objects. Two 
objects can only be distinguished as two separate objects if their distance is at least λ/2. Only 
the wavelength of X-rays is small enough (10 - 0.01 nm) to achieve this high resolution. The 
dependence on X-rays raises two major problems. First, lenses are not able to refocus the 
scattered rays to the image of the sample like in a microscope. The second problem is that 
only undetectable amounts of X-rays are scattered at a single protein, because X-rays are 
weakly interacting with organic materials. To circumvent the latter, protein crystals that are 
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constituted by many systematically ordered proteins are used. The X-rays are diffracted by 
the sum of electrons in the crystal delivering a detectable diffraction pattern if the waves 
positively interfere with each other. The distribution of the electrons can be recalculated from 
the diffraction pattern to create a model of the protein sample (Figure 13) (Rupp, 2009; 
Rhodes, 2006).  
 
Figure 13: Principles of protein X-ray crystallography. X-rays are scattered on the electrons of the proteins in a crystal.  Dif-
fracted X-rays that positively interfere with each other can be detected. The distribution of the electrons in three-dimen-
sional space can be recalculated from the diffraction pattern with a Fourier transform (FT) and used to create a model of the 
protein sample. The image is reproduced with permission from Biomolecular Crystallography by Bernhard Rupp, © 2009-
2014 Garland Science/Taylor & Francis LLC. 
3.2.6.1.1 Protein crystallization 
During protein crystallization the molecules from an aqueous solution assemble into a peri-
odically arranged crystal lattice, when the solution is brought into supersaturation. In this 
case the proteins undergo a phase transition that can be illustrated by a typical crystallization 
phase diagram, which is compartmentalized in four zones (Figure 14 A). In the unsaturated 
zone the protein is fully dissolved and will not crystalize. In the area of high supersaturation, 
precipitation occurs. Spontaneous nucleation will take place in the moderate supersaturation 
zone (nucleation zone). The formation of crystal nuclei is fundamental for crystal growth. The 
growth takes place in the metastable zone, an area of lower supersaturation, where crystals 
are stable. The transition from the nucleation to the metastable zone ideally happens as the 
protein concentration in the solution automatically drops during the assembly of the mole-
cules. To induce the transition from the undersaturated aqueous protein solution into satu-
ration, several methods have been implemented. Only the most widely used vapor diffusion 
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method (Figure 14 B) will be discussed. Here the protein solution is combined with a precipi-
tant solution, either as hanging or sitting drop and equilibrated against a reservoir that con-
tains a precipitant solution with a higher concentration than in the drop. In the sealed system 
vapor diffuses from the droplet to the reservoir to compensate the concentration gradient. 
This way, the concentration of protein and/or precipitants are increased, lowering the solu-
bility of the protein. This might eventually lead to a supersaturated state in the nucleation 
phase, which can continue in crystal growth until an equilibrium is established. (Chayen, 2004; 
Chayen & Saridakis, 2008) 
Unfortunately, it is unpredictable which precipitants lead to a successful crystallization pro-
cess, making the screening for the right conditions inevitable. Commercially available 96-well 
matrix screens that are constituted of different combinations of precipitants including salts, 
organic solvents, long-chain polymers or organic compounds allow a high-throughput screen-
ing to identify initial crystals. One important factor to increase the probability of crystal 
growth is a highly pure protein solution with a high concentration (  ̴ 20 mg/ml) but below the 
solubility limit. (McPherson & Gavira, 2013)        
 
Figure 14: Protein crystallization process. A) Schematic illustration of the protein crystallization phase diagram. Adjustable 
parameters are the precipitant or additive concentrations, pH and temperature. This diagram represents the path of four 
crystallization methods: microbatch (i), vapor diffusion (ii), dialysis (iii) and free interface diffusion (iv). Grey dots represent 
the initial condition. Reprinted from Chayen, 2004, Copyright (2004), with permission from Elsevier Ltd. B) Experimental set 
up of hanging and sitting drop vapor diffusion methods. Light blue dashed lines indicate water diffusion.  
46 | M a t e r i a l  a n d  M e t h o d s  
 
3.2.6.1.2 Diffraction 
The diffraction of X-rays results from the interaction of electromagnetic radiation with peri-
odically arranged molecules in the protein crystal. Protein crystals can be described as repet-
itive assemblies of small building blocks, the so-called unit cell. A unit cell contains the protein 
that is edged by the unit lattice, which is defined by three vectors a, b and c that come from 
a common origin 0 and the angles α, β and γ between them (Figure 15A).     
 
Figure 15: Principles of crystal assembly and X-ray diffraction. A) Description of a crystal by periodical arrangements of unit 
cells, which contain the protein motif and the unit lattice. B) Lattice planes that slice the unit lattice. They are described by 
the Miller indices hkl, which define in how many pieces the planes intersect the lattice planes. C) Geometrical construction 
of Bragg’s law. In Bragg’s law, the X-ray diffraction is treated as reflection from lattice planes. D) 2D representation of the 
Ewald construction. The green sphere is the crystal, which is the center of the Ewald Sphere with a radius of 1/λ. A detectable 
X-ray reflection (red arrows) occurs if a reciprocal lattice point lies on the Ewald sphere. The blue square is the beam stop 
and lies at the center of the reciprocal lattice. By rotating the protein crystal during the measurement, the reciprocal lattice 
is also rotated, and other lattice points hit the Ewald sphere resulting in other reflections. The figures are adapted and re-
produced with permission from Biomolecular Crystallography by Bernhard Rupp, © 2009-2014 Garland Science/Taylor & 
Francis LLC. 
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If the electromagnetic wave hits an atom, the interaction with the electrons deviates it. The 
scattering of the X-rays by the electrons results in detectable diffraction if the scattered rays 
sum up by positive interference. The requirements that have to be fulfilled for constructive 
interference can be described by the Bragg equation (8) and visualized by the geometric con-
struction in Figure 15 C. 
                                                        ?J	  	2 ∙ 	KL( ∙ MN?	O																																																														(8) 
n – integer, λ – wavelength, dhkl – distance between lattice planes, θ – scattering angle 
Here, X-ray diffraction is interpreted as a reflection from lattice planes. These planes period-
ically intersect the unit lattice. One set of perpendicular planes with equal spacing is described 
by the Miller indices hkl, which define in how many slices the unit cell vectors a, b and c are 
divided by the planes (Figure 15B). The distance of the planes is dhkl. Figure 15 C describes 
how electromagnetic waves with the same wavelength hit different planes, are scattered with 
the same angle θ but have to travel distinct distances. Only if this distance is a positive multi-
ple integer of λ, the X-rays constructively interfere and add up to a strong diffracted beam. 
Otherwise, they are destructively interfering and no or a weaker signal is detected. Besides, 
the intensity of the resulting reflection is always dependent on the amount of electron density 
that lies on a particular set of planes. To understand how a typical protein X-ray diffraction 
pattern (Figure 13) is obtained, one has to enter the mathematically constructed reciprocal 
space, which is inverse to the real space. In reciprocal space a reciprocal lattice exists, in which 
each lattice point h, k and l is defined by the lattice vector d*hkl. Bragg’s law can be rewritten 
and related to the reciprocal space after equation (9).   
PKL(∗  1PKL(	 
2 ∙ MN?O
J 																																																									9	 
d*hkl – lattice vector in reciprocal space, dhkl – real space interplanar spacing vector, θ – diffraction angle,            
λ – wavelength 
A condition that results in diffraction can be described with the Ewald construction (Figure 
15 D). Here, Bragg’s scattering diagram is overlaid with the Ewald sphere, which is drawn 
around the protein crystal with a radius of 1/λ, representing the X-rays in reciprocal space. 
The origin of the reciprocal lattice is where the incident X-ray beam travels through the crystal 
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and hits the Ewald sphere. Only where the reciprocal lattice points collide with the Ewald 
sphere, Bragg’s law is fulfilled and the constructive interference can be measured as a reflec-
tion point on an X-ray detector. The rotation of the crystal also leads to the rotation of the 
reciprocal lattice, which causes different lattice points to lie on the Ewald sphere. The position 
of each reflection in the reciprocal space can be assigned with the indices h, k and l from the 
origin (hkl = 000) of the centrosymmetric diffraction pattern. The central reflection is not 
measurable because it would be overlaid by the unscattered X-ray beam, which is shielded 
by the beam stop. The beam stop prevents that the beam hits the detector and is positioned 
behind the crystal. (Rhodes, 2006; Rupp, 2009) 
3.2.6.1.3 Fourier transformation and the phase problem 
Every spot on the diffraction pattern is caused by an electromagnetic wave that is the sum of 
scattering events from all electrons in the unit cell. Electromagnetic waves are periodic func-
tions that can be represented in the complex number plane as a vector with a real and an 
imaginary part (Figure 16 A). They can be described as in equation 10, using basic trigonom-
etry and Euler’s formula.  
T    N'  |T|VMW  NMN?W  |T| ∙ X                                     (10) 
F – electromagnetic wave vector, |F| – amplitude of the vector F, A – real part, iB – imaginary part B,                 
ϕ – phase angle 
In the complex number plane, the summation of waves can be described by vector addition 
(Figure 16 B) where the resulting wave F is the sum of all contributing waves as defined in 
equation 11 (Rupp, 2009).   
T Y|TZ| ∙ X[ 	

Z\]
																																																														11 
F – sum of n waves, |Fj| – amplitude of each partial wave Fj, ϕj – phase angle of partial wave j 
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Figure 16:  Representation (A) and addition of waves (B) in the complex number plane, which is spanned by the real part axis 
(re) and the imaginary part axis (i). A) The vector F is defined by its real part A = |F|cosϕ and the imaginary part B =|F|sinϕ. 
B) Vector addition of waves F1 and F2 results in the new wave F3, with the amplitude |F3| and phase angle ϕ3. The figures are 
adapted and reproduced with permission from Biomolecular Crystallography by Bernhard Rupp, © 2009-2014 Garland Sci-
ence/Taylor & Francis LLC. 
A reflection hkl on the diffraction pattern is the sum of scattered waves from the atoms in 
the crystal and can be described by a vector sum that is called the complex structure factor 
Fhkl (Equation (12)).  It is the Fourier transform of the electron density. Equation (12) describes 
the structure factor Fhkl that is proportional to the sum of diffraction contributions from all 
atoms j in the unit cell that contains a total of n atoms. In detail, it is the sum of all partial 
waves from each single atom at position (xyz) with each individual scattering factor fj. The 
scattering factor is a function that describes the atom as an electron density sphere and is 
different for each element depending on the element’s amount of electrons.   
TKL( Y%Z^0K[_L`[_(a[1

Z\]
																																																	12 
Fhkl – complex structure factor, n – number of atoms in the unit cell, fj – individual scattering factor of atom j 
For calculating the electron density ρ(xyz) from the diffraction pattern, an inverse Fourier 
transform is operated according to equation (13). It describes the electron density as a trans-
form of the structure factors Fhkl in the directions (hkl) for the whole volume of the unit cell. 
Here, the structure factor is expressed as a complex vector in Euler’s formula (14).    
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ρ(xyz) – electron density at position xyz, V – volume of the unit cell, |Fhkl|- amplitude of the complex structure 
factor, αhkl – phase angle of the complex structure factor, Fhkl – complex structure factor 
The structure factor amplitude |Fhkl| is proportional to the measured intensities Ihkl of the 
collected reflections hkl (Ihkl = |Fhkl|2). The amplitude can be determined from the diffraction 
experiment, but the information for the phase angle is lost. This results in the phase problem 
as the phase information is crucial for calculating the electron density (Rhodes, 2006). 
3.2.6.1.4 Solution of the phase problem using molecular replacement and anoma-
lous scattering atoms 
Several methods have been developed to overcome the phase problem and to calculate in-
terpretable electron density. Molecular replacement (MR) is a method that requires the de-
termined structure of a protein with a similar architecture (search model). The phases of the 
search model are used as initial estimates for the unknown phases of the target protein struc-
ture. For this, the search model has to be placed into the unit cell in the same location as the 
target protein. At first, a rotation search is performed to find the right orientation followed 
by a translational search to identify the correct position. The correct position is identified by 
calculating the search model’s structure factors at every position and by comparing their am-
plitudes with the actual amplitude derived from the diffraction experiment with the target 
protein. The search model is correctly positioned if the structure factors have the highest 
possible consistency so that the computed phases can be used to solve the phase problem 
and to calculate the initial electron density of the target protein.   
In cases where suitable MR search models are not available, the phases have to be deter-
mined experimentally. One method for experimental phasing is the heavy-atom method that 
uses the anomalous scattering properties of those atoms. This usually requires the introduc-
tion of heavy atoms into the protein crystal that have a higher atomic number regarding 
lighter elements like C, N or O. Heavy atoms can be introduced to the protein crystal by soak-
ing or by crystallizing proteins that have heavy atoms incorporated. One possibility here is to 
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use a protein that was produced with selenomethionine (MSE) substituting the naturally oc-
curring methionine (MET). In addition, intrinsic catalytically or structurally relevant ions like 
zinc or iron can be used. The single-wavelength anomalous diffraction (SAD) phasing method 
was the only heavy-atom method used in this study. SAD requires the collection of only one 
dataset of the heavy-atom containing protein crystal. The dataset is measured with X-rays 
that exhibit a wavelength at the characteristic absorption peak of the introduced heavy-atom 
(Figure 17A), which entails the breakdown of Friedel’s law.  
 
Figure 17: A) X-ray edge scan. f’’ schematically represents the structure of an experimental absorption edge. f’ is derived 
from f’’ by a mathematical transformation (Kramers-Kronig transform). SAD measurements are conducted at the absorption 
peak wavelength, where the signal of f’’ and thus the anomalous differences are maximal. B) Friedel pair in the complex 
number plane. Two centrosymmetrically related reflections at hkl and -h-k-l, have identical identities (|Fh|2=|F-h|2) but in-
verse phases ϕ. C) Breakdown of Friedel’s law through anomalous scattering. Friedel pairs have different intensities (FPA- ≠ 
FPA+), caused by a phase shift because of the anomalous scattering at heavy atoms. D) Harker construction for SAD phasing. 
Anomalous differences allow the identification of heavy-atom structure factors (FA+). Two possible phase angles (ϕp) for the 
protein are found at the intersection of circles with a radius that corresponds to the amplitudes of FPA+ und FPA- and originate 
at the respective vector origins. The figures are adapted and reproduced with permission from Biomolecular Crystallography 
by Bernhard Rupp, © 2009-2014 Garland Science/Taylor & Francis LLC. 
Friedel’s law is based on the centrosymmetry of the reciprocal space or the diffraction pattern 
and it states that two centrosymmetrically related reflections (Friedel’s pairs) have identical 
intensities but inverse phases (Figure 17 B). If the X-rays wavelength is near the absorption 
edge of the introduced heavy-atom, part of the scattering will have an anomalous phase shift 
of π/2 compared to the normal scattering events. This leads to the breakdown of Friedel’s 
law because it alters the intensities of otherwise corresponding Friedel’s pairs that now have 
different intensities (Figure 17 C). The anomalous differences allow the extraction of the 
heavy-atom contributions (Figure 17 D), which in turn enables the identification of the loca-
tion of the anomalous scattering atoms in the unit cell with the Patterson method. This 
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method is independent of the phase information and only requires the measured intensities 
to get initial phase information. Therefore, it enables the solution of the heavy-atom sub-
structure. This information can be used to calculate an initial electron density map of the 
whole protein (Rupp, 2009; Taylor, 2010; Terwilliger et al., 2016). 
3.2.6.2 Experimental set up 
3.2.6.2.1 Crystal screening and optimization 
The sitting drop vapor diffusion method was used with commercially available crystallization 
screens (3.1.5) to identify initial crystallization conditions. The solutions were dispensed at 
20 °C with a Honeybee (Zinsser Analytic) or at 4 °C with an OryxNano (Douglas Instruments) 
robot in 96-3 high profile Intelli-Plates® (Art Robins Instruments). The crystallization drops 
consisted of different concentrated protein solutions (0.2 µl) and reservoir solution (0.2 µl). 
The drops were equilibrated against 60 µl reservoir. All plates were sealed and incubated at 
20 °C in the automated Rock Imager system (Formulatrix).  
To improve the diffraction quality and the shape of initial crystals, the composition of crystal-
lization conditions regarding the pH and the concentration of the ingredients as well as the 
protein concentration were optimized in grid screens, using either sitting or hanging drop 
vapor diffusion method. The crystals were optimized in the sitting drop format as described 
for the initial screening. Here the Formulator liquid handler (Formulatrix) premixed the res-
ervoir solutions. The hanging drop vapor diffusion method was performed in 24-well grid 
screen format using 24-well VDXm™ plates (Hampton Research). The reservoir was filled with 
500 µl of reservoir solution. The reservoir solution (1 µl) was mixed with protein solution 
(1 µl) on a glass slide that was used to seal the reservoirs. These plates were also incubated 
at 20 °C but the drops were monitored manually under a microscope. A summary of the initial 
and final crystallization conditions, as well as the applied protein concentrations are listed in 
Table 11. Additive screens with Silver BulletsTM and Silver Bullets BioTM screen (Hampton Re-
search) were performed to improve the diffraction quality of PA2723 crystals. For this, the 
additive screen was added to the reservoir solution (0.3 M CaCl2, 19 % (w/v) PEG3350) in a 
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ratio of 1:10. This screen was set up in 96-3 high profile Intelli-Plates® (Art Robins Instru-
ments) using the Honeybee (Zinsser Analytic) robot that mixed the protein solution (0.2 µl) 
with the reservoir solution (0.2 µl). 
Table 11: Crystallization conditions.  
Protein 
Initial hit 
condition 
Method 
c[protein] 
(mg/ml) 
Final condition Cryo (% (v/v)) 
PA1359-CTD 
0.1 M Tris pH 8.5, 
8 % (w/v) 
PEG8000 
(JCSGII, A12) 
X 20 initial hit 
10 % 2R,3R-bu-
tanediol 
PA2721 
30 % PEG6000, 
0.1 M MES pH 5 
(JCSG IV, G6) 
96-well sit-
ung drop† 
20 
0.1 M MES pH 5.7,                        
28 % (w/v) PEG6000 
10 % 2R,3R-bu-
tanediol 
PA2722 
0.1 M MES pH 6.5, 
12 % (w/v) 
PEG20000 
(JCSGII, D11) 
24-well 
hanging 
drop 
20/15* 
0.1 M MES pH 6.3,                   
14 % (w/v) PEG20000 
20 % glycerol 
PA2723 
0.2 M CaCl2,          
20 % (w/v) 
PEG3350           
(PEG-I , E7) 
24-well 
hang-
ing/96-well 
sitting 
drop‡ 
1.5 
19% (w/v) PEG3350, 0.3 M CaCl2, 
0.2% (w/v) caffeine/cytosine/nico-
tinamide/gallic acid ∙ H2O/tetraso-
dium pyrophosphate ∙ 10H2O,                   
0.02 M HEPES pH 6.8 
20 % glycerol 
PA418316-155 
SEM 
1 M K/Na tartrate, 
0.2 M LiSO4, 0.1 M 
CHES pH 9.5           
(JCSG IV, A5) 
X 30 initial hit 20 % glycerol 
PA418316-155 x 
24-well 
hanging 
drop 
15 
0.7 M K/NA tartrate, 0.2M LiSO4,             
0.1 M CHES pH 9.6 
20 % glycerol 
*The crystal obtained in the initial screen used for Zn2+-phasing of PA2722 grew at 20 mg/ml, while the opti-
mized crystal grew at 15 mg/ml. †Dispensed with OryxNano (Douglas Instruments). ‡Dispensed with the Hon-
eybee (Zinsser Analytic). 
3.2.6.2.2 Cryoprotection of crystals  
The crystals were cryoprotected in the reservoir solution supplemented with a cryoprotect-
ant (Table 11). They were harvested with a nylon loop and subsequently flash cooled in LN2. 
3.2.6.2.3 Soaking and cocrystallization 
To obtain protein-ligand complex structures, the ligands were either soaked into crystals or 
cocrystallized with the protein. For soaking experiments, well-diffracting crystals were trans-
ferred with a nylon loop into a drop that consisted of 80 % (v/v) reservoir solution, 10 % (v/v) 
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cryoprotectant (2R,3R-butanediol) and 10 % (v/v) of the ligand (Table 12). For soaking crystals 
of PA2722 a soaking solution was prepared that contained the reservoir solution (0.1 M MES 
pH 6.5, 14 (w/v) PEG20000), 10 mM GSH and 20 % (v/v) glycerol. The crystals were soaked 
for several minutes to 24 h in hanging or sitting drop format equilibrated against 500 µl or 
60 µl of reservoir solution, respectively.  
Table 12: Soaking conditions. 
Crystal‡ Ligand∗ Condition Soaking time hit 
PA2721 (20, 25) in SEC 
buffer 
proflavine, CoCl2, CdCl2, (15) 
chlorodinitrobenzeneD (2.5) 
0.1 M MES pH 5.7, 
28 % (w/v) PEG6000 
24h no 
dichlofluanidD, captanD (1.5) 24 h yes 
PA2722 (15, 20) in SEC 
buffer 
GSH (10) 
0.1 M MES pH 6.5, 
14 % (w/v) 
PEG20000 
1, 4.5, 24 h no 
‡*Values in parentheses refer to the initial protein concentration in mg/ml (Crystal) or to the final ligand concen-
tration in mM (Ligand). DThe soaking condition for this compound additionally contained 10 % (v/v) DMSO. 
If soaking was not possible cocrystallization experiments were performed. For this, protein 
solutions were incubated with a 10-times higher concentration of the ligand for 10 min at RT 
before initial crystallization screens were carried out as described in 3.2.6.2. Crystals were 
harvested as described in 3.2.6.2.2. 
Table 13: Cocrystallization conditions. 
Protein‡ Ligands* Condition Cryo Hit 
PA1672 
(20 mg/ml) in 
50 mM HEPES pH 
7, 150 mM NaCl 
promethazine (15) No xtals in JCSG+, PACT, pH clear II, Morpheus® 
chlorpromazine (15) 
1 M LiCl2, 30 % (w/v) 
PEG6000, 0.1 M bicine 
pH 9 
10 % (v/v) 
2R,3R-butane-
diol 
No diffraction 
PA2722                  
(20 mg/ml) in SEC 
buffer 
GSH (5) 
0.2 M NaCl, 20 % (w/v) 
PEG8000, 0.1 M CAPS pH 
10.5 
20 % (v/v) glyc-
erol 
3.7 Å, no ligand 
GSH/GSSG (10/0.1) 
No xtals in JCSG I-IV, Morpheus®, IndexTM, ComPAS, MIDASTM, 
PGA-LMTM Screens 
‡Protein was mixed 1:1 with the crystallization condition. *Values in parentheses refer to the final ligand con-
centration in mM. 
3.2.6.2.4 Diffraction data collection 
All diffraction experiments were performed at 100 K. The diffraction of crystals was first ana-
lyzed at the home source, which is a MicroMaxTM 007 HF rotating Cu-anode X-ray (λ = 
1.54187 Å) generator (Rigaku, Tokyo, Japan) with a Saturn 944+ CCD detector (Rigaku, Tokyo, 
Japan). High resolution and SAD data were collected at synchrotrons as described in Table 14. 
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Table 14: Diffraction data collection.  
Protein Method Wavelength (Å) Synchrotron* Beamline Detector 
PA2723 high resolution 1.033 
PETRA III, DESY, 
Hamburg, Germany 
P11 Pilatus 6M 
PA2722 high resolution 
1 SLS, PSI, Villigen, 
Switzerland 
X06DA Pilatus 2M PA1359-CTD high resolution 
PA418316-155 SEM Se-SAD 0.97901 
PA418316-155 high resolution 0.91841 BESSYII, HZB, Berlin, 
Germany 
BL14.2 MarCCD 
PA2722 Zn-SAD 1.282416 BL14.1 Pilatus 6M 
*PETRA: Positron-Elektron-Tandem-Ring-Anlage. DESY: Deutsches Elektronen-Synchrotron. SLS: Swiss Light Source. PSI: 
Paul Scherrer Institut. BESSY: Berliner Elektronenspeicherring-Gesellschaft für Synchrotronstrahlung. HZB: Helmholtz-
Zentrum Berlin. 
3.2.6.2.5 Data processing and phasing 
All datasets were indexed and integrated with XDS (Kabsch, 2010) and scaled with Aimless 
(Evans & Murshudov, 2013) from the CCP4 program suite (Winn et al., 2011). The content of 
the asymmetric unit was estimated with the Matthews_Coef tool from the CCP4 suite (Winn 
et al., 2011). The SAD data for PA2722 and PA418316-155 SEM were used for experimental 
phasing with AutoSol from the PHENIX program suite (Adams et al., 2010). The program iden-
tified the sites of anomalous scatterers, carried out the phasing, density modification and 
built an initial model. The native high-resolution structures of PA2722 and PA418316-155 were 
phased by MR with Phaser from the PHENIX suite (Adams et al., 2010) using experimentally 
determined search models. PA1359-CTD was phased with the MR pipeline BALBES (Long et 
al., 2008) using the structure from PDB entry 1Y9Q (sequence identity 18.5 %) as a search 
model. PA2723 was phased ab initio with the program Arcimboldo LITE (Rodríguez et al., 
2009). Arcimboldo uses Phaser (McCoy et al., 2007) for a MR approach that places small struc-
ture fragments like α-helices. Based on a secondary structure prediction of PA2723 (Figure 
S6), Arcimboldo (Rodríguez et al., 2009) was advised to search for 3 helices. Second the main-
chain auto tracing program SHELXE (Thorn & Sheldrick, 2013) extended the successfully 
placed helices. That partial model of PA2723 was further extended by the AutoBuild program 
of the PHENIX suite (Adams et al., 2010).  
3.2.6.2.6 Structure refinement and analysis 
The initial structure models after phasing were improved by alternating cycles of manual re-
finement in COOT (Emsley et al., 2010) and automated refinement with phenix.refine (Adams 
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et al., 2010). Restraints for ligands were created with phenix.eLBOW (Moriarty et al., 2009). 
Figures of structure models were created with PyMOL (DeLano, 2002). Chemical structures 
of ligands were drawn with ChemDraw Professional 17.0 (PerkinElmer Informatics, Inc., Wal-
tham, MA, USA). Protein-ligand interactions were analyzed with Discovery Studio Visualizer 
v16.1. (Dassault Systèmes BIOVIA Corp, San Diego, CA, USA) or UCSF Chimera (Pettersen et 
al., 2004).  
3.2.6.2.7 Crystallographic fragment screening of PA2721 crystals 
Crystallographic fragment screening (FS) was performed with an updated version of the re-
cently published HZB 96-compound library (Huschmann et al., 2016) and optimized PA2721 
crystals that were obtained as described in 3.2.6.2. The fragment library was provided by the 
HZB in a 96-3 low profile Intelli-Plate® (Art Robins Instruments). The fragments were immo-
bilized in two wells per reservoir. The soaking solution was prepared by mixing the crystalli-
zation condition (0.1 M MES pH 5.7, 28 (w/v) % PEG6000) with 2R,3R-butanediol as cryopro-
tectant (10 % (v/v) final concentration) and DMSO (10 % (v/v) final concentration) to dissolve 
the fragments. The reservoirs were supplemented with 60 µl of soaking solution. To reach a 
final fragment concentration of 100 mM, 0.3 µl of the soaking solution were pipetted to each 
well. At least two optimized PA2721 crystals were transferred with a loop to each well and 
soaked for 24 h at 20 °C with the respective compound. Crystals soaked with fragments 100, 
121 and 123 did not diffract after 24 h. For those, diffracting crystals were obtained by reduc-
ing the soaking time to 1 h for fragment 100 and to 5 h for fragment 121 and by decreasing 
the concentration of fragment 123. The crystals were observed under the microscope during 
the soaking time to monitor possible changes in crystal shape. Crystals were harvested in 
nylon loops and flash frozen in LN2. Diffraction datasets were collected at the home source 
(3.2.6.2.4) or on beamline BL14.2 at BESSY II (λ=0.9184 Å, (Mueller et al., 2012, 2015). The 
data collected at BESSYII were processed with XDSAPPv2.99 or v2.0 GUI (Krug et al., 2012; 
Sparta et al., 2016) in space group P1 or P21. The phase problem was solved by MR with the 
published PA2721 model (PDB-ID: 1U69; Nocek et al., 2006) for one high resolution dataset 
in each space group. The respective structures were refined without waters (3.2.6.2.6) and 
used as search models for the automated HZB refinement pipeline. The pipeline performed 
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molecular replacement and refinement with PHENIX (Adams et al., 2010). The home source 
data were processed and phased as explained in 3.2.6.2.5. The resulting electron density 
maps were manually inspected in COOT (Emsley et al., 2010) to identify difference electron 
density caused by the presence of bound fragments. Hits were refined as described under 
3.2.6.2.6. 
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4 Results and Discussion  
4.1 Open reading frames PA2721 – PA2723 
The previously published crystal structure of class III βαβββ-module-containing protein PA2721 
builds a homodimer by edge-to-edge contacts (Bergdoll et al., 1998; Nocek et al., 2006). In 
contrast to all other known βαβββ-module-containing proteins, PA2721 has an additional 
three-helix bundle. The three helices close the characteristic U-shaped binding site to form a 
tunnel together with a flexible loop that is only visible in one monomer (Figure 18 A).  
 
Figure 18: A) Crystal structure of PA2721 (PDB-ID: 1U69, Nocek et al., 2006). Displayed is the homodimer with differently 
colored monomers in cartoon and surface representation. The black dots highlight the location of the potential binding tunnels. 
The amino acid side chains flanking one tunnel are shown in balls and sticks representation. The dashed lines indicate a flexible 
loop region. Members of the three-helix bundle are numbered according to their location on the peptide chain. B) Operon 
organization and genomic localization of open reading frames PA2721-PA2723 in PAO1 as derived from pseudomonas.com 
(Winsor et al., 2016). Genes colored in teal are part of one operon. The transposon insertion site (Tn) of the PAO1 PA2721::Tn 
mutant is indicated by a grey arrow. The position of the insertion in the ORF is given in units of bp. The total length of the gene 
is given in brackets. C/D) Magnification of the potential binding/active site in different orientations. The flanking amino acid 
side chains are represented as balls and sticks. Oxygen (O), nitrogen (N) and sulfur (S) atoms are colored in red, blue or yellow. 
Dashed lines represent H-bonds with a maximum distance of 3.2 Å. The surface of the potential binding tunnel is shown in light 
blue as visualized with Caver3.0 (Chovancova et al., 2012). 
A closer look at the amino acid side chains that point into the tunnel reveals many potential 
residues that might contribute to the function of PA2721 (Figure 18 B), such as the side chains 
of H35 and E53, which are in H-bonding distance to each other and belong to the amino acids 
that are most frequently found in catalytic centers of proteins (Bartlett et al., 2002). Both often 
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serve as acid-base catalysts and also participate in the stabilization of transition states or act as 
nucleophiles (Holliday et al., 2009). The two cysteine residues C8 and C105 might also be of 
functional importance, as their thiol side chains can also participate in general acid/base catal-
ysis but also in covalent catalysis by forming disulfide bridges (Bartlett et al., 2002; Holliday et 
al., 2009). C105 is of special interest as it is surrounded by M142 and M143. Though MET resi-
dues are not crucial in protein catalysis (Bartlett et al., 2002; Holliday et al., 2009), they can 
serve as antioxidants through forming methionine sulfoxide (Kim et al., 2014). This way, MET 
residues were shown to serve as endogenous protection of residues that are essential for ca-
talysis (Reddy et al., 1994; Levine et al., 1996; Kim et al., 2014). A comparable protective mech-
anism might be mediated by M142 and M143 to keep the potentially relevant C105 reduced 
and functional. The coordinates of the structure were input for the 3D search for protein sites 
(SPRITE) server. It scans the protein and compares its surface residues to a database of 3D side 
chain arrangements from sites and motifs with characterized function to identify conserved 
functionally relevant motifs independent of structure and sequence similarities (Nadzirin et al., 
2012). This search did not discover any relevant patterns in the potential binding tunnel so no 
hint towards a potential function of PA2721 was derived from the structure.  
The gene that codes for PA2721 is expressed in an operon with the downstream gene PA2722 
(Figure 18 C) according to a transcriptome analysis (Wurtzel et al., 2012). A protein sequence-
based BLAST (Altschul et al., 1997) and InterPro (Hunter et al., 2009) analysis predicted PA2722 
to be a Glutathione-dependent formaldehyde-activating enzyme/centromere V protein. A 
Phyre2-prediction modelled 81 % of the protein with a confidence of 99.9 % to a reliable struc-
ture with a glutathione-dependent formaldehyde-activating enzyme/centromere V protein 
fold. The template with the highest sequence coverage (80 %) was the crystal structure of the 
glutathione-dependent formaldehyde-activating enzyme (Gfa) from Paracoccus denitrificans 
(Pd. Gfa), which contains two zinc centers (PDB-ID: 1X6M, Neculai et al., 2005). As the cysteine 
residues that complex the zinc ions are conserved in PA2722 (Figure 32, lower panel), it was 
assumed that the target protein can also bind Zn2+-ions. To confirm the protein fold, the struc-
ture of PA2722 was determined and biochemical data were collected to find evidence for a Gfa-
like function. The adjacent gene PA2723 was also part of the investigations in this study. A ho-
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mology-based structure prediction with the Phyre2-server (Kelley et al., 2015) gave no reliable 
output as only 13% of the protein residues were modelled with 24 % confidence. Besides, a 
protein sequence-based BLAST analysis (Altschul et al., 1997) could not identify conserved do-
mains in PA2723 so the protein could not be assigned to a known protein family. Therefore, 
the focus for this was the identification of the structure with the intention to discover a new, 
previously undescribed protein fold.   
 PA2721 
4.1.1.1 Phenotyping of a PAO1 PA2721::Tn mutant 
The transposon insertion in the gene coding for PA2721 (PAO1 PA2721::Tn) was introduced by 
Held et al., 2012 and the respective strain was kindly provided by Prof. S. Häußler from the HZI. 
The insertion of the ISlacZ/hah transposon was confirmed by PCR and sequence analysis after 
bp 328 as stated by the manufacturer (Held et al., 2012) (Figure 18 C). To identify the physio-
logical relevance of PA2721 the phenotype of PAO1 PA2721::Tn was compared to the wt strain 
in motility and planktonic growth assays as well as under distinct growth conditions in Pheno-
typic MicroArraysTM. 
4.1.1.1.1 Motility and planktonic growth 
In addition to planktonic growth, motile bacteria like P. aeruginosa can migrate over different 
surfaces and colonize distinct environments. This enables them to colonize larger areas and 
invade host tissues to establish an infection (Gellatly & Hancock, 2013; Josenhans & Suerbaum, 
2002). Swimming motility is a flagellum-dependent movement of individual bacterial cells 
through liquid or low viscosity media. Swarming motility is a multicellular behavior on semisolid 
surfaces that also requires a functional flagellum but is also dependent on type IV pili and the 
secretion of surface-active agents (surfactants). Surfactants are amphiphilic wetting agents that 
are secreted by the bacteria to reduce the surface tension and facilitate the bacterial move-
ment (Kearns, 2010). The swimming and swarming motility assays conducted here revealed 
that the PAO1 PA2721::Tn mutant had no deficiencies in comparison to the wt, since both 
strains were able to migrate equally through a low viscosity swimming agar (Figure 19 B/D) or 
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over the semisolid swarming agar (Figure 19 C/E). Similar phenotypes were also discovered in 
planktonic growth assays (Figure 19 A).   
 
 
Those findings indicate that the PA2721 protein does not participate in the basic cellular func-
tions that are involved in these processes. Moreover, no morphological differences occurred. 
Colonies of the wt and the mutant exhibited the same shape on LB agar plates and developed 
comparable levels of green color when reaching high cell densities during solid and planktonic 
growth. Since the coloration of P. aeruginosa is caused by the production of the most abundant 
phenazines pyocyanin and pyoverdine (Pierson & Pierson, 2010), one can conclude that the 
disruption of the PA2721 gene does not interfere with the production and secretion of these 
secondary metabolites. 
4.1.1.1.2 Phenotype MicroArraysTM  
Phenotype MicroArraysTM (PM) were performed to monitor the phenotypic response of the 
mutants to distinct conditions and use differences to the wt as starting points for functional 
characterization. Instead of cell growth, the respiration rate of the cells is measured trough a 
Figure 19: Phenotypic characterization of a P. aeruginosa PAO1 PA2721 mutant (PAO1 PA2721::Tn) in comparison to the PAO1 
wt and a swimming deficient mutant (PAO1 flgK::Tn). A) Planktonic growth curves of the mutant and the wt. Displayed is the 
increase in optical density over time (t (min)) as measured from the cell cultures in regular intervals at 600 nm (OD600). The 
bacteria were incubated in LB-medium under shaking conditions at 37 °C. B/C) The diameter of swimming and swarming colo-
nies were determined from three independent experiments (Figure S2/S3), after incubation for 19 h (swimming) and 18 h 
(swarming) at 37 °C. Error bars represent the deviation calculated from the mean triplicates. D/E) Examples of the respective 
swimming and swarming colonies. 
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reporter system. This system is based on the reduction of a tetrazolium dye with NADH that is 
produced during cell metabolism. This creates a purple color which can be measured colori-
metrically (Bochner, 2009). Like growth curves, the respiration curves are sigmoidal with a lag 
phase in which the cell proteome is adopted to the growth conditions and an exponential phase 
until the stationary phase is reached. The respiration curves have no death or decline phase 
since the reduction of the dye is irreversible and remains even if the cellular metabolism 
stopped after the nutrient source is consumed (Bochner, 2009). Since the βαβββ-module pro-
teins were suspected to participate in resistance mechanisms, PMs were the method of choice 
for functional characterization as they enable the parallel high-throughput screening of 240 
compounds with antibacterial activity provided in four different concentrations. The participa-
tion of βαβββ-module proteins in carbon source metabolism was also tested by applying PMs 
with 190 different compounds as sole carbon source. The comparative analysis of PAO1 
PA2721::Tn with the PAO1 wt revealed coinciding respiration curves on most conditions (Figure 
S5). One significant change occurred when the dipeptide Gly-Pro served as the sole carbon 
source (Figure 20 A). In this case, the maximum respiration rate in the stationary phase of 
PA2721::Tn was reduced by approximately 50 %. Interestingly, no deficiency was detected if 
similar compounds, such as proline or hydroxyproline were available as sole carbon sources 
(Figure 20 B/C). 
 
Figure 20: Carbon source utilization Phenotype MicroArraysTM of PAO1 PA2721::Tn. A, B, C: Displayed are the respiration curves 
of PA2721::Tn (grey) in comparison to the PAO1 wt strain (black) for cells that were incubated on three proline derivatives that 
served as sole carbon sources in the Phenotype MicroArraysTM. The red color highlights the reduced phenotype of the mutant. 
The values in parentheses describe the number of the respective Phenotype MicroArrayTM and of the wells containing the 
compound. The respiration curves were obtained by plotting the measured absorbance in arbitrary units from 0-400 detected 
at 490 nm (y-axes) against the incubation time from 0-48 h (x-axes). To highlight the growth deficiency of the mutant, the area 
between the respiration curves was colored red D,E,F: Chemical structures of the proline derivatives were obtained from the 
PubChem database (Kim et al., 2016) and visualized with ChemDraw Professional 17.0.  
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This means that the mutant can generate energy from glycyl-l-proline but not as effective as 
from other proline derivatives. A possible explanation is that PA2721 directly participates in the 
catabolism of glycyl-L-proline in a pathway upstream of the catabolism of L-proline and hy-
droxyl-L-proline. It is also possible that PA2721 detoxifies compounds that emerge from the 
breakdown of glycyl-L-proline but not from the other derivatives, which is not possible in the 
mutant and kills the bacteria after accumulation of the toxic compound. Further studies are 
required to proof the intervention of PA2721 in the glycyl-L-proline metabolism.  
In the chemical sensitivity assays, several phenotypic changes occurred (Figure 21). Since the 
manufacturer of the PM plates does not provide the exact compound concentrations, the re-
sults were evaluated qualitatively. PAO1 PA2721::Tn was more susceptible to 13 compounds 
and more resistant to six. They mediate diverse antimicrobial effects by targeting distinct sites 
in the bacterial cell. The diversity of these compounds makes it very challenging to suggest a 
clear physiological role of PA2721 that could explain all the observed phenotypes. Nafcillin is 
for example a β-lactam antibiotic that inhibits the synthesis of the cell wall (Wright, 1999), while 
serine hyrdoxamate is a serine analogue that inhibits the seryl-tRNA synthase and thus protein 
synthesis (Tosa & Pizer, 1971b,a). Further, monothioglycerol inhibits bacterial growth by ac-
cepting the methyl group from the central methyl donor S-adenosyl methionine (SAM) and thus 
lowers its concentration and prevents crucial metabolic functions that require SAM (Javor, 
1983). Further, the heteroaromatic acridines, acriflavine, proflavine and 9-aminoacridine inter-
calate into DNA, interfere with DNA replication and lead to problems during reproduction. They 
also release ROS under UV light, which leads to increased oxidative stress in the cell (Gatasheh 
et al., 2017; Wainwright, 2001). The interpretation of the results towards a PA2721 function 
was further complicated by the fact that some compounds are supposed to target the same 
bacterial process induce contrary phenotypes, such as the detergent domiphen bromide and 
the polymyxin antibiotic colistin. Despite their distinct chemical structures (Figure 21), they are 
both amphiphilic compounds with positive charges and lipophilic moieties that act on the cell 
membranes. They cause the disruption of both membranes, leading to cell leakage and death 
(Biswas et al., 2012; McDonnell & Russell, 1999).  
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Other compounds that are active against the cell membrane of gram-negative bacteria and 
increase the permeability are poly-L-lysine (Hyldgaard et al., 2014) as well as the phenolic com-
pounds gallic acid (Borges et al., 2013) and 8-hydroxyquinoline (Prachayasittikul et al., 2013). 
Figure 21: Chemical sensitivity Phenotype MicroArraysTM of PA2721::Tn. Respiration curves of the wt (black) and the mutant 
(grey). They were incubated on four concentrations of antimicrobial compounds. Displayed are the results for compounds that 
induced significant changes between the respiration rate of the wt and the mutant. The values in parentheses describe the 
number of the respective Phenotype MicroArrayTM and of the wells containing the compound. The respiration curves were 
obtained by plotting the measured absorbance in arbitrary units from 0-400 detected at 490 nm (y-axes) against the incubation 
time from 0-48 h (x-axes). To highlight the differences, the area between the respiration curves was colored green if the mutant 
respired better than the wt or red if the respiration of the mutant was inhibited. The chemical structures were obtained from 
the PubChem database (Kim et al., 2016) and visualized with ChemDraw Professional 17.0. 
R e s u l t s  a n d  D i s c u s s i o n  |  65 
 
Phenolic compounds are known to induce several antimicrobial effects and can also inhibit cy-
toplasmic proteins and enzymes (McDonnell & Russell, 1999), which is also suspected for 8-
hydroxyquinoline and gallic acid. A large group of compounds that induced reduced pheno-
types (Figure 21) cause the increase of oxidative stress in bacteria. This group includes the toxic 
cations CdCl2 and CoCl2 (Blundell & Wild, 1969; Nies, 1999), patulin (Puel et al., 2010), chloro-
dinitrobenzene (Habig et al., 1974; Vuilleumier, 1997) and dichlofluanid (Schuphan et al., 1981). 
Dichlofluanid is a perhalogenmethylmercapto fungicide and is structurally and functionally re-
lated to captan (Schuphan et al., 1981), yet these two compounds induce contrary phenotypes 
(Figure 21). The increase of oxidative stress caused by the before mentioned compounds is 
based on their reactivity against sulfhydryl groups. They can react with GSH and lead to the 
depletion of the glutathione pool (Habig et al., 1974; Nies, 1999; Puel et al., 2010; Rahden-
Staroń et al., 1994; Schuphan et al., 1981; Vuilleumier, 1997). As GSH is an important compound 
during detoxification of ROS by what its depletion indirectly increases oxidative stress and 
might lead to cell death (Masip et al., 2006). Some of them are even able to covalently modify 
active site cysteine residues of enzymes (Puel et al., 2010) or replace catalytically active metals 
(Nies, 1999), which might inhibit important metabolic functions. Besides that, captan and di-
chlofluanid also exhibit a mutagenic effect in prokaryotes introducing severe DNA damage (Bar-
rueco and de la Peña, 1988; Rahden-Staroń et al., 1994). The complexity of these findings indi-
cates that further studies are required to make a statement about the intervention of PA2721 
in the detoxification of the identified compounds.  
4.1.1.2 Analysis of interactions between PA2721 and compounds that lead to chem-
ical sensitivity 
To find out if the discovered phenotypic changes indicate a precise function, the interaction of 
the change inducing compounds with the recombinantly expressed PA2721 (159 aa, 17.4 kDa) 
(Figure S1) protein was tested. For a fast screen the protein was utilized in a TSA to identify 
compounds that affect the melting temperature (Tm) of the protein upon binding. The com-
pounds that induced a shift in thermal stability (Figure 22 A) were forwarded to an MST-screen.  
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Figure 22: Interaction of PA2721 with antimicrobial compounds that induced significant changes in the chemical sensitivity 
PMs. A) Changes in thermal stability (ΔTm) of PA2721 (Tm: 61°C) as measured with a TSA. ΔTm were determined by averaging 3 
independent experiments. B) MST dose-response curves were derived by plotting the thermophoresis signal Fnorm (‰) against 
the compound concentration in µM. For the MST experiment 100 nM Cy5-labelled PA2721 were titrated against a 1:1 dilution 
series of dichlofluanid (◊) with a starting concentration of 100 µM and of captan (♦) with a starting concentration of 250 µM. 
MST data were collected at 293 K in standard capillaries with 30 % LED-power and 40 % MST-power. The final reaction condi-
tions contained 20 mM Tris/HCl pH 8, 150 mM NaCl, 0.5 % BSA, 10 % (v/v) DMSO. From the curve fit after the Hill-equation (5) 
an EC50 of 5.7 ± 0.3 µM for dichlofluanid and 6.3 ± 0.6 µM for captan was calculated.     
Significant changes in the thermophoretic behavior of PA2721 were discovered if the protein 
was incubated with gallic acid (MST response amplitude: 0-6), captan (MST response ampli-
tude:   ̴15) and dichlofluanid (MST response amplitude: 10). To verify possible binding MST ti-
tration experiments were performed. This showed that gallic acid does not bind to PA2721 
under the tested conditions. However, a sigmoidal binding curve as obtained for the related 
compounds captan and dichlofluanid (Figure 22 B/C). The curves were well fitted with the Hill-
equation (5), leading to similar Hill-coefficients of 2.1 (captan) and 2.3 (dichlofluanid), indicative 
of positive cooperativity in both binding events (Cattoni et al., 2015). The EC50 derived from 
these curves was 6.3 ± 0.6 µM for captan and 5.7 ± 0.3 µM for dichlofluanid. 
4.1.1.3 Dichlofluanid and captan covalently modify PA2721 
To get a detailed insight into the binding of captan and dichlofluanid, both ligands were soaked 
into PA2721 crystals (Figure 24). Furthermore, proflavine was soaked because its fluorescence 
properties did not allow interaction studies with a TSA or MST experiment. However, proflavine 
was not discovered in the structure and might not bind there. The full processing and refine-
ment statistics for the soaks with dichlofluanid and captan are displayed in Table S1. In both 
cases the electron density map revealed no mFo-DFc difference density that would have been 
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interpretable with a ligand. However, one of the potential active site residues C105 (Figure 23 
B/C/F/G) showed extra density caused by a covalent modification.  
 
Figure 23: Cysteine modification in PA2721 after soaking the crystals in reservoir solution (0.1 M MES pH 5.7, 28 % (w/v) 
PEG6000), supplemented with 1.5 mM captan or dichlofluanid, 10 % (v/v) DMSO and 10 % (v/v) butane diol. A) Overall struc-
ture of the PA2721 dimer soaked with dichlofluanid. The positions of the modified CYS in the potential binding site are high-
lighted. B/C/F/G) Modified C105 in both monomers of a PA2721 crystal soaked with captan (B/C) and dichlofluanid (F/G). D/E) 
Examples of an unmodified C8 from monomer B from crystals soaked with captan (D) and dichlofluanid (E). The crystal soaked 
with captan diffracted to 2.1 Å and the one soaked with dichlofluanid to 1.46 Å. Full processing and refinement statistics are 
displayed in Table S1. The mFo-DFc difference electron density is displayed in green and contoured at 2.5 σ. The 2mFo-DFc is 
displayed in grey contoured at 1 σ. Monomer A is colored in grey and monomer B in teal. CYS residues are represented as balls 
and sticks. The oxygen atoms are red, the nitrogen atoms are blue, and the sulfurs are yellow.  
It is likely that this modification was specifically introduced to C105 upon the contact with the 
ligand, as the other solvent exposed cysteine (C8) in the binding site was unmodified (Figure 
23 D/E). Further, it is very unlikely that the extra density of C105 was caused by oxidization, as 
such a modification was unique to the crystals soaked with captan and dichlofluanid. In addi-
tion, no modification of C105 was discovered in reference crystals soaked with the same 
amount of DMSO (10 % (v/v)), which was required for dissolving the compounds or in the al-
most 100 crystals that were analyzed during the fragment screening campaign (4.1.1.4). Taken 
the results from both experiments together, one can conclude that PA2721 is covalently mod-
ified upon the incubation with captan and dichlofluanid in a concentration dependent manner 
at the specific amino acid C105. In vitro studies of enzyme-free reactions with dichlofluanid and 
free cysteine identified that a disulfide bridge is formed between the side chain of the cysteine 
and the flourodichlormethylthio moiety of dichlofluanid (Schuphan et al., 1981), which could 
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also be the case for the C105 in PA2721. Unfortunately, the covalent modification of the protein 
does not allow to determine KD-values from the MST experiment, as the covalently attached 
molecule does not dissociate of the protein. However, the EC50 defines that at a captan con-
centration of 6.3 ± 0.6 µM and at a dichlofluanid concentration of 5.7 ± 0.3 µM 50 % of the 
protein molecules are occupied, making them equally effective in the modification of PA2721. 
These findings could suggest that PA2721 might be able to catalyze the breakdown of di-
chlofluanid and captan over a covalent intermediate that must be transferred to a cosubstrate 
for further metabolism of the compound and to release the CYS for a new reaction cycle.  
Since captan and dichlofluanid are agricultural fungicides, they were released into the environ-
ment where they possibly came into contact with soil-dwelling bacteria such as P. aeruginosa. 
Another soil-dwelling human pathogen is Bacillus circulans, which was identified to utilize cap-
tan as sole energy source (Megadi et al., 2010). From a cell-free extract of B. circulans the ac-
tivity of a captan hydrolase was identified, which is supposed to catalyze the first step in a 
proposed captan degradation pathway (Megadi et al., 2010). Although the respective gene 
from B. circulans was not identified by now and therefore cannot be compared with PA2721 it 
is possible that P. aeruginosa also developed a specific resistance mechanism towards these 
agricultural compounds but further investigations are necessary to support this hypothesis. 
However another study identified that captan is hydrolyzed in H2O so it should be considered 
that one of its hydrolysis products could be CYS reactive and responsible for the modification 
seen in PA2721 (Wolfe et al., 1976).   
4.1.1.4 Fragment screening of PA2721 with the HZB 96-compound library 
A crystallographic fragment screening was performed with PA2721 to identify ligands in the 
potential binding site to derive ideas about the chemical structure of potential substrates. 
PA2721 is a very suitable target for such an approach as PA2721 rod shaped crystals are highly 
reproducible in amount, diffraction quality and resolution limits (Figure 24).  
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An updated, immobilized version of the published 96-fragment library from HZB was chosen 
for individual soaking into the crystals, because the library offers a broad diversity with com-
pounds from five chemical classes, namely buffer ingredients, carbohydrates and their deriva-
tives, nucleotides, amino acid- and peptide-like fragments and various organic, drug-like com-
pounds (Huschmann et al., 2016). The compounds are small fragments ranging from 101 to 549 
Da with an average MW of 205 Da. The crystals were individually soaked with the library and 
used for diffraction data collection. The diffraction data were processed in triclinic space group 
P1 or in monoclinic P21. Crystals in the P1 space group contained 8 monomers per ASU and data 
set 19 was used as the search model for the phasing pipeline. Full processing and refinement 
statistics for data set 19 can be found in Table S4 and Table S5. The pipeline phased and refined 
all 46 data sets from SG P1 that were collected at BESSY II (HZB), giving Rfree values from 19 % 
to 37 % (Table S2). P21 SG crystals contained one homodimer in the ASU, which resembled the 
oligomerization state of the protein in solution. Data set 90 was chosen as pipeline input model 
for SG P21 (Table S4/S5). The 39 data sets collected at BESSYII (HZB) and processed in SG P21 
were phased and refined to Rfree values from 18.3 to 30.9 % (Table S3). Ten data sets were 
collected at the rotating anode X-ray source at the HZI. One was processed in SG P1 and the 
rest in P21. They were phased “manually” and refined to Rfree values in the range of 22.5 to 34 % 
(Table S2/S3). The resolution limits of all data sets were between 1.04 and 2.2 Å. Taken to-
gether, the fragment screening campaign yielded well interpretable electron density maps. 
4.1.1.4.1 Quality of fragment screening hits 
The difference density map of crystals that were soaked with fragments 8, 10, 61 and 100 re-
vealed clear electron density that was interpretable with the respective fragments (Figure 25 
Figure 24: A/B) PA2721 crystals grown in 28 % (w/v) PEG6000, 0.1 M MES pH 5.7 
for soaking the HZB 96-fragment library. Scale bar 300 µm. 
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A/C/D/F/I), which are bis-tris propane, N-benzyloxycarbonyl-L-proline (CBZ-Pro), 4-nitrochate-
chol and barbituric acid. Full processing and refinement statistics of all data sets are displayed 
in Table S4 and Table S5. With real space correlation coefficients (RSCC) between 0.91 and 0.95 
(Table 15) most of the protein-ligand models had a good quality according to the validation 
values of Deller & Rupp, 2015, who stated that ligands fit the electron density well if RCSSs are 
between 0.9 and 1 (Deller & Rupp, 2015). Only the complex of F10 with one binding site (site 
1) of PA2721 was of lower quality with a RSCC of 0.83.                                                               
Table 15: Refined occupancies and real-space correlation coefficients (RSCC)# 
of FS hits, named by the fragment ID and the chemical name. 
ID Name Occupancy RSCC 
8‡ bis-tris propane 0.72 0.95 
10 site 1 
N-benzyloxycarbonyl-L-proline 
0.92 0.83 
10 site 2 0.96 0.91 
61 4-nitrocatechol 0.79 0.95 
100 barbituric acid 0.73 0.93 
#Occupancy refinement and calculation of RSCC was carried out with PHENIX.refine (Ad-
ams et al., 2010). ‡Fragment 8 has two alternate conformations with occupancies of 0.52 
and 0.31 respectively, while RSCC did not differ. 
Figure 25 A shows the binding of bis-tris propane with two alternate conformations for most of 
the hydroxyl groups of the two tris moieties. The refined occupancies of the individual confor-
mations are 52 % and 31 % (Table 15). Both conformations are stabilized by a variety of H-
bonds formed either directly between the protein and the fragment or mediated by H2O (Figure 
25 A). In this case, amino acids of three symmetry-related PA2721 homodimers contribute to 
the binding of bis-tris-propane (Figure 25 B). The difference electron density of 4-nitrocatechol 
was clearly interpretable with one conformation of the fragment (Figure 25 F). It had an occu-
pancy of 79 % (Table 15). This fragment is complexed between two symmetry-related homodi-
mers via three direct H-bonds (Figure 25 H). The fragment is further stabilized by π-alkyl inter-
actions established by two ALA and one ARG side chain with the aromatic ring of the fragment 
(Figure 25 G). Barbituric acid is also bound between two symmetry-related homodimers (Figure 
25 J). It reaches an occupancy of 76 % (Table 15). Direct and indirect H-bonds stabilize the in-
teraction of protein and ligand (Figure 25 I).  
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Figure 25: Binding mode of FS hits to PA2721. The left side (A, C, D, F&I) are stereo images of the unbiased mFo-DFc difference 
electron density contoured at 2.5 σ with the respective fragments and the amino acid residues that interact with the fragments. 
Amino acids of distinct protein chains are colored differently. Waters are represented as light blue spheres. H-bonds with a 
maximum distance of 3.2 Å are shown as black dashed lines. G) Amino acids that are participating in the binding of 4-nitrocat-
echol by alkyl interactions. The right side (B, E, H & J) displays the location of the fragments in the overall structure. Symmetry 
related homodimers of PA2721 have different colors (B, H&J). In E, each monomer of PA2721 is colored differently. 
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The only compound that was discovered in the potential binding site of PA2721 was N-ben-
zyloxycarbonyl-L-proline. It occupied the equivalent binding tunnels of the protein dimer (Fig-
ure 25 E). Both ligands are complexed by equivalent residues and have similar occupancies. The 
occupancies for the fragment in site 1 was 92 % for the fragment in site 2 it was 96 % (Table 15). 
The strongest interactions are three H-bonds. They are formed between the W107 side chain 
and the fragment’s carbonyl oxygen and between the C105 side chain and the carboxyl of the 
proline moiety. The third H-bond is formed between the side chain carbonyl of Q117 and the 
fragment (Figure 25 C/D). Since most fragments are complexed between symmetry-related 
protein chains that do not occur in solution their binding mode in the crystal likely is a crystal-
lographic artefact and therefore not relevant. The only functionally relevant hit is CBZ-Pro that 
occupies the potential ligand-binding site of the protein.   
4.1.1.4.2 Functional relevance of N-benzyloxycarbonyl-L-proline binding to PA2721   
CBZ-Pro is the first ligand found to bind in the binding tunnel of PA2721, suggesting that this 
fragment has some chemical features of the protein’s substrate. The fragment is complexed by 
equivalent residues in both binding tunnels such that only one site will be analyzed here (Figure 
26). The side chain of the fragment’s proline moiety is stabilized by alkyl-interactions mediated 
by the protein side chains L50 and L64 and by π-alkyl interactions with Y41. The benzene ring 
establishes only rather week hydrophobic interactions with the surrounding residues (M142, 
I127 and T119). One of the three H-bonds is formed between one proline carboxyl-oxygen and 
C105. Since this CYS residue might play a major role in the proteins function as discussed earlier 
(4.1, Figure 18 B), this interaction indicates a functional importance for the carboxyl-moiety of 
CBZ-Pro.   
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Figure 26: Stereo view of the potential binding site of PA2721 occupied with CBZ-Pro represented in different orientations. 
Amino acids surrounding the ligand (white) are displayed in balls and stick representation. The amino acids of chain A are 
colored in teal and the residues of chain B in grey. H-bonds with a maximum distance of 3.2 Å are shown as black dashed lines. 
The HZB 96-fragment library contains four other proline derivatives (Figure 27) that were not 
discovered in the electron density. They all contain the carboxyl-oxygen of the proline-moiety 
that H-bonds with the C105 residue of the protein. The two smaller compounds 4-hydroxyl-L-
proline and pyroglutamic acid have an additional hydroxyl- or carbonyl at the proline-ring, 
which might destroy the alkyl interaction between the proline and the protein. At the same 
time, there are no residues nearby that could form new H-bonds with the hydroxyl- or the car-
bonyl, such that the one possible H-bond that could be established seems to be insufficient for 
the complexation of these fragments. N-acetyl-L-proline and glycyl-L-proline still share the sec-
ond carbonyl oxygen that mediates the H-bond with W107 and have no modifications at the 
proline, such that the alkyl interactions could also be preserved and the additional amino group 
in glycyl-L-proline might even be able to mediate the third H-bond with Q117. Nonetheless, 
both did not bind to the protein under the soaking conditions. This suggests that the aromatic 
benzyl-moiety is an important part of the compound. This indicates that longer molecules that 
occupy larger parts of the protein tunnel have a higher affinity to the protein and can bind.    
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Figure 27: Proline derivatives from the HZB 96-fragment library with their fragment ID in brackets. Parts of the molecules that 
are different to N-benzyloxycarbonyl-L-proline are marked red. 
MST-measurements for determining the dissociation constant (KD) were conducted to deter-
mine the affinity of CBZ-Pro to PA2721 (Figure 28). The titration of CBZ-Pro from a maximum 
ligand-concentration of 5 mM did not result in a binding curve. This means that the KD is either 
above 5 mM or the ligand only binds to the protein under the soaking conditions.  Based on the 
chemical structure of the fragment one could search for similar natural compounds to perform 
a second screening to identify better binding ligands and get a better impression of the natural 
substrate.  
 
Figure 28: MST results of PA2721 with N-benzyloxycarbonyl-L-proline. The normalized fluorescence (Fnorm) is plotted against 
the concentration of N-benzyloxycarbonyl-L-proline in µM. The measurement was conducted at 293 K as a 1:1 dilution series 
with highest ligand concentrations of 50 µM (A) and 5 mM (B) in standard capillaries. The buffer consisted of 50 mM Tis/HCl 
pH 7.4, 150 mM NaCl, 10 % (w/v) DMSO and 0.5 mg/ml BSA. The concentration of PA2721 was 200 nM. The LED- and MST-
power were 20 %. 
N-benzyloxycarbonyl-L-proline is a competitive substrate analogue inhibitor for human 
prolidase (King et al., 1989; Lupi et al., 2005). Prolidase is a metallo-peptidase that cleaves di-
peptides with C-terminal proline or hydroxyproline in the final stages of protein catabolism. 
Prolidase inhibitors are used to simulate the effects caused by prolidase deficiency in humans 
that causes a variety of sever clinical symptoms (Myara et al., 1984; Wilk et al., 2017). The 
R e s u l t s  a n d  D i s c u s s i o n  |  75 
 
comparison of prolidase active site and the N-benzyloxycarbonyl-L-proline binding site in 
PA2721 revealed no similarities. This indicates that PA2721 cannot fulfill the function of 
metallo-peptidases that are also able to interact with N-benzyloxycarbonyl-L-proline.  
 PA2722 
4.1.2.1 Protein purification 
The predicted Gfa PA2722 is a 130 aa protein with a theoretical MW of 14.6 kDa (Winsor et al., 
2016) and was first purified in this study. It was expressed in soluble form in E. coli with an N-
terminal His6-purfication tag and isolated via a three-step purification, during which the His6-
tag was removed by TEV-cleavage leaving two extra amino acids (GLY and HIS) at the N-termi-
nus. The final yield was 11 mg of highly pure PA2722 per liter cell culture (Figure S1), suitable 
for crystallization and biochemical assays. 
4.1.2.2 From crystallization to structure refinement  
Good quality crystals grew in the initial screen (Figure 29 A). One of them was used to confirm 
the presence of the predicted Zn2+-ions by an X-ray fluorescence scan (Figure S9). Based on this, 
Zn-SAD data were collected with reasonable overall diffraction (2.4 Å) and enough anomalous 
signal (3.4 Å) for phasing the structure of PA2722 (Table 16). Optimization enhanced crystal 
quality (Figure 29 B/C) and resulted in a high-resolution structure (1.25 Å).  
 
Full data collection, processing and refinement statistics are listed in Table 16. Since the space 
group, cell parameters and structures were the same for the initial and the high-resolution 
model, only the latter was fully refined to a final Rcryst of 13.55 % and Rfree of 15.12 %. The ASU 
Figure 29: PA2722 crystals. A: Initial crystals in 0.1 M MES pH 6.5, 12 % (w/v) PEG20000 used 
for anomalous phasing at BESSYII. Scale bar: 300 µm. B: Optimized crystals in 0.1 M MES pH 6.3, 
14 % (w/v) PEG20000. C: Optimized crystal during data collection at SLS. 
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contained 8 molecules of PA2722, which corresponds with the calculated Matthews coefficient 
(Matthews, 1968) of 2.6 Å/Da and a solvent content of 53 %. The electron density was well 
interpretable so that all 130 amino acids of the eight protein chains in the ASU including the 
extra N-terminal residues GLY and HIS were modelled. 
Table 16: PA2722 data collection and processing statistics at Zn-peak wavelength (Zn-SAD) and for high-resolution (Native) 
data as well as structure refinement statistics of the high-resolution data. 
Data collection and processing Zn-SAD∗ Native Structure refinement Native 
Beamline† BL14.1, BESSYII X06DA, SLS Resolution range (Å) 47.79-1.25 
Detector Pilatus 6M Pilatus 2MF Completeness (%) 99.7 
Wavelength (Å) 1.282416 1 Final Rcryst 13.22 
Temperature (K) 100 100 Final Rfree 14.75 
Crystal-detector distance (mm) 313 135 No. of reflections  
Rotation range per image (°) 0.2 0.1 Working set 344867 
Total rotation range (°) 1200 360 Test set 17486 
Exposure time per image (s) 0.2 0.1 No. of non-H atoms  
Space group P212121 P212121 Protein 8837 
a, b, c (Å) 84.76 85.24 170.7 84.62 86.25 172.04 Ion 16 
α, β, γ (°) 90 90 90 90 90 90 Buffer molecule 240 
Mosaicity (°)# 0.17 0.05 Water 1960 
Resolution range (Å) 47.32-2.48               
(2.48-2.40) 
47.79-1.25                
(1.27-1.25) 
Total 11053 
 R.m.s. deviations  
Total No. of reflections 2145819 (186060) 4505463 (178863) Bonds (Å) 0.011 
No. of unique reflections 48303 (4349) 345072 (16564) Angles (°) 1.224 
Completeness (%) 98.4 (97.3) 99.8 (97.4) Average B-factor (Å2)  
Multiplicity 44.4 (42.8) 13.1 (10.8) Protein 16.58 
Mean I/σ(I) 17.7 (2.9) 19.2 (2.6) Ion 10.73 
CC1/2+ 99.9 (82.7) 99.8 (80.7) Buffer molecule 27.43 
Rpim$ 4.3 (29.2) 2.2 (29.5) Water 32.81 
Rmeas¥ 28.6 (192.7) 7.9 (98.9) Ramachandran plot  
Wilson B-factor (Å2) 29.9 10.1 Favored regions (%) 97.60 
Phasing   Outliers (%) 0.0 
Anom. Completeness 98.6 (97.4)  MolProbity Score‡ 1.13 
Anom. Multiplicity 23.0 (21.8)    
Values in parentheses are for the highest resolution shell, ∗Data collection statistics for unmerged Friedel pairs. †BESSYII (HZB, Berlin, Ger-
many), SLS (PSI, Villigen, Switzerland), #Value as reported by AIMLESS (Evans & Murshudov, 2013). +CC1/2 as reported by (Karplus & 
Diederichs, 2012), $Rpim = Σhkl (1/(N – 1))1/2 Σi | Ii (hkl) – < I (hkl) > | / Σhkl Σi Ii (hkl); ¥Rmeas = Σhkl (N/(N – 1))1/2 Σi | Ii (hkl) – < I (hkl) > | / Σhkl Σi Ii (hkl), 
where N is the number of observations of the reflection with index hkl and Ii is the intensity of its ith observation (Weiss, 2001). ‡MolProbity 
score as reported by MolProbity (Chen et al., 2010). 
4.1.2.3 Topology and Oligomerization of PA2722 
The crystal structure of one PA2722 monomer is dominated by a mixed, extremely curved 
eight-stranded β-sheet. A second antiparallel three stranded β-sheet (β1-β2-β5) faces the anti-
parallel arrangement (β6-β7-β8-β9) of the bigger β-sheet (Figure 30 A/B). This forms the core of 
the so called β-tent fold (Lupas et al., 2015). This tent fold is stabilized by a conserved Zn-bind-
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ing center. The Zn-binding center is at the top of the tent between two hairpin loops that con-
nect the β1- and β2-strand and the β7- and β8-strand. This Zn2+ is tetrahedrally coordinated by 
CYS side chains with two being located on each hairpin (Figure 30 D).  
 
These CYS are usually found in two conserved CxxC-motifs, but PA2722 has a slightly modified 
CxC-motif on the first hairpin (Lupas et al., 2015). Another conserved feature of β-tent fold 
proteins is a β-hairpin formed by β3 and β4 while extending the four-stranded β-sheet. The hair-
pin β-strands are connected by the only α-helix of PA2722 that is not part of the core β-tent 
fold. There, a second Zn-binding site is also tetrahedrally complexed by three CYS (Figure 
30 B/C) and the additional N-terminal HIS side chain from a symmetry related monomer that 
remains from the purification tag after TEV-cleavage (Figure 31 C/D), suggesting a crystallo-
graphic artefact. As the tetrahedral coordination is the lowest possible for Zn2+ (Laitaoja et al., 
2013), the artificial HIS side chain must be replaced by another molecule in vivo to keep the Zn-
binding site functional. In the simplest case the fourth ligand could be H2O, which is in general 
the case for catalytically active Zn2+-ions (Vallee & Auld, 1993). Next to that, the β10- and β11-
strands not participating in the core tent-fold elongate the central β-sheet. A DLS experiment 
calculated a MW of 33.7 kDa for PA2722 in solution, which is consistent with the theoretical 
size of a dimer which would be 29.7 kDa. To identify the natural dimer among the 8 molecules 
in the ASU, the intermolecular contacts were evaluated and a analysis with the 'Protein inter-
faces, surfaces and assemblies' service PISA (Krissinel & Henrick, 2007) was performed.   
Figure 30: Topology of a PA2722 monomer. Secondary structure elements are numbered from N- to C-terminus. α-helices are 
colored in teal, β-strands are colored in grey and loop regions are white. Zn2+-ions are colored purple. A) Schematically repre-
sentation drawn with TopDraw (Bond, 2003). B) 3-D representation of the protein. C and D) are magnifications of both Zn2+-
binding centers with the complexing cysteine residues shown in ball and stick representation with sulfur atoms appearing in 
yellow. Dashed lines connect the Zn-ions with the complexing cysteine residues. Distances range from 2.29 to 2.36 Å. The 
anomalous Zn-electron density is shown in purple, contoured at 8 σ.    
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Figure 31: PA2722 monomers that contact each other in the ASU. A) Displayed are all four monomers 1-4 (different shades of 
green and teal) that interact with a central monomer 5 (grey). B-E) Representation of the interfaces that are encircled in A) but 
with rotated orientations. The parts of the residues that participate in H-bonds or salt-bridges are displayed as balls and sticks 
with oxygen atoms colored red, nitrogen blue and sulfur yellow. Black dashed lines are H-bonds or salt bridges with a maximum 
distance of 3.2 Å. Purple dashes connect the metal complexing residues with the Zn2+-ion (purple sphere). Light blue spheres 
represent waters. F) Electrostatic potential from -5 (red) to 5 (blue) kT/e, as calculated by the PDB2PQR server Version 2.0.0 
(Dolinsky et al., 2004) of monomer 4 at the probable dimer interface between monomer 4 (teal) and monomer 5 (grey).  
Each monomer contacts four other monomers (Figure 31). Interestingly, two of the contacts 
are mediated by the N-termini, especially by the interaction of the remaining nonnative G-1 
and H0 of the purification tag. This includes the already mentioned complexation of the His-
side chain with one of the Zn2+-ions (Figure 31 C/D). While the third interface is only stabilized 
by indirect water-mediated and a few direct H-bonds (Figure 31 B) the fourth interface displays 
several H-bonds and salt bridges (Figure 31 E), together with a large uncharged interface (Fig-
ure 31 F). A PISA-analysis assigned the complex of monomer 4 and monomer 5 from Figure 
31 A/E/F, as the only thermodynamically stable assembly in solution with a calculated value of 
6.6 kcal/mol for the free energy of assembly dissociation (ΔGdiss), as ΔGdiss-values above zero 
determine assemblies as thermodynamically stable and with an interface of 1912 Å2 that is four 
times larger than the next bigger interface. Therefore, monomer 4 and 5 most probably repre-
sent the native dimer in solution (Figure 31/32).  
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4.1.2.4 Comparison of PA2722 with Gfa/CENP-V like proteins 
The newly identified PA2722 structure was compared to already characterized Gfa-like proteins 
to find evidence for a functional relation. A sequence-based BLAST analysis (Altschul et al., 
1997) revealed that PA2722 is highly conserved in the family of Pseudomonadaceae with more 
than 1000 genes coding for proteins similar to PA2722. Even the P. aeruginosa PAO1 strain 
itself has three more genes (PA2702, PA4177, PA5465) that encode predicted Gfa-like proteins, 
that share a protein sequence identity of 25-49 %. The PA2722 sequence is further conserved 
in prokaryotes like in other γ- (18 homologues), in α-proteobacteria (140 homologues) and in 
cyanobacteria (5 homologues).  
Unfortunately, functional data are only available for more distantly related proteins, such as 
the already mentioned Pd. Gfa and the human centromere protein-V (CENP-V). Based on cellu-
lar studies Pd. Gfa (EC4.4.1.22) was declared as a carbon-sulfur lyase that was supposed to 
accelerate the spontaneous transfer of formaldehyde to reduced glutathione (GSH) to form S-
hydroxymethylglutathione (HMG) as the first step of the formaldehyde detoxification pathway. 
This was hypothesized as a rather unusual mechanism where GSH is first covalently attached 
to the active site C56, thereby replacing the Zn2+. However the actual reaction was supposed 
to occur at the detached Zn2+, which becomes complexed by other glutathione molecules and 
the formaldehyde to polarize the respective bonds of formaldehyde and GSH to activate them 
for nucleophilic addition (Goenrich et al., 2002; Neculai et al., 2005). A later study could not 
find any evidence for the acceleration of this reaction through Gfa but confirmed the covalent 
modification of cysteine with glutathione (Hopkinson et al., 2015). The centromere protein-V 
(CENP-V) is a two-domain protein with a C-terminal Gfa domain containing both conserved cys-
teine centers. CENP-V was found to be crucial for the hypercondensation of chromatin during 
mitosis (Tadeu et al., 2008). Moreover, the mutation of its conserved catalytic site cysteine 
(Figure 32) inhibited the hypercondensation (Tadeu et al., 2008) and confirmed the conserved 
functional importance of this residue in more distantly related Gfa-like proteins. Besides that, 
the importance of CENP-V for the directional motility of cells has been shown. It is based on 
protein-protein interactions between the Gfa-domain and microtubules (Honda et al., 2009). 
These findings suggest that PA2722 might also be part of a protein-protein complex. However, 
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no structure of a CENP-V protein has been determined until now, such that the surface amino 
acid residues of PA2722 could not be compared with residues from the Gfa-like domain of 
CENP-V.  
To search for structural homologs of PA2722 the structure similarity server PDBeFold (Krissinel 
and Henrick, 2004) was used. It identified only the Pd. Gfa and the functionally uncharacterized 
protein RSP_2168 from Rhodobacter sphaeroides 2.4.1 (PDB-ID: 3FAC, to be published). A se-
quence alignment revealed that the sequences are non-homologous but that the Zn2+ complex-
ing CYS residues are highly conserved. This includes the active site cysteine (C32 in PA2722) 
that was identified to play a crucial role for the activity of Pd. Gfa and hCENP-V and might 
therefore play an important role for the function of PA2722 as well. Despite the non-homolo-
gous sequences, the overall 3D-structure of the monomers are conserved. They share the char-
acteristic β-tent core fold and PA2722 and the Pd. Gfa both contain the two additional β-sheets 
β10 and β11. The location of both Zn-binding centers and the complexing cysteines are also con-
served but no metal ions were implemented in the structure of RSP_2168. This stands in con-
trast to the Fo-Fc-electron density of RSP_2168, which revealed positive spots at the conserved 
metal binding sites. This indicates that metal ions were present in the structure but were not 
considered during refinement. In contrast to the conserved overall fold, the quaternary struc-
tures of PA2722 and Pd. Gfa are strikingly different. The Gfa from P. denitrificans is an experi-
mentally confirmed dimer that has an alternative arrangement that is mediated by two addi-
tional α-helices in the C-terminal region (Figure 32). A consequence of this assembly is that the 
active sites of each monomer are facing each other and are combined to one big cavity. PA2722 
and RSP_2168 are lacking the C-terminal helices and must thus assemble in an alternate way.   
The comparison shows that RSP_2168, which crystallized in the same space group and with a 
similar ASU content as PA2722, has the potential to form a similar dimer as PA2722 (Figure 32), 
however a PISA analysis (Krissinel & Henrick, 2007) stated that RSP_2168 appears to be a mon-
omer in solution. As experimental data are lacking, no further statement upon the oligomeri-
zation state of RSP_2168 is possible. Either way, the potential active sites of RSP_2168 and 
PA2722 are independent on separate places of the protein dimer (Figure 32) or isolated in case 
of the monomeric state of RSP_2168 and are only half the size of the Pd. Gfa cavity. 
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Figure 32: Comparison of PA2722 with other Gfa-fold proteins. The upper panel highlights the oligomerization forms of the 
Gfa from P. denitrificans, PA2722 and the possible, experimentally unconfirmed dimer of RSP_2168 in identical orientations. 
The monomer structures align with RSMD values of 2.7 Å for PA2722 vs. Pd. Gfa and with 2.4 Å for PA2722 vs. RSP_2168 (Holm 
& Laakso, 2016). One monomer is colored from blue to red (N- to C-term.) and the attached monomer in grey. Zn2+ are repre-
sented as violet spheres. The covalently attached glutathione in Pd. Gfa is represented as balls and sticks. The middle panel 
displays the electrostatic potential of the above proteins as calculated by the PDB2PQR server Version 2.0.0 (Dolinsky et al., 
2004). The triangles highlight the location of the potential active site cysteine. The lower panel shows the sequence alignment 
of the structural characterized proteins and the Gfa-like domain of hCENPV, as performed with Clustal Omega (Li et al., 2015) 
and colored with ESPript 3.0 (Robert & Gouet, 2014). The secondary structure assignment is based on PA2722. Sequence iden-
tities between PA2772 and the other range from 24 % (hCENPV) to 18 % (RSP_2168). Diamonds highlight the structural relevant 
CYS and triangles highlight functional relevant CYS. The ovals mark the residues that are participating in Pd. Gfa glutathione 
binding.   
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4.1.2.5 Contraindications for a Gfa-like function of PA2722  
As the P. denitrificans protein it is the only characterized Gfa from prokaryotes to date, it was 
the only lead to a functional prediction for PA2722. However, at first sight there are many dif-
ferences, such as the dissimilar size and shape of the active/binding site cavities, which will 
most probably have a huge impact on the functionality (Figure 32, middle panel). Despite the 
obvious differences a detailed comparison of the potential active sites of Pd. Gfa and PA2722 
with emphasis on the GS binding site was performed. The covalently attached GS is further 
stabilized by several H-bonds which are formed between GS and the side chains of S146, E149, 
T57, K58 and R98 and the main chain amine hydrogen of I94 (Figure 33 left).  
 
Figure 33: Potential active sites of Pd. Gfa monomer in glutathione (GSH) bound form (left panel, PDB-ID: 1XA8, Neculai et al., 
2005) and of a PA2722 monomer (right panel). The dashed lines in the left panel represent H-bonds with a maximal distance 
of 3.2 Å. The violet sphere represents the Zn2+-ion. The residues in the binding cavity are shown as balls and sticks. Nitrogen 
atoms are blue, oxygen red and sulfur yellow.  
From the sequence alignment, the only conserved GS binding residue was R98 (Pd. Gfa), which 
corresponds to R63 in PA2722. The position of these residues is also conserved in the 3D ar-
rangement of the active site, as both are located at the N-terminal end of the β7-strand. Since 
this remains the only similarity also with respect to the contrasting surface charges, (Figure 32, 
middle panel) it seems rather unlikely that GSH can interact with PA2722. 
Nevertheless, several experiments were conducted to investigate if GSH and PA2722 can inter-
act. A TSA gave some evidence to believe that GSH binds to PA2722, since the presence of GSH 
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increased the Tm of PA2722 (45 °C) by 1°, but MST measurements did not indicate any signifi-
cant interaction. Besides, X-ray crystallography-based methods could not contribute in resolv-
ing the question of glutathione binding. The PA2722 crystals (Figure 29) were expected to be 
not suitable for soaking as the potential binding site was occupied by a buffer molecule and by 
the Zn2+-coordinating H0 from a symmetry mate. Indeed, after soaking crystals with GSH no 
changes in the e--density compared to unsoaked crystals were detected. Therefore, a cocrys-
tallization experiment was set up that yielded weakly diffracting crystals only. The highest res-
olution obtained was 3.7 Å, which was not enough for an unambiguous identification of GSH in 
the electron density of the ligand-binding site. To find out if GSH can covalently modify PA2722 
a MALDI mass spectrometry experiment was carried out. After the full-length protein was in-
cubated with GSH (MW: 307.32 Da) it did not show a higher mass than the reference PA2722 
not incubated with a ligand. Therefore, GSH did not covalently modify PA2722 under the tested 
conditions.   
4.1.2.6 PA2722: from structure to function? 
To derive a lead towards the potential function of PA2722 the protein’s active site was exam-
ined. Extra mFo-DFc e--density (Figure 34 A) was visible in the binding site. It was interpretable 
as two distinct molecules of 2-(N-morpholino)ethanesulfonic acid (MES) from the crystalliza-
tion buffer. One MES molecule (MES1) is tightly complexed by several direct H-bonds. They are 
formed between two MES sulfate oxygen atoms and the sidechains of R234, R122 and Y98 and 
between the nitrogen and the oxygen of the morpholino part and the sidechains of E82 and 
C32 (Figure 34). The tight binding is reflected by the well interpretable e--density (Figure 34 A) 
to which MES fits well with a RSCC of 0.99 and an occupancy of 100 %. A crystallographic arte-
fact might cause the tight binding, because the non-native residues H0 and G-1 close the oth-
erwise solvent exposed binding cavity and thereby enclose the MES molecule (Figure 34 C). The 
binding of MES1 in the active site could also assist in the mediation of this crystal contact as 
indicated by the H-bond that is formed between the N-terminal amine of G-1 and a sulfate 
oxygen atom of MES1 and thus promote the crystallization process (Figure 34 C). 
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Figure 34: MES molecules in the potential binding site of PA2722. A) Electrostatic surface of the potential binding pocket of 
PA2722 with the unbiased mFo-DFc difference electron density contoured at 2.5σ that can be interpreted with MES molecules. 
The location of the Zn2+-atom is marked by violet dots. B/C) Amino acids complexing MES molecules are shown as balls and 
sticks. Oxygen atoms are red, nitrogen are blue and sulfur are yellow. The violet sphere refers to Zn2+. The violet dashes connect 
the Zn2+ with its complexing residues. Direct H-bonds between protein and ligand, with a maximum distance of 3.2 Å are shown 
as black dashed lines. C) The N-terminal part of a symmetry related monomer is displayed in green.  
The other MES molecule (MES2) is only occupied by 75 %. It has a well interpretable e--density 
for the ethanesulfonic acid part. It is stabilized by H-bonds that are formed between two sulfate 
oxygen atoms and the R104 side chain and the main chain nitrogen of L30 (Figure 34 A/B). The 
morpholino moiety is rather loosely bridged between W101 and D31 by π-cation interactions 
and attractive charges. Based on the close proximity of MES2 to H0 from a symmetry mate, the 
crystallization contact might also influence the interaction with the MES2 molecule (Figure 
34 C). Nevertheless, the MES molecules probably share some chemical and structural proper-
ties with the actual binding partner of PA2722. Even if they do not provide a concrete image of 
the substrate they might assist in the identification of the real substrate. 
 PA2723 
4.1.3.1 Protein purification and thermal stability 
The PA2723 gene codes for a 92 aa protein with an estimated molecular weight of 10.3 kDa 
(Winsor et al., 2016). The purification of PA2723 was first described during this study and per-
formed as for PA2722 (4.1.2). The final yield of PA2723 was 8 mg per liter of cell culture with a 
high final purity (Figure S1). Interestingly, the protein starts to precipitate at protein concen-
trations that exceed 3.4 mg/ml. Nevertheless, the protein was stable in the used buffer with a 
melting temperature of 59 °C as verified with a TSA (Figure S8).    
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4.1.3.2 From crystallization to structure refinement  
Initial screening hits were optimized (Figure 35 A) but the crystals were still multi-layered and 
had an insufficient diffraction quality. The application of additive screens gave reasonable crys-
tals and diffraction data quality. A crystal grown in 19% (w/v) PEG3350, 0.3 M CaCl2 supple-
mented with 0.2% (w/v) caffeine/cytosine/nicotinamide/gallic acid monohydrate/sodium py-
rophosphate tetrabasic decahydrate, 0.02 M Hepes pH 6.8 (Silver Bullets E1, Figure 35 B) dif-
fracted best with a maximum resolution of 1.35 Å (Table 17). 
 
Since no homologous structures were available for PA2723, the phasing was done ab initio with 
the program Arcimboldo LITE (Rodríguez et al., 2009). The crystal structure contained two mol-
ecules of PA2723 in the ASU and was refined to a final Rcryst of 15.91 % and an Rfree of 18.02 % 
(Table 17). The Matthews coefficient (Matthews, 1968) for two molecules per ASU was calcu-
lated to a rather low value of 1.78 Å/Da, which corresponds to a solvent content of only 31 % 
indicating that PA2723 is rather densely packet. The electron density was well interpretable 
such that all 92 aa of both protein chains in the ASU including the extra N-terminal residues              
G-1 and H0 were modelled. 
 
 
 
 
 
 
Figure 35: PA2723 crystals. A: Initial crystals in 0.2 M CaCl2, 20 % (w/v) PEG3350. B: Optimized crystals in 19% 
(w/v) PEG3350, 0.3 M CaCl2 supplemented with 0.2% (w/v) caffeine/cytosine/nicotinamide/gallic acid mon-
ohydrate/sodium pyrophosphate tetrabasic decahydrate, 0.02 M Hepes pH 6.8. Scale bar: 200 µm. 
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Table 17: PA2723 data collection, processing and refinement statistics 
Data collection and processing                          PA2723 Refinement                                     PA2723 
Beamline† P11, Petra III Resolution range (Å) 39.39-1.35 
Detector Pilatus 6MF Completeness (%) 94.03 
Wavelength (Å) 1.033 Final Rcryst (%) 15.91 
Temperature (K) 100 Final Rfree  (%) 18.02 
Crystal-detector distance (mm) 172 No. of reflections  
Rotation range per image (°) 0.2 Working set 30262 
Total rotation range (°) 288 Test set 1500 
Exposure time per image (s) 0.2 No. of non-H atoms  
Space group P1 Protein 1466 
a,b,c (Å) 33.00 33.03 41.34 Ion 1 
α,β,γ (°) 93.92 103.17 118.33 Water 255 
Mosaicity (°)# 0.19 Total 1722 
Resolution range (Å) 39.39-1.35 (1.37-1.35) R.m.s. deviations  
Total No. of reflections 105451 (4731) Bonds (Å) 0.009 
No. of unique reflections 30273 (1508) Angles (°) 1.243 
Completeness (%) 94.0 (91.7) Average B factors (Å2) 
 
Multiplicity 3.5 (3.1) Protein  15.09 
Mean I/σ(I) 17.7 (1.7) Ion 20.07 
CC1/2+ 99.9 (73.1) Water 28.81 
Rpim$ 2.3 (54.9) Ramachandran plot  
Rmeas¥ 4.4 (100.1) Favored regions (%) 97.28 
Wilson B factor (Å2) 8.6 Outliers (%) 0 
 
 
MolProbity score‡ 1.17 
Values in parentheses are for the highest resolution shell, † Petra III (DESY, Hamburg, Germany), # Value as reported by AIMLESS (Evans & 
Murshudov, 2013). + CC1/2 as reported by (Karplus & Diederichs, 2012), $ Rpim = Σhkl (1/(N – 1))1/2 Σi | Ii (hkl) – < I (hkl) > | / Σhkl Σi Ii (hkl) (Weiss, 
2001); ¥Rmeas = Σhkl (N/(N – 1))1/2 Σi | Ii (hkl) – < I (hkl) > | / Σhkl Σi Ii (hkl), where N is the number of observations of the reflection with index hkl 
and Ii is the intensity of its ith observation (Weiss, 2001). ‡ MolProbity score as reported by MolProbity (Chen et al., 2010). 
4.1.3.3 Architecture of PA2723 
The overall structure of one PA2723 monomer revealed a central three-stranded antiparallel 
β-sheet (β1, β2, β3) flanked by three α-helices α1, α2 and α3 (Figure 36 A/B). The two molecules 
in the ASU are connected by a variety of H-bonds that are mediated between the two β2-strands 
of monomer A and B and thus create a central six-stranded antiparallel β-sheet (Figure 36 C/D). 
Further, side chains and main chain atoms of β2-strand amino acids are H-bonding with side 
chains that belong to α2-helices of both monomers (Figure 36 F/G). Besides that, a dense H-
bond network connects the amino acids at the N-terminal parts of both α3-helices, the preced-
ing loop regions as well as some amino acids of both β2-strands and of β3-strand of monomer A 
(Figure 36 E/H).  
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Figure 36: Architecture of PA2723. A/B) Topology of the monomer. Secondary structure elements are numbered from N- to C-
terminus. Alpha helices are colored in teal, β-strands are colored in grey and loop regions are white. A) Representation of the 
3D arrangement. B) Schematically representation drawn with TopDraw (Bond, 2003). C/F) Content of the ASU in different 
orientations. Monomer B is colored in teal and monomer A is colored grey. D/E/G/H) Enlargement of regions in which H-bonds 
are formed between both monomers in the ASU. H-bonds with a maximum distance of 3.2 Å are displayed as dashed lines. 
Oxygen atoms are colored red and nitrogen atoms are blue.  
A vast number of interactions between the monomers in the ASU, which are not formed to 
other symmetry related proteins suggest that the molecules in the ASU represent the actual 
oligomerization state of PA2723. Unfortunately, it was not possible to verify the dimeric state 
of the protein in solution experimentally. DLS did not give a result because the protein sample 
was polydispers and the calculated MW from the analytical SEC was 15.1 kDa (Figure S7) which 
is right in between the monomer (10.5 kDa) and a possible dimer (21 kDa). A PISA analysis (Kris-
sinel and Henrick, 2007) indicated that the content of the ASU may or may not be thermody-
namically stable in solution, as the ΔGdiss had a slightly negative value of -0.6 kcal/mol.  
4.1.3.4 Calcium binding site 
The actual oligomerization state would also have a decisive influence on a potential metal bind-
ing site that is located between the N-terminal tips of the α3-helices from both monomers in 
the ASU. There, a spherical mFo-DFc electron density could not be explained by a water mole-
cule, as the electron density remained positive after refinement. The binding site is located at 
a negatively charged spot on the protein surface, suggesting that a cation binds there. Potential 
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candidates from the crystallization buffer (Table 11) were Na+ and Ca2+, but only Ca2+ had 
enough electrons to interpret the e--density. The calcium is coordinated by seven atoms in an 
octahedral geometry. The carboxyl oxygen of D66 (chain B) mediates a bidentate interaction. 
A carboxyl oxygen of D64 (chain B) and of D66 (chain A) as well as three water molecules occupy 
the other coordination sites (Figure 37).  
 
 
The octahedral geometry of the Ca2+-binding site, which is constituted by carboxylate side chain 
oxygen atoms, represents the typical environment of Ca2+-ions complexed in protein structures 
(Zheng et al., 2008) and supports the identity of the metal. The same accounts for the distances 
between the calcium and the carboxylate and the H2O oxygen (Figure 37 A). A further analysis 
with the metal binding site validation server checkMyMetal (Zheng et al., 2014, 2017) con-
firmed the identity of the metal as Ca2+. It is not clear if the presence of a metal-ion in the 
PA2723 structure has any functional or structural relevance since the ion-binding site would be 
disrupted if PA2723 is a monomer in solution. It is also possible that the binding site is a crys-
tallographic artefact, provoked by the high concentration of 300 mM CaCl2 in the crystallization 
condition.   
4.1.3.5 PA2723 adopts the R3H domain fold 
The online structure alignment tool PDBeFold (Krissinel & Henrick, 2004) was applied to find 
homologous structures. It detected only the NMR structure of the R3H domain of human 
sperm-associated antigen 7 (aa 37 to 130 of full-length protein, 10.59 kDa, PDB-ID: 2CPM), 
Figure 37: PA2723 Ca2+-binding site. A) Close up of the amino acid side chains and waters (blue 
spheres) that are complexing the Ca2+ (red sphere). The distances are given in Å. B) Location of the 
Ca2+-binding site on the overall structure.  
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which had more than 70 % of matching secondary structure elements. Both structures shared 
the same topology (Figure 38 A) and the core fold aligns with an RMSD of 3.6 Å (Holm & Laakso, 
2016) while the sequence identity is only 7 %.  
 
Figure 38: A) Overlay of a PA2723 monomer (grey) with the R3H-domain (rainbow coloring from the blue N-term. to the red C-
term.) of human sperm-associated antigen 7 (PDB-ID: 2CPM) in different orientations. B) Enlargement of α2-helices containing 
the conserved R3H-motif in the R3H-domain and the respective residues of PA2723 at the same position. Nitrogen atoms are 
blue and oxygen atoms are red. 
R3H domains are named after their conserved R3H-motif on the α2-helix. It consists of a con-
served ARG- and HIS-residue that are separated by three other amino acids (Figure 38 B). R3H-
domains are usually part of bigger protein complexes, where they mediate nucleic acid binding 
by the R3H-motif (Grishin, 1998; Jaudzems et al., 2012). In PA2723 Q33 and N36 (Figure 38 B) 
replace the nucleic acid binding amino acids. This indicates that PA2723 does not have the same 
nucleic acid binding functions as other R3H-domains.    
A further search conducted with DALI (Holm & Laakso, 2016; Holm & Rosenström, 2010) against 
the PDB archive revealed almost 500 hits with Z-scores above 3.0 and sequence identities be-
tween 3 and 16 %. The best hit (Z-score: 5.9) was the already described R3H-domain from 
sperm-associated antigen 7. Most of the other hits were either nucleic acid binding proteins or 
functionally uncharacterized and hypothetical proteins such that this search did not deliver 
new indications towards a potential function. 
4.1.3.6 Protein surface mapping 
To identify a potential active or ligand-binding cavity, the electrostatic surface of PA2723 was 
generated. The surface of the monomer and the dimer were analyzed separately since the oli-
gomerization state is unclear (Figure 39 A/B).  
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Figure 39: Surface mapping of PA2723. The monomers in the ASU are colored in gray and teal. The electrostatic surface of the 
grey monomer at the potential dimer interface (A) and of the whole dimer surface (B) is colored from red (-5 kT/e) to blue (5 
kT/e). Amino acid side chains that are facing the dimer interface (C) and that are at the surface of a possible binding cavity are 
represented as balls and sticks. Nitrogen atoms are colored blue, oxygen atoms are red and sulfur atoms are yellow. Dashed 
lines are H-bonds with a maximum distance of 3.2 Å. The molecules from A, B and C are oriented equally and the monomer in 
figure D is rotated 45° along the y-axis. Flexible residues that were not modelled completely are highlighted by grey nametags. 
The potential dimer interface was quite uncharged. This could indicate that this part is not sol-
vent exposed but buried in the dimer interface and would support the dimerization of the pro-
tein. Besides that, the interface lacks any cavities and has only a low amount of potential func-
tionally relevant amino acids. In general about two thirds of the residues that participate in 
catalysis are charged and one third are polar residues, while under 10 % are aliphatic (Bartlett 
et al., 2002), but the potential interface comprised almost 50 % of aliphatic residues like ILE, 
LEU, VAL and ALA (Figure 39 C). The charged and polar residues are mainly distributed along 
the α2 and α3 helix including the already mentioned Q33 and N36 (Figure 39 C). However, most 
of those residues would participate in the dimerization and can therefore not be of functional 
relevance.  An interesting part of PA2723 is the negatively charged pit between the α1 and the 
α3 helix (Figure 39 D). It is on the other side of the interface, is independent from the other 
monomer and is therefore not influenced by the dimerization. The most mentionable residues 
are H8, as HIS are most abundant in active sites (18 % of catalytic residues) (Bartlett et al., 
2002), Y22, which is in H-bonding distance to the HIS side chain, and C24 in the immediate 
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vicinity of these two residues. HIS and TYR side chains often participate in acid/base catalysis 
and HIS is known to activate catalytic water molecules, cofactors or other residues, while TYR 
often stabilizes transition states. CYS most often acts as a nucleophile during catalysis (Bartlett 
et al., 2002). To see if this arrangement is important for the function of other enzymes the 
amino acid pattern search for substructures and motifs (ASSAM) server was run. It compares 
the 3D pattern of the input amino acids with the structures deposited in the PDB (Nadzirin et 
al., 2012). In this case, H8, Y22, C24 and D25 were input. Several hits with near identical ar-
rangement of respective residues were determined. The residues were found to be also sand-
wiched between an α-helix and a β-strand as in PA2723. However, the equivalent residues in 
other proteins were buried either in the protein or not near the active or ligand-binding site. 
Therefore, they were either not comparable to the situation in PA2723 or did not give new 
hints towards the function of the protein. Unfortunately, this was also true for cases were 
equivalent residues participated in ligand or metal binding. In most ligand binging sites HIS, 
TYR, CYS and ASP were part of a long tunnel that buried the ligand in the protein. Such a sce-
nario would not be possible for PA2723 as the residues are exposed. Therefore, it stays unclear 
if the residues H8, Y22, C24 and D25, which are often found in enzyme active centers, partici-
pate in an enzymatic reaction, in ligand binding or if they just stabilize the overall structure. 
Other residues that are abundant in active sites like D55, R79 and E85, R75 interact with each 
other via salt bridges and might thus stabilize the overall structure. Four negatively charged 
residues along the surface of the α1 helix create a charged patch at the protein surface and 
could be of functional relevance, i.e. for a protein-protein interaction.  
To derive functional relevant information from the structure, the coordinates were forwarded 
to the SPRITE-server (Nadzirin et al., 2012). This revealed only one relevant pattern, as most 
identified motifs did not participate in ligand binding or catalysis of the respective proteins. The 
only conclusive hit was found in levansucrase (EC 2.4.1.10, PDB-ID: 1OYG, (Meng & Fütterer, 
2003)). These bacterial proteins catalyze the synthesis of the polysaccharide levan. Relevant 
residues that are arranged as in PA2723 are the nucleophile D86 (equal to D55 in PA2723), the 
transition state stabilizer D247 (equal to D25 in PA2723) and the proton donor/acceptor E342 
(equal to E85 in PA2723). The active site and the identified pattern of levansucrase are at the 
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bottom of a deep binding tunnel that is enclosed by several residues that mediate sugar binding 
(Martínez-Fleites et al., 2005; Meng & Fütterer, 2003; Wuerges et al., 2015). Since the much 
smaller PA2723 does not have a deep binding tunnel and lacks other residues that are im-
portant for sugar binding it is quite doubtful that PA2723 could fulfill a function comparable to 
the levansucrase. 
 Conclusion and Outlook 
The experiments for the functional characterization of PA2721 delivered serval approaches for 
follow up experiments to identify the physiological role of this class III βαβββ-module protein. 
The comparative phenotypic characterization of the PAO1 PA2721::Tn mutant and the wt 
demonstrated that PA2721 plays no role for proper swimming and swarming motility and for 
the secretion of secondary metabolites like pyocyanin. The protein played no major role during 
central metabolism but might be involved in the proper catabolism of glycyl-L-proline if it is the 
only available carbon source. Glycyl-L-proline was not identified, as binding partner for PA2721 
during a crystallographic fragment screening campaign, which seems to indicate that the pro-
tein does not directly interact with the ligand. Fragment screening identified only one out of 96 
molecules that was able to bind in the potential binding tunnel of PA2721. Interestingly, this 
was the proline derivative N-benzyloxycarbonyl-L-proline. Since two independent experiments 
point to a connection between PA2721 and proline derivatives, proline metabolism is sug-
gested as a good starting point to search for compounds that interact with the protein or are 
processed by it.  
Chemical sensitivity assays indicated that PA2721 might indeed participate in the mediation of 
resistance mechanisms, since the PAO1 PA2721::Tn mutant had an altered respiration rate in 
the presence of compounds with antimicrobial activity. It was not possible to suggest a clear 
function because the identified compounds target different sites in the bacterium. However, 
many compounds lead to increased oxidative stress in bacterial cells. Therefore, PA2721 could 
contribute to anti-oxidant defense systems. The most promising leads were captan and di-
chlofluanid, which both covalently modified a potential catalytically active CYS in the binding 
tunnel. The mechanism that leads to the covalent modification and which part of captan and 
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dichlofluanid bind to the protein need to be identified. Mass spectrometry analysis to deter-
mine the total protein weight after the incubation with the compounds could be conducted to 
identify the mass of the attached molecule. High-performance liquid chromatography (HPLC) 
mass spectrometry could be used to analyze the reaction products after the compounds were 
incubated with and without the protein and be compared to respective standard molecules to 
identify the reaction products and if the compounds are hydrolyzed independent of the pres-
ence of the protein. Before PA2721 can be declared as captan and dichlofluanid resistance pro-
tein, the physiological relevance needs to be clarified. The chemical sensitivity assay supports 
this theory since P. aeruginosa is more susceptible to dichlofluanid in the absence of the pro-
tein but the result for captan contrasts with this. Therefore, the assays with dichlofluanid and 
captan should first be repeated to exclude that one of the results was a false positive or nega-
tive. Minimal inhibitory concentrations (MIC) should also be determined. One experiment to 
identify if PA2721 is specifically able to mediate the resistance towards both compounds would 
be a spot plate assay. For this, the protein could be expressed from a plasmid in E. coli cell 
cultures that are applied onto an agar plate supplemented with dichlofluanid or captan to as-
sess if E. coli acquires resistance. Before one can identify a connection between all results from 
the PMs, the interaction with captan and dichlofluanid and the fragment screening the PMs 
with the other identified compounds also need to be repeated to exclude any false positives. 
Further, it is necessary to perform a rescue experiment with these compounds to see if the wt 
phenotype can be reconstituted by expression of PA2721 from a transformed plasmid in the 
PAO1 PA2721::Tn mutant. This could proof that the phenotype is solely caused by the loss of 
PA2721 and not by a spontaneous mutation in another gene. It would also rule out that the 
transposon insertion influences the expression of the downstream gene PA2722 and be caused 
by a reduced amount of PA2722. 
Next to the results that were obtained for PA2721, successful purification strategies for high 
amounts of pure recombinantly expressed PA2722 and PA2723 were established during this 
study. The high-resolution crystal structure of the dimeric PA2722 had the characteristic β-tent 
fold found in the Gfa/CENP-V-like protein family. This study did not find indications that the 
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glutathione formaldehyde activating function is conserved in PA2722, since the conducted ex-
periments found no evidence for the interaction with glutathione. The only functionally char-
acterized member of the Gfa-like protein family in prokaryotes has an alternative dimerization 
mode to PA2722 and a distinct glutathione-binding pocket. Therefore, it is likely that PA2722 
fulfills a function that is independent of glutathione. PA2722 could even be part of a protein-
protein complex, like the human CENP-V protein that also contains a predicted Gfa-like domain. 
Since PA2722 will not have the same target as the human protein, a pulldown assay with pseu-
domonal crude extract or a yeast two-hybrid screen could be applied to identify a potential 
protein interaction partner.  
Crystallographic analysis of the unpredictable structure of PA2723 revealed that the protein 
does not display a novel fold but consists of a dimer of two R3H-like domains, which seems to 
be the first example of such a protein since R3H-like domains are usually part of multimeric 
proteins. Since the nucleic acid binding R3H-motif is not conserved in PA2723, it was not pos-
sible to suggest a potential function for PA2723. Especially in this case, a structure based func-
tional prediction was very difficult, since the surface revealed no clear binding cavity for small 
molecules. A crystallographic fragment-based screening as performed with PA2721 would be 
an approach for an experimental surface mapping to discover residues or patches that are im-
portant for small molecule binding. However, the PA2723 crystals have to be checked if they 
meet the requirements for a fragment screening. It should also be considered that PA2723 may 
not interact with small molecules but with other proteins. A protein interaction partner could 
be identified by a pulldown assay in which PA2723 is immobilized to a matrix and exposed to 
P. aeruginosa cell lysate to bait a protein that has an affinity to PA2723. Alternatively, a yeast 
two-hybrid screen as suggested for PA2722 could also be applied here. The physiological role 
of PA2722 and PA2723 could also be investigated in microbiological assays as done for PA2721 
with transposon insertion mutants that are available for both genes in the PA14 background.   
4.2 PA1672 
The class III βαβββ-module protein PA1672 (13.5 kDa, 126 aa) is encoded in an ORF that is not 
part of a bigger operon according to Wurtzel et al., 2012. The structure of the homodimeric 
protein was initially determined and bioinformatically analyzed in a preceding study (Vit, 2015) 
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but no leads towards a potential function of PA1672 have been derived. Recently, the crystal 
structure of the βαβββ-module-containing protein Rv0577 (MW: 27 kDa, 261 aa) from Myco-
bacterium tuberculosis was discussed in the literature (PDB-ID: 3OXH, Buchko et al., 2017). It 
belongs to the monomeric type that encodes four βαβββ-modules per protein chain with dis-
tinct binding sites. One site contained the conserved aromatic residues from class II proteins, 
but the second site had none of the conserved aromatic and metal-complexing residues and 
can be assigned to class III. Therefore, the focus was on the comparison between PA1672 and 
the second class III-like site of Rv0577 (Rv0577_S2, aa 141-261). The sequences that participate 
in each binding site were aligned individually to the sequence of PA1672 (Figure 40).  
 
Figure 40: Sequence alignments of PA1672 with Rv0577_S1 (upper panel) and Rv0577_S2 (lower panel). Sequences were 
aligned with Clustal Omega (Li et al., 2015) and colored with ESPript 3.0 (Robert & Gouet, 2014).  
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The sequence of PA1672 is not homologous (seq-ID:  ̴20 %) to both sites of Rv0577 but based 
on the conserved βαβββ-fold the overall structures align fairly well (Figure 41 A, RMSD: 3.6 Å). 
However, only 6 of the conserved residues (Figure 40) point into the potential binding sites and 
most of them are aliphatic or hydrophobic amino acids, suggesting that these do not participate 
in enzyme catalysis but might rather contribute to ligand binding (Bartlett et al., 2002; Holliday 
et al., 2009). Conserved residues that could participate in catalysis (Bartlett et al., 2002) are the 
polar Y72 and the negatively charged E8 from PA1672, which align with Y80 and D16 in the first 
binding site of Rv0577 (Rv0579_S1; Figure 40, upper panel) and with Y208 and E148 in the sec-
ond (Rv0577_S2; Figure 40, lower panel). The direct comparison of all amino acids flanking the 
potential binding sites revealed that PA1672 has some similarities to Rv0755_S2 that were not 
conserved in the sequence alignment and that are not present in Rv0755_S1 (Figure 41).  
 
Figure 41: Crystal structures of βαβββ-module-containing proteins PA1672 (Vit, 2015) and Rv0577 (PDB-ID:3OXH, Buchko et 
al., 2017). A) Overlay of the tertiary structures in different orientations (RMSD: 3.6 Å). B) Detailed insight in the aligned poten-
tial binding sites of PA1672 and Rv0577_S2. All figures show the binding sites of the monomeric Rv0577 in light (S1) and dark 
(S2) red, the monomers of PA1672 in light (chain A) and dark (chain B) grey and related amino acid residues from PA1672 and 
Rv0577 S2 are shown as balls and sticks. Dashed lines represent H-bonds with a maximum distance 3.2 Å. 
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In the structures, M40 of PA1672 aligns with M149 from Rv0577. Two HIS residues and a further 
TYR residue that is in H-bonding distance to the conserved GLU side chain are also present in 
both structures (Figure 41 B). They create a mirror-inverted but conserved amino acid pattern 
in both potential active sites. Since, HIS belongs to the most abundant catalytic residues to-
gether with charged amino acids, followed by residues with polar groups (Bartlett et al., 2002), 
this pattern might play a crucial role in the function of both proteins. The rest of both binding 
sites are dominated by hydrophobic and unpolar aromatic amino acids that are partially align-
ing with each other (Figure 40, lower panel). Independent of the low sequence identity, these 
structural similarities between PA1672 and the second binding site of Rv0577 point to a similar 
function. Unfortunately, the molecular function of Rv0577 is not yet known, but the protein is 
secreted by M. tuberculosis (Rosenkrands et al., 2000) and overexpressed during tuberculosis 
infections such that it is also discovered in the sputum of tuberculosis patients (Huard et al., 
2003). Moreover, Rv0577 was shown to interact with human Toll-like receptor 2 (TLR2), which 
leads to an altered immune response (Byun et al., 2012). Since, Rv0577 has two distinct binding 
sites and is probably able to fulfill several functions, it is difficult to suggest which of the men-
tioned roles of Rv0577 could also be carried out by PA1672. 
 Phenotyping of a PA14 PA1672::Tn mutant 
The physiological role of PA1672 was propped by comparative analysis of the PA14 wt and the 
PA1672 transposon insertion mutant in the PA14 background (PA14 PA1672::Tn, Figure 42). 
The PA14 PA1672::Tn mutant from Liberati et al., 2006 was kindly provided by Prof. S. Häußler 
of the HZI. PCR and sequencing of the PCR product confirmed the MAR2xT7 transposon in the 
ORF of PA1672 at bp 185 as stated by the manufacturer (Liberati et al., 2006).  
 
Figure 42: ORF of PA14_42870, which is the PA14 homologue of PA1672 from PAO1. The genomic localization given in bp  was 
derived from pseudomonas.com (Winsor et al., 2016). The transposon insertion site (Tn) of the PA14 PA1672::Tn mutant used 
in this study is indicated by a grey arrow. The position of the insertion in the ORF is given in units of bp and the total length of 
the gene in brackets. 
98 | R e s u l t s  a n d  D i s c u s s i o n  
 
The phenotypes of the bacteria were characterized towards planktonic growth, swimming and 
swarming motility and on Phenotype MicroArraysTM towards the utilization of carbon-sources 
and towards their chemical sensitivity for antimicrobial compounds. 
4.2.1.1 Planktonic growth and motility 
The mutant had comparable planktonic growth and was able to migrate through the low-vis-
cous swimming agar to a similar extent as the wt (Figure 43 A/B/D). A strong reduction of the 
swarming motility was observed (Figure 43 C/D). In contrast to the swarming negative-control 
(PA14 rhlR::Tn), the swarming colony of PA14 PA1672::Tn was able to migrate a small distance 
away from the point of inoculation but was unable to build out the characteristic tendrils that 
give the wt PA14 swarming colonies the characteristic pattern (Figure 43 C/E).  
 
Figure 43: Phenotypic characterization of a P. aeruginosa PA14 PA1672 transposon insertion mutant (PA14 PA1672::Tn) in 
comparison to the respective wild type (PA14 wt) and a swimming (PA14 flgK::Tn) and swarming (PA14 rhlR::Tn) deficient 
mutant. A) Planktonic growth curves of the mutant and the wt. Displayed is the increase of the optical density of the cell 
cultures measured at 600 nm (OD600) over time (t (min)). The bacteria were incubated in LB medium under shaking conditions 
at 37 °C. B/C) The diameters of swimming and swarming colonies were determined from three independent experiments, after 
incubation for 19 (swimming) and 18 h (swarming) at 37 °C. Error bars represent the deviation calculated from the mean trip-
licates. D/E) Examples of the respective swimming (Figure S2) and swarming colonies (Figure S3). 
Swarming motility is dependent on a properly functioning flagellum, type IV pili and the pro-
duction and secretion of rhamnolipids (Köhler et al., 2000). In contrast to that, swimming is 
only dependent on flagellar movement. Since the PA1672 mutant exhibited the same surface 
coverage as the wt during swimming assays (Figure 43 B/D) the protein is unlikely to influence 
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the proper movement of the flagellum. Type IV pili also play a crucial role during biofilm for-
mation for the initial adherence of the bacteria (Gellatly & Hancock, 2013) so that mutant 
strains that are deficient in type IV pili formation fail to develop a biofilm (O’Toole & Kolter, 
1998). However, the PA1672 mutant exhibited a thick biofilm layer at the interface between 
the bacterial culture and air attached to the glass wall of the beaker during planktonic growth 
experiments. This was not discovered during planktonic growth of the wt and the other PA14 
Tn mutants, indicating that PA1672::Tn has an upregulated biofilm phenotype. This phenotype 
is contraindicative to any connection between PA1672 and the proper function of the type IV 
pili and may indicate that PA1672 rather influences the production or secretion of rhamno-
lipids. Rhamnolipids are glycolipidic surface-active agents (surfactants). They are essential as 
wetting agent, reducing the surface tension between the bacterium and the environment to 
enable the movement over the surface (Kearns, 2010). The amphiphilic molecules are consti-
tuted of one (monorhamnolipids) or two (dirhamnolipids) hydrophilic rhamnose groups and a 
hydrophobic 3-(3-hydroxyalkanoyloxy)alkanoic acid (HAA) moiety (Soberón-Chávez et al., 
2005). The HAA precursors of rhamnolipids are also secreted by the bacterium and also exhibit 
a crucial role during swarming motility (Déziel et al., 2003). Interestingly, if the rhamnolipid 
secretion is completely suppressed, the swarming motility is also abolished, but if only HAAs 
are secreted, the swarming phenotype is not completely abolished but significantly reduced 
compared to the wt (Déziel et al., 2003). Since this resembles the swarming phenotype of PA14 
PA1672::Tn, which is only reduced, and not completely abolished as in the PA14 rhlR::Tn nega-
tive control, the discovered phenotype of PA14 PA1672::Tn might be connected to a reduced 
level of rhamnolipids while HAAs are produced.  
The reduced motility phenotype in connection with an increased biofilm formation indicates 
that the mutant promotes the sessile lifestyle of P. aeruginosa (Rasamiravaka et al., 2015), 
since such a phenotype was discovered before for components that participate in the inverse 
regulation of biofilm formation and swarming motility (Caiazza et al., 2007; Li et al., 2017). 
However, this inverse regulation is a complex network to which a variety of complex bacterial 
systems contribute, such as the quorum sensing system, two-component regulatory system 
pathways such as GacS/GacA (Rasamiravaka et al., 2015) or chemotaxis-related regulatory 
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pathways (Caiazza et al., 2007) together with others and probable yet unidentified systems. 
The complexity of the regulatory pathways for motility and biofilm behavior, which are not 
even fully understood today, makes it impossible to suggest a precise function for the PA1672 
protein from these findings and requires further investigations.  
4.2.1.2 Phenotypic MicroArraysTM - carbon source utilization 
Phenotypic MicroArraysTM were performed to analyze the ability of PA14 PA1672::Tn to catab-
olize different compounds as sole carbon source. The PA1672 mutant was not able to metabo-
lize 13 carbon sources as effectively as the wt since the mutant was unable to reach the same 
respiration activity in the stationary phase (Figure 44).  
 
Figure 44: Carbon source utilization Phenotype MicroArraysTM of PA14 PA1672::Tn. Displayed are the respiration curves of 
PA14 PA1672::Tn (grey) in comparison to the wt strain (black). The red color is highlighting the reduced phenotype of the 
mutant. The values in parentheses describe the number of the respective Phenotype MicroArrayTM and of the wells containing 
the compound. The respiration curves were obtained by plotting the measured absorbance in arbitrary units from 0-400 de-
tected at 490 nm (y-axes) against the incubation time from 0-48 h (x-axes). To highlight the deficiency of the mutant, the area 
between the respiration curves was colored red. The chemical structures of the respective compounds were obtained from 
the PubChem database (Kim et al., 2016) and visualized with ChemDraw Professional 17.0. 
Since the compounds belong to several chemical classes, including purine nucleosides (inosine, 
adenosine), amino acids (aspartic acid, arginine), carbon acids, glycerol and the monosaccha-
ride N-acetyl-D-glucosamine, it would be very difficult to deduce the actual reaction that influ-
ences the breakdown of those compounds and might go back to PA1672. To narrow down the 
possibilities, the interaction of these compounds with the PA1672 protein was examined by a 
TSA as described in section 4.2.2. 
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4.2.1.3 Phenotypic MicroArraysTM - chemical sensitivity 
The chemical sensitivity of PA14 PA1672::Tn towards 240 compounds with antimicrobial activ-
ity was also tested with PMs. This revealed significant phenotypic differences. The mutant dis-
played a better respiration rate on 14 compounds and a decreased rate when incubated on 12 
compounds in comparison to the wt (Figure 45). However, to suggest a physiological role for 
PA1672 the common connection between the compounds’ antibacterial mechanism has to be 
identified. Based on their chemical structure or their site of action, some compounds can be 
differentiated in functional groups. Since the distinct groups target different sites in bacteria, it 
is challenging to derive a physiological function for PA1672.  
One big functional group, for example, comprises membrane active agents that destroy the 
membrane integrity and cause cell leakage, leading to death. Among them are the last resort 
peptide antibiotic Polymyxin B (Evans et al., 1999), the detergent lauryl sulfobetaine and the 
organic acid caprylate (Royce et al., 2013). Phenolic compounds also increase the membrane 
permeability, such as chloroxylenol (McDonnell & Russell, 1999), 2-phenylphenol (Hugo & 
Bloomfield, 1971) and gallic acid (Borges et al., 2013). Hexachlorophene is another phenolic 
compound that can disturb the membrane integrity but its primary antimicrobial action is the 
inhibition of the membrane-bound electron transport chain (McDonnell and Russell, 1999). The 
antimicrobial activity of 8-hydroxyquinoline is due to its metal-chelating properties for bivalent 
cations. It depletes metals that are essential for metabolism on the one hand and cations that 
are important for stabilizing the negative charge of the membrane surface on the other (Pra-
chayasittikul et al., 2013). Albeit the membrane active compounds have the same target, they 
induce contrasting phenotypes: whereas polymyxin B, chloroxylenol and 2-phenylphenol in-
hibit the respiration of the PA1672::Tn mutant, the others increase the phenotype in compari-
son to the wt (Figure 45). That some functionally similar compounds induce opposing pheno-
types makes the interpretation of the PM assays difficult. The β-lactam antibiotics cefsoludin, 
azlocillin and nafcillin also induced opposing phenotypes. Despite all inhibit the bacterial cell 
wall synthesis by covalent modification of the penicillin-binding protein that catalyzes the pep-
tidoglycan cross-linkage (Kong et al., 2010), PA1672::Tn is more susceptible to azlocillin and 
nafcillin but more resistant to cefsoludin (Figure 45). 
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Figure 45: Chemical sensitivity Phenotype MicroArraysTM of PA14 PA1672::Tn. Displayed are the overlaid respiration curves of 
the wt (black) and the mutant (grey) that were incubated on four concentrations of substances with potential antibacterial 
function, that induced significant changes between the wt and the mutant. The values in parentheses describe the number of 
the respective Phenotype MicroarrayTM and of the wells containing the compound. The respiration curves were obtained by 
plotting the measured absorbance in arbitrary units from 0-400 detected at 490 nm (y-axes) against the incubation time from 
0-48 h (x-axes). To highlight the differences, the area between the respiration curves was colored green if the mutant respired 
better than the wt or red if the respiration of the mutant was inhibited. The chemical structures were obtained from the 
PubChem database (Kim et al., 2016) and visualized with ChemDraw Professional 17.0. 
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Other compounds that act on a variety of targets are for example the aminoglycoside antibiotic 
tobramycin, which blocks the protein biosynthesis by the inhibition of ribosomes (Bendush & 
Weber, 1976; Brogden et al., 1976). The fluoroquinolone antibiotic enoxacin inhibits DNA rep-
lication by direct interaction with the DNA-unwinding gyrase and topoisomerase IV (Drlica, 
1999). The antimicrobial activity of dichlofluanid is based on its reactivity against sulfhydryl 
groups (Schuphan et al., 1981). It can react with glutathione and cause depletion of the bacte-
rial glutathione pool, which ultimately increases the oxidative stress (Masip et al., 2006). Phe-
nylmethylsulfonyl fluoride (PMSF) is a serine protease inhibitor (Fahrney & Gold, 1963). P. ae-
ruginosa PAO1 encodes the two potential serine proteases MucD and PA3535 (EprS). The se-
creted protease MucD degrades human interleukin-8, which helps to protect the bacteria 
against the human immune response (Okuda et al., 2011). EprS was demonstrated to activate 
host inflammation by activation of human protease-activated receptors (Kida et al.). Since the 
human targets of the proteases are not available, it was not possible to find an explanation for 
the gain of function phenotype that is induced by the inhibition of serine proteases by PMSF in 
the PM. Further, it was not possible to suggest how serine proteases and PA1672 interplay with 
each other such that this open question remains to be elucidated in another study. Another 
detected compound, sulfanilamide, is a sulfonamide antibiotic. It is a substrate analog to para-
aminobenzoic acid (PABA) (Woods, 1940) and thus a competitive inhibitor of folic acid produc-
tion, which is an important cosubstrate during purine and pyrimidine synthesis (Stokstad & 
Jukes, 1987).  
Another aspect that needs to be considered with respect to deriving a function of PA1672 from 
these PM data are the results from PMs conducted with the other transposon mutants of 
βαβββ-module genes in the PA14 background (Figure S4). The comparison with the respiration 
curves from PA14 PA4183::Tn (Figure 54), PA1358::Tn (Figure 59 A) and PA4518::Tn (Figure 
67 A) revealed that enoxacin, polymyxin B, azlocillin, 2-phenylphenol and lauryl sulfobetaine 
caused significant changes in several mutants. Tobramycin and chloroxylenol even caused 
changes in all tested PA14 mutants. This could indicate that the function of all four class III 
βαβββ-proteins are at some point affecting each other or that the inserted transposon itself is 
responsible for the altered phenotype in comparison to the wt. Therefore, these results should 
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be regarded and discussed with caution. One group of compounds exclusively altered the res-
piration of the PA1672::Tn mutant. It contains the structurally related phenothiazines chlor-
promazine, promethazine and thioridazine as well as amitriptyline, pridinol and procaine (Fig-
ure 45). They are human therapeutics that act on receptors or ion channels and are used as 
antidepressants, muscle relaxants or local anesthetics. Albeit their antimicrobial activity has 
been confirmed on a wide range of bacteria (Hendricks et al., 2003; Ramu & Ramu, 1992; 
Schmidt & Rosenkranz, 1970), the actual cause of it is not well understood. They also mediate 
opposing phenotypes in the mutant, which is more susceptible to procaine but less susceptible 
to the others (Figure 45). Therefore, no connection between the function of PA1672 and these 
human therapeutics could be made.    
 Phenothiazines interact with PA1672 
To identify a precise enzymatic function from the phenotypic changes, the respective com-
pounds were tested in in vitro interaction studies with the recombinantly expressed PA1672 
protein (Figure S1). The first experiment was a TSA to identify compounds that cause a signifi-
cant change in the proteins Tm (ΔTm) upon binding. A TSA was conducted with all available com-
pounds (Figure 46).  
 
Figure 46: Result of the TSA to analyze the influence of compounds, identified in Phenotype MicroArraysTM with carbon sources 
and chemical sensitivity with the PA14 PA1672::Tn, on the thermal stability of the isolated protein PA1672. Changes in thermal 
stability (ΔTm) of PA1672, that were caused upon incubation with the respective compounds in comparison to the reference 
Tm of 59 °C, measured under the same buffer conditions but without the compounds. ΔTm were determined by averaging 3 
independent experiments. 
This revealed that none of the carbon sources altered the thermal stability of the protein, which 
has a Tm of 59 °C in the reference condition. This indicates that the carbon sources are not 
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directly interacting with PA1672 under the tested conditions. Five compounds from the chem-
ical sensitivity assay induced a significant Δ Tm of ± 1 ° and were further tested in MST experi-
ments together with the compounds that only caused changes of ± 0.7 °. Most of the tested 
compounds did not yield a significant change in the MST signal or a sigmoidal binding curve, 
indicating that these compounds do not interact with the protein under the tested conditions. 
However, the related compounds promethazine and chlorpromazine decreased the fluores-
cence signal. A SD-test (3.2.4.4) confirmed that the fluorescence change is caused by a binding 
event such that the interaction of chlorpromazine and promethazine with PA1672 was corrob-
orated by this method. To derive the dissociation constant (KD), both compounds were titrated 
against PA1672 (Figure 47 A/B). The KD could only be estimated from the derived curves since 
the saturation baseline was not measurable. Both had rather a low affinity with a KD of 
335 ± 12 µM for chlorpromazine and 382 ± 19 µM for promethazine. Due to the low affinity of 
promethazine and chlorpromazine, the concentration of the compounds had to be increased 
to reach saturation of the protein. Unfortunately, saturation was not accurately measurable 
since the compounds started to unspecifically change the fluorescence at concentrations 
higher than 1.25 mM for promethazine and 0.625 mM for chlorpromazine. Additional ITC-ex-
periments were performed to verify binding without covalent labelling of the protein. This con-
firmed the low affinity binding of chlorpromazine and promethazine to PA1672 but a sigmoidal 
curve, required to derive a reliable KD, was also not established for this experiment (Figure 47 C-
F). In the case of ITC-experiments, the concentration of the binding partner in the cell has to be 
at least 10 times higher than the KD to derive an evaluable curve (Buurma & Haq, 2007). This 
means that according to the KD derived from MST a concentration of roughly 4 mM PA1672 
would have been required. To achieve this, the amount of 100 mg of protein would have been 
necessary for each measurement, which could not be provided. 
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Figure 47: MST- (A/B) and ITC- (C-F) experiments of PA1672 with promethazine (○) and chlorpromazine (●). A/B) Titration of 
promethazine (KD: 382 ± 19 µM) and chlorpromazine (KD: 335 ± 12 µM) against Cy5-NHS-labeled PA1672. The collected data 
points that were not considered for curve fitting are represented in grey. Error bars represent the deviation calculated from 
the mean triplicates. The data were evaluated with the MO.Affinity Analysis software v2.15 (NanoTemper Technologies GmbH). 
C-F) Titration of promethazine and chlorpromazine against unlabeled PA1672. C/D) Raw data of the titration of the compounds 
(black) and of the buffer reference (grey) against PA1672. ITC profiles were evaluated with Origin7 (OriginLab Corp.). 
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A complex crystal structure with the identified compounds could have helped to suggest an 
enzymatic function. Unfortunately, the PA1672 crystal was not reproducible for soaking exper-
iments and cocrystallization gave no or not diffracting crystals. Regardless, the biophysical ex-
periments above indicate that the phenothiazine compounds chlorpromazine and prometha-
zine are direct binding partners of PA1672. However, it remains necessary to identify if PA1672 
can use them as a substrate and turn them over or if these ligands might represent substrate 
analogues that might not be able to bind as effectively as the actual substrate and could explain 
the weak affinity. Based on these ligands it would also be possible to screen for compounds 
with a similar chemical structure to identify ligands with a higher affinity that might lead to the 
actual substrate of PA1672. Phenothiazines are histamine analogues that inhibit the histamine 
H1-receptor in human cells (H1-antihistamines) by competitive interaction with the receptor 
(Simons & Simons, 2011). Therefore, the natural compound histamine that plays a major role 
during inflammation and immunomodulation (Simons & Simons, 2011) is considered as good 
starting point for a substrate search for PA1672. 
 Conclusion and Outlook 
The phenotypic characterization delivered many starting points for follow-up experiments that 
might lead to the functional characterization of the βαβββ-module protein PA1672. With the 
Phenotypic MicroArraysTM the most promising lead was discovered, since the interaction be-
tween PA1672 and the phenothiazines chlorpromazine and promethazine was demonstrated 
with two independent methods. Phenothiazines are histamine analogues that inhibit the hista-
mine H1-receptor in human cells (H1-antihistamines) by competitive interaction with the recep-
tor (Simons & Simons, 2011). Therefore, the natural compound histamine that plays a major 
role during inflammation and immunomodulation (Simons & Simons, 2011), is considered as a 
good starting point for a substrate search for PA1672. Interestingly histamine indirectly en-
hances the sensitivity of endothelial cells towards gram-negative cell wall components since it 
induces the expression of the human Toll-like receptors (TLR) 2 and 4 (Talreja et al., 2004). TLR 
are a central part of the innate immune system that sense the invasion of pathogens by recog-
nition of conserved bacterial particles and transduce signals that lead to the secretion of cyto-
kines (Kumar et al., 2011). Cytokines of the Interleukin type (IL) such as IL-6 or IL-8 again trigger 
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the immune response and inflammation to combat the bacterial infections (Akdis et al., 2011; 
Li et al., 2001). To establish a successful infection, P. aeruginosa developed several mechanisms 
to evade the human immune response. One of them is the formation of biofilms that protects 
the bacterial aggregates (Alhede et al., 2014). Active anti-immune mechanisms are mediated 
by secreted proteases that degrade human immune signal proteins. One example is the already 
mentioned secreted protease MucD that degrades IL-8 and therefore helps to reduce immune 
signaling (Okuda et al., 2011). If histamine indeed interacts with PA1672 a similar mechanism 
is also imaginable for PA1672, since it is encoded in the genomic neighborhood of the second 
type 6 secretion system (H2-T6SS) and has a conserved active site amino acid pattern with the 
βαβββ-module protein Rv0577 that is a virulence factor of M. tuberculosis. Accordingly, 
PA1672 could be secreted to the host cell via the T6SS and degrade histamine to reduce the 
histamine mediated production of TLR 2 and 4 to evade the immune response. To promote this 
hypothesis, one has to conduct further experiments that proof the interaction or the reaction 
between PA1672 and histamine and the secretion of PA1672.  
A further idea for the physiological function of PA1672 takes the reduced swarming motility in 
combination with an enhanced biofilm formation phenotype that was discovered in the PA14 
PA1672::Tn mutant into consideration. If PA1672 is not secreted it could bind histamine that 
diffuses into the bacterial cytoplasm after host infection. PA1672 could then fulfil a sensor-like 
function to promote the sessile lifestyle with reduced motility and enhanced biofilm produc-
tion. The first step to substantiate the involvement of PA1672 in swarming motility and biofilm 
formation would be a complementation experiment of the PA14 PA1672::Tn mutant with a 
plasmid that expresses the PA1672 protein. If the complemented bacterium is able to swarm 
in the same extend as the wt, the swarming deficiency would indeed have been caused by the 
disruption of the PA1672 gene. 
4.3 Open reading frame PA4183  
The structurally uncharacterized class III βαβββ-module protein PA4183 (155 aa, 17.2 kDa (Gas-
teiger et al., 2005)) was a subject of a preceding study (Vit, 2015). There, the full-length protein 
was insoluble during recombinant expression in E. coli but a successful purification strategy was 
established for an N-terminally truncated version (Vit, 2015). The truncated PA4183 lacks the 
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first 15 aa and is referred to as PA418316-155 (140 aa, 15.6 kDa (Gasteiger et al., 2005)). Accord-
ing to Wurtzel et al., 2012 PA4183 is encoded in an operon with the upstream gene PA4184 
(Figure 48).  
 
Figure 48: ORFs PA4183 and souR in the P. aeruginosa PA14 strain. The actual locus ID of the PA4183 homologue in the PA14 
strain is PA14_09780. Operon organization and genomic localizations are derived from pseudomonas.com (Winsor et al., 2016). 
The verified transposon insertion site (Tn) of the PA14 PA4183::Tn mutant from Liberati et al., 2006 is indicated by a grey arrow. 
The position of the insertion in the gene is given in units of bp. The total length of the gene is given in brackets.  
PA4184 (340 aa, 38 kDa (Gasteiger et al., 2005)) is a two-domain transcriptional regulator from 
the glutamine amidotransferase I-like (GATR) subfamily. It was recently identified as sarcosine 
oxidation and utilization regulator (SouR) (Willsey & Wargo, 2016). Willsey & Wargo, 2016, 
found out that SouR induces the expression of genes coding for proteins that are required for 
the catabolism of sarcosine (N-methylglycine) in response to sarcosine and that this regulator 
is essential for bacterial growth if sarcosine is the only available C- and N-source. Further, they 
conducted a growth assay with a PA4183 transposon mutant in a PA14 background offering 
sarcosine as sole C-/N- source. This mutant displayed a growth defect compared to reference 
strains but was less sensitive than the souR-deficient mutant. This indicates that PA4183 is not 
essential but involved in the sarcosine catabolism to achieve its optimal utilization (Willsey & 
Wargo, 2016). Therefore, the sarcosine catabolism served as a starting point to search for po-
tential substrates of PA4183 to reveal its function. 
 Background information for sarcosine metabolism 
Sarcosine occurs in the natural habitat of P. aeruginosa or as metabolism intermediate during 
the breakdown of glyphosate, creatine, carnitine or choline (Kishore & Jacob, 1987; Meadows 
& Wargo, 2018; Nimmo-Smith & Appleyard, 1956; Wargo & Hogan, 2009; Wargo et al., 2008). 
An overview of the sarcosine pathway and the enzymes so far identified to participate in its 
breakdown are displayed in Figure 49. SouR was identified to directly up-regulate the transcrip-
tion of the sox-operon, which contains the genes coding for the heterotetrameric sarcosine 
oxidase SoxBDAG, the serine hydroxymethyltransferase GlyA1 and the formyltetrahydrofolate 
deformylase PurU2 (Willsey & Wargo, 2016). The sarcosine oxidase catalyzes the FAD- and 
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FMN-dependent oxidative demethylation of sarcosine to glycine by transformation of the me-
thyl group to tetrahydrofolate (THF). Under THF-limited conditions, H2O serves as alternative 
methyl group acceptor and formaldehyde is produced (Wagner & Jorns, 1997). In both cases, 
the final electron acceptor is O2, which is reduced to H2O2. To cope with the cytotoxic effects 
of formaldehyde, SouR also upregulates the expression of the formaldehyde detoxification 
genes fdhA, adhC and PA3628 (Willsey & Wargo, 2016), which code for the glutathione-inde-
pendent (FdhA) and the glutathione-dependent formaldehyde dehydrogenase (AdhC) as well 
as for a S-formylglutathione hydrolase (PA3628).  
 
Figure 49: Excerpt from the sarcosine metabolism and the formaldehyde detoxification pathway under the transcriptional 
regulation of SouR (grey boxes) from P. aeruginosa. The red box displays the reaction catalyzed by PurU2, which is, with GlyA1 
and SoxBDAG, encoded in the sox-operon and controlled by SouR. Characterized enzymes, which participate in the pathway 
are shown in bold letters. The diagram is adapted from Willsey & Wargo, 2016 and Meadows & Wargo, 2018. 
 Potential interaction of PA4183 with compounds from the sarcosine pathway 
To find indications for the function of PA4183 and its involvement in the sarcosine metabolism, 
evidence for the interaction with possible substrates or ligands (Figure 50) from the sarcosine 
pathway (Figure 49) were searched. A TSA was conducted with the previously purified 
PA418316-155 (Vit, 2015) to identify compounds that alter the Tm.  
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Figure 50: Ligands from the sarcosine metabolism, which were tested in a TSA with PA418316-155 and in MST-experiments with 
His6-PA418316-155. The chemical structures were obtained from the PubChem database (Kim et al., 2016) and visualized with 
ChemDraw Professional 17.0.  
None of the tested compounds changed the Tm of PA418316-155, which was 48 °C in SEC buffer. 
This was verified by MST experiments conducted with the recombinantly expressed His6-la-
belled version of the protein, His6-PA418316-155 (Figure S1), where no binding curves were ob-
served. Since none of the compounds from the central sarcosine pathway interacts with the 
protein, one approach to identify a binding partner would be to extend the search for com-
pounds in pathways that are branching of from the sarcosine metabolism. In addition, the path-
ways that detoxify the harming side products of sarcosine demethylation, as formaldehyde 
should be taken into consideration. The search for a potential binding partner could be facili-
tated by identifying the tertiary structure of PA4183, because the location of the active sites of 
βαβββ-proteins is well conserved and would give a detailed insight into the substrate or ligand 
binding site.   
 From crystallization to structure refinement  
Since PA418316-155 has two MET residues, a SeMET-labelled version of PA418316-155                   
(PA418316-155 MSE, Figure S1) was recombinantly expressed and used for crystallization to solve 
the phase problem through experimental phasing. During initial crystallization of PA418316-155 
MSE, many big and well-shaped crystals were discovered but did not or poorly diffract. The only 
condition from which well-diffracting crystals emerged contained 1 M K/Na tartrate, 
0.2 M LiSO4 and 0.1 M CHES pH 9.5 (Figure 51 A). With a crystal (Figure 51 C) that had an overall 
resolution of 1.8 Å, Se-SAD data were collected. The anomalous signal went to a resolution of 
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2.9 Å and was sufficient to solve the phase problem (Table 18). The SeMET structure was re-
fined to an Rcryst of 15.3 % and an Rfree of 17.7 % (Table 18). Based on the initial crystallization 
condition crystals of the native PA418316-155 could be reproduced and optimized (Figure 51 B). 
 
 
A data set with a resolution of 1.52 Å was collected from a crystal grown in 0.7 M K/NA tartrate, 
0.2M LiSO4, 0.1 M CHES pH 9.6. The native structure was solved by MR with the SeMET model 
and refined to an Rcryst and an Rfree of 13.9 % and 15.5 % (Table 18). Both structures contained 
four protein chains in the ASU, which corresponds to a rather high Matthews coefficient (Mat-
thews, 1968) of 3.3 Å/Da concomitant with a high solvent content of 63 %. The SeMET-labelled 
and the native protein structure were identical, therefore only the native, higher resolution 
structure was discussed. The electron density of the native protein was well interpretable for 
the vast part of the protein structure. In protein chain A, only the final C-terminal residue could 
not be modelled, which was also not interpretable in the other chains due to missing electron 
density. Some residues from the N-terminus were not modelled in the other chains, due to 
missing electron density. In chain B, the first five amino acids are missing, including the extra 
amino acids GLY and HIS that remained after removal of the purification tag. In chain C and D, 
the first four amino acids are missing. 
 
 
 
 
 
Figure 51: PA418316-155 crystals. A) Crystals of SeMET-labelled protein in 1 M K/Na tartrate, 0.2 M LiSO4 and 0.1 M CHES pH 9.5
from JCSG Core IV A5 (Qiagen). Scale bar: 200 µm. B) Native PA418316-155 crystals in 0.7 M K/NA tartrate, 0.2M LiSO4, 0.1 M 
CHES pH 9.6. C) SeMET-labelled protein crystal during data collection at SLS (PSI, Villigen, Switzerland).  
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Table 18: Data collection, processing and refinement statistics for SeMet-labelled (PA418316-155 
MSE) and native PA418316-155. 
Data collection and processing PA418316-155 MSE PA418316-155 
Beamline†/detector X06DA, SLS/Pilatus 2M-F BL14.2, BESSYII/MarCCD 
Wavelength (Å) 0.97901 0.91841 
Temperature (K) 100 100 
Crystal-detector distance (mm) 155 170 
Rotation range per image (°) 0.1 0.25 
Total rotation range (°) 720 90 
Space group P3221 P3221 
a, b, c (Å) 155.52 155.52 59.35 155.49 155.49 59.52 
α, β, γ (°) 90 90 120 90 90 120 
Mosaicity (°)# 0.08 0.10 
Resolution range (Å) 47.18 - 1.80 (1.84-1.80) 47.26-1.52 (1.55-1.52) 
Total No. of reflections 3097174 (172775) 682412 (20968) 
No. of unique reflections 75818 (4439) 126391(6076) 
Completeness (%) 100 (99.5) 99.8 (98.0) 
Multiplicity 40.9 (38.9) 5.4 (5.3) 
Mean I/σ(I) 22.7 (2.1) 19.1 (2.0) 
CC1/2+ 99.9 (77.9) 99.9 (79.5) 
Rpim$ 2.9 (36.9) 2.1 (36.9) 
Rmeas$ 18.6 (231.8) 4.5 (61.9) 
Wilson B factor (Å2) 19.8 17.6 
Anom. completeness 100 (99.4)  
Anom. multiplicity 20.7 (19.5)  
Refinement   
Resolution limit (Å) 47.18 - 1.80 47.26-1.52 
Completeness (%) 99.97 99.81 
Final Rcryst (%) 15.3 13.9 
Final Rfree (%) 17.7 15.5 
No. of non-H atoms   
Protein 4249 4501 
Solvent water/buffer 753/64 963/52 
Total 5066 5516 
R.m.s. deviations   
Bonds (Å) 0.009 0.017 
Angles (°) 1.289 1.512 
Average B factors (Å2)   
Protein 29 28 
Solvent water/buffer 42/52 43/32 
Ramachandran plot   
Favored regions (%) 98.5 97.61 
Outliers (%) 0 0.37 
MolProbity score‡ 1.06 1.41 
Values in parentheses are for the highest resolution shell. †BESSYII (HZB, Berlin, Germany), SLS (PSI, Villigen, 
Switzerland). # Value as reportet by AIMLESS (Evans & Murshudov, 2013). +CC1/2 as reported by (Karplus & 
Diederichs, 2012), $ Rpim = Σhkl (1/(N – 1))1/2 Σi | Ii (hkl) – <I (hkl)> | / Σhkl Σi Ii (hkl); Rmeas = Σhkl (N/(N – 1))1/2 Σi | Ii (hkl) 
– <I (hkl)> | / Σhkl Σi Ii (hkl), where N is the number of observations of the reflection with index hkl and Ii is the 
intensity of its ith observation (Weiss, 2001). ‡ MolProbity score as reported by MolProbity (Chen et al., 2010). 
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 Topology of the PA4183 dimer 
The crystal structure of PA418316-155 revealed the typical βαβββ-fold where one monomer con-
tains two βαβββ-motifs in this case formed by β2-α1-β3-β4-β5 and β6-α3-β7-β8-β9 (Figure 52 A/B). 
PA418316-155 forms a dimer in solution as confirmed by a DLS analysis. It calculated a MW of 
28 kDa, which corresponding to twice the theoretical MW of the monomer. Therefore, the four 
protein chains in the ASU do not represent a higher-order oligomer. The stable dimer was es-
tablished by the less common back-to-back dimerization form (Figure 52 C).  
 
Figure 52: Protein X-ray structure of PA418316-155. A/B) Topology of a PA418316-155 monomer as 3D-arrangement (A) and as 
schematically representation (B) drawn with TopDraw (Bond, 2003). The secondary structure elements are colored differently. 
C) Architecture of the stable dimer. The chains are colored differently and a dashed line indicates the interface that is formed 
by back-to-back contacts according to Bergdoll et al., 1998. The secondary structure elements are numbered from N- to C-
terminus. D) Electrostatic surface of the PA418316-155 dimer in two distinct orientations, as calculated by the PDB2PQR server 
Version 2.0.0 (Dolinsky et al., 2004). Black arrows are indicating the openings to the potential binding sites.   
The topology of the monomer is dominated by the characteristic U-shaped antiparallel β-sheet 
(Figure 52). It is built up by eight β-strands β2-β9 of the duplicated βαβββ-motif and the addi-
tional β1-strand at the truncated N-terminus. Another additional secondary structure element 
is the α2-helix that connects both motifs. Regarding the electrostatic potential of the dimer, it 
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is quite striking that the surface is dominated by a negative charge, which is only interrupted 
by a rather uncharged patch (Figure 52 D). 
 Potential active site of PA4183 
In the back-to-back dimerization, a single protein chain forms the potential active site. Here it 
is an L-shaped tunnel that stretches through the half-barrel (Figure 53 A). 
 
Figure 53: Potential active site of PA418316-155. The surface of the potential binding tunnel (teal) was visualized with Caver3.0 
(Chovancova et al., 2012). A) PA418316-155 protein dimer with distinct colored chains displayed in different orientations.                              
B) Amino acid side chains of monomer A, which flank the potential binding tunnel. They are represented as balls and sticks in 
two orientations. Oxygen atoms are red, nitrogen blue and sulfur yellow. Dashed lines represent H-bonds with a maximum 
distance of 3.2 Å. C) Binding site of a CHES molecule. The residues that stabilize CHES are represented as balls and sticks in two 
orientations. Oxygen atoms are displayed in red, nitrogen in blue and sulfur in yellow. Black dashed lines represent H-bonds 
with a maximum distance of 3.2 Å. Yellow dashed lines indicate π-alkyl and π-sulfur interactions. The chemical structure of 
CHES was obtained from the PubChem database (Kim et al., 2016) and visualized with ChemDraw Professional 17.0. D) Locali-
zation of CHES molecules in the protein dimer. The left monomer shows the position of CHES in the binding tunnel. The right 
monomer shows the unbiased mFo-DFc difference e--density as green mesh with a contour level of 2.5 σ.  
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The most abundant catalytic residues in proteins are HIS and CYS (Bartlett et al., 2002), which 
are also found in the potential PA4183 active site as H148 and C132 (Figure 53 B). Especially 
the CYS seems to be a promising candidate for an enzymatic active residue as it is close to E143, 
which is in turn in H-bonding distance to R39 and T100 two more amino acids that often have 
catalytic importance (Holliday et al., 2009). Conspicuous is also the location of C132 at the kink 
of the L-shaped tunnel close to one end of the tunnel. Opposite to the kink and to C132, is a 
cove formed by aliphatic and hydrophobic side chains (Figure 53 B). The rest of the tunnel is 
also abundant in aliphatic and hydrophobic side chains (Figure 53 B). Since uncharged and non-
polar residues do usually not participate in catalysis (Bartlett et al., 2002; Holliday et al., 2009), 
they might play an important role for binding of the potential substrate. Interestingly the tunnel 
entrance close to this hydrophobic cove is positioned in the uncharged patch found at the pro-
teins electrostatic surface (Figure 52 D) and might indicate a functionally relevant connection.  
The binding tunnel of each molecule in the ASU was occupied with extra mFo-DFc e--density 
that was well interpretable with a N-cyclohexyl-2-aminoethanesulfonic acid (CHES) molecule 
from the crystallization buffer (Figure 53 D). The CHES molecule is stabilized by H-bonds formed 
between two distinct oxygen of the ligand’s sulfonic acid moiety, the side chains of H148 and 
T129 and between the side chain of E144 and the proton of the ligand’s amine. The sulfhydryl 
group is further stabilized by π-sulfur interaction with F66. The nonpolar cyclohexyl part of 
CHES interacts with the nonpolar kink of the binding tunnel and is stabilized by a π -alkyl inter-
action with F94 (Figure 53 C). The presence of the buffer molecule gives another starting point 
for the PA4183 substrate search. Since CHES must share some structural and chemical similar-
ities with the substrate that enabled the binding of the molecule a search for other molecules 
based on the architecture of the buffer ingredient might deliver new potential ligands for 
PA4183 that can be tested in binding assays. 
 Bioinformatic characterization of the PA413816-155 crystal structure 
Due to the conserved overall structure of the βαβββ-module-containing protein family, a struc-
ture-based search for functionally related proteins to derive a possible function for PA4183 
seemed unpromising. Indeed, an analysis performed with PDBeFold-server (Krissinel & Henrick, 
2004) returned 10 distinct hits, but none of them provided new leads towards the function of 
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PA4183 as most of the proteins were uncharacterized and/or the architecture of the potential 
active sites were not conserved to the one of PA4183. Despite this, a search for amino acid 
patterns in 3D space was conducted with the SPRITE-server (Nadzirin et al., 2012). This was 
supposed to identify patterns in PA4183, which are similar to functionally important patterns 
from structures deposited in the PDB, independent of similarities in the sequence or the overall 
fold. The SPRITE-analysis based on the PA418316-155 dimer returned 31 hits, of which most were 
not interesting as the discovered motifs were located on the protein surface. Only two hits 
implied residues in the potential binding tunnel. Part of the first hit was H148 together with 
S28 and L11 that are close by. They were arranged in similar fashion as three analogous resi-
dues (S18, H20, L22) that participate in the DNA interaction of the DNA-binding protein ArtA 
(PDB-ID: 3GXQ; Ni et al., 2009). However, it is very unlikely that these residues can mediate the 
interaction between PA4183 and DNA as the SER and the HIS sidechains are both hidden in the 
protein and not accessible for DNA molecules. They are also not in H-bonding distance as it is 
the case in ArtA (Ni et al., 2009). The second motif was very interesting as it contained C132, 
N134 and A127 (Figure 53 B). The analogous amino acids identified by SPRITE were located on 
the NADP-dependent, glyceraldehyde 3-phosphate (G3P) dehydrogenase (GAPN). Its ASP 
(N145) is involved in the binding of the substrate G3P, which is covalently attacked by the re-
spective CYS (C284) (PDB-ID: 2ESD; D’Ambrosio et al., 2006). Unfortunately, the other amino 
acid side chains, three ARG and a TYR, which stabilize G3P in GAPN, are absent in PA418316-155 
and make the binding of G3P rather unlikely. To be certain, a binding study like ITC or MST must 
be performed. 
 Characterization of PA14 PA4183::Tn with Phenotype MicroArraysTM 
Since the experiments above did not lead to the functional characterization of PA4183 the 
physiological role of the protein was further investigated with PM. The PA14 transposon inser-
tion mutant (PA14 PA4183::Tn) from Liberati et al., 2006 used here was kindly provided by Prof. 
S. Häußler from the HZI. The integrity of the mutant was confirmed by PCR and sequencing of 
the PCR product. The insertion site of the MAR2xT7 transposon in the ORF of PA4183 was dis-
covered at bp 6 (Figure 48) in agreement with the manufacturer’s information (Liberati et al., 
2006).     
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4.3.7.1 Carbon source utilization assay 
PMs were performed to test the ability of the PA14 PA4183::Tn mutant to utilize different car-
bon compounds as sole energy source with the intention to find other C-sources besides sar-
cosine that are not metabolized as effectively as by the wt but deliver an explanation for the 
reduced ability of the transposon mutant to grown on sarcosine. Unfortunately, the respiration 
curves of the wt and the mutant on all tested C-sources were congruent (Figure S4) and gave 
no further lead to the physiological function of PA4183. However, this assay confirmed that the 
wt and the PA14 PA4183::Tn are both able to use pyruvate as sole carbon source without inhi-
bition of the phenotype (Figure S4, PM2 H8) as shown before in a cell density based planktonic 
growth assay by Willsey & Wargo, 2016. 
4.3.7.2 Chemical sensitivity assay 
The chemical sensitivity assay identified 11 compounds that induced a significant change in the 
respiration rates of the PA14 PA4183::Tn mutant in comparison to the wt (Figure 54). The mu-
tant had a more activated metabolism upon incubation with enoxacin and compound 48/80. A 
clearly reduced phenotype was visible on chlorodinitrobenzene, polymyxin B, pheneticillin, 
chloroxylenol and azlocillin. Tobramycin, 2-phenylphenol, nafcillin and SbCl3 only caused a 
slight extension of the lag-phase. The comparison with the results obtained from the PMs with 
the other PA14 βαβββ-module gene mutants (Figure S4) revealed that SbCl3 is the only com-
pound that exclusively has an impact on the phenotype of the PA4183::Tn mutant. SbCl3 was 
shown to replace Zn2+-ions complexed in enzymes and proteins, like the nucleic acid binding 
zinc-finger domains, which can lead to the loss of crucial cellular functions and result in cell 
death (Demicheli et al., 2008; Frézard et al., 2012). Like other toxic cations it has a high affinity 
for sulfhydryl groups and can thus deplete GSH and directly promote oxidative stress in the 
bacterial cells (Nies, 1999). A direct interaction between SbCl3 and PA4183 is rather unlikely 
since the protein lacks metal-complexing residues. If the phenotypes that were caused by the 
rest of the compounds are directly connected to the disruption of the PA4183 gene and there-
fore to the function of PA4183 must be further evaluated.  
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Figure 54: Chemical sensitivity Phenotype MicroArraysTM of PA14 PA4183::Tn. Displayed are the overlaid respiration curves of 
the PA14 wt (black) and the mutant (grey), which were incubated on four concentrations of substances with potential antibac-
terial function, that induced significant changes between the wt and the mutant. The values in parentheses describe the num-
ber of the respective Phenotype MicroarrayTM and of the wells containing the compound. The respiration curves were obtained 
by plotting the measured absorbance in arbitrary units from 0-400 detected at 490 nm (y-axes) against the incubation time 
from 0-48 h (x-axes). To highlight the differences, the area between the respiration curves was colored green if the mutant 
respired better than the wt or red if the respiration of the mutant was inhibited. The chemical structures were obtained from 
the PubChem database (Kim et al., 2016) and visualized with ChemDraw Professional 17.0. 
Taken together, the PM results make it rather challenging to suggest a physiological role for 
PA4183, since a common connection between the compounds’ antibacterial mechanisms must 
be identified, which are divers and partially not fully understood. Chloroxylenol and 2-phe-
nylphenoly are, for example, suggested to target the bacterial membrane based on the general 
mechanism identified for phenolic compounds. They can permeabilize the membrane and in-
troduce cell leakage and lysis. Besides that, phenolic compounds can denature cytoplasmic pro-
teins that lead to the inhibition of essential cellular functions (McDonnell & Russell, 1999). The 
aminoglycoside antibiotic tobramycin inhibits protein synthesis (Bendush & Weber, 1976; Brog-
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den et al., 1976) while enoxacin is a fluoroquinolone antibiotic that inhibits enzymes required 
for DNA replication (Drlica, 1999). The β-lactam antibiotics phenethicillin, azlocillin and nafcillin 
inhibit peptidoglycan synthesis and therefore cell proliferation (Kong et al., 2010). Compound 
48/80 is a synthetic stimulant of eukaryotic mast cell granulation (Lagunoff et al., 1983). The 
antibacterial activity of compound 48/80 was confirmed (Lenney et al., 1977) and said to induce 
cell membrane permeability (Hall et al., 1983; Nakao et al., 2011). The mechanism is supposed 
to be similar to that of polymyxin antibiotics. Both have a cationic amphiphilic character at 
physiological pH due to their abundant amino groups combined with hydrophobic moieties. 
This enables the interaction with the negatively charged membrane surface and the integration 
and pore formation in the membrane. The compound can then pass through the pores and act 
on the cytoplasmic membrane to induce lethal cell leakage (Brogden, 2005; Vaara, 1992). How-
ever, the PA4183::Tn mutant has contrasting sensitivity to compound 48/80 and polymyxin B, 
since it displayed a reduced phenotype on polymyxin B and an enhanced phenotype on com-
pound 48/80. This indicates that these compounds either do not act on the same target at the 
bacterial membrane or that one of them has another activity, for example on targets in the 
cytoplasm. 
 Analysis of interaction between PA4183 and compounds discovered from 
chemical sensitivity PM 
The compounds that altered the phenotype of the PA4183 mutant in comparison to the wt 
were tested in thermal shift and MST assays to find evidence for a direct interaction with the 
protein. In the TSA, the untagged PA418316-155 (Vit, 2015) was incubated with the available 
compounds. Enoxacin, chloroxylenol and nafcillin induced significant increase in the proteins 
Tm (Figure 55). To see if this increase is caused by an actual interaction with the protein, the 
compounds were tested in an MST experiment. For this, a His6-tagged version of PA4183 (His6-
PA418316-155, Figure S1) was used to fluorescently label the protein with a His-reactive dye as 
the only lysine residue (K71) of PA418316-155 that could have been labeled with a primary amine 
reactive dye was close to the potential active site (Figure 53 B) such that the label might have 
blocked the binding tunnel. In contrast to this, the N-terminus points away from the active site 
(Figure 53 A) such that the risk of an interference with the potential binding site is diminished.  
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Figure 55: Result of the TSA to analyze the influence of compounds, identified in Phenotype MicroArraysTM with the PA14 
PA4183::Tn, on the thermal stability of the isolated protein PA418316-155. Changes in thermal stability (ΔTm) of PA418316-155, 
which were caused upon incubation with the respective compounds in comparison to the reference Tm of 48 °C, measured 
under the same buffer conditions but without the compounds. ΔTm were determined by averaging 3 independent experiments. 
Since the TSA melting curve of PA418316-155 with chlorodinitrobenzene was not interpretable 
this compound was also tested with MST. However, with none of the tested ligands a sigmoidal 
binding curve could be recorded. This means either that these compounds indeed do not bind 
or that the used conditions prevented the actual binding event. Besides, it is also possible that 
the His6-tag, which elongates the N-terminus by 17 aa, folds back on the protein and might then 
interfere with binding. Therefore, to get a clearer statement about the binding of these com-
pounds, one should consider a method that does not require the labeling of the protein, such 
as e.g. ITC. Considering the distinct chemical structures of the compounds, it is very unlikely 
that they are all able to bind to PA418316-155. 
 Conclusion and Outlook 
The class III βαβββ-module-containing protein PA4183 is expressed in one operon with the sar-
cosine oxidization and utilization regulator SouR (Wurtzel et al., 2012). Albeit it was shown that 
PA4183 is involved in the effective degradation of sarcosine when this compound serves as the 
sole carbon and nitrogen source (Willsey & Wargo, 2016), this study could not find evidence 
for a direct interaction between PA4183 and compounds from the central sarcosine catabolism. 
Further, no growth deficiencies were observed if other carbon sources are the sole energy 
source for the PA14 PA4183::Tn mutant. This could mean that PA4183 is not involved in central 
metabolic pathways and only indirectly connected to the sarcosine degradation. Therefore, the 
search for a potential substrate of PA4183 could be extended to the pathways that neutralize 
the toxic side products that are generated during sarcosine demethylation, like formaldehyde 
or H2O2.      
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The chemical sensitivity assays revealed that the PA14 PA4183::Tn mutant has an altered re-
sistance to compounds with antimicrobial activity than the wt. Therefore, the function of 
PA4183 might in fact be linked to the mediation of resistance mechanisms. Since a direct inter-
action of the change-inducing compounds could not be confirmed, it is not possible to suggest 
a physiological function for PA4183 from this. The compounds have distinct targets in bacterial 
cells and a collective link that could be connected to PA4183 was not identified. To confirm the 
results and to eliminate false positives the PM should be repeated with the compounds that 
induced phenotypic changes. MICs should be determined as well, with a stepwise dilution se-
ries of the respective change inducing compounds. In addition, it must be confirmed that the 
phenotypes are only caused by the lack of the functional PA4183 protein. The chemical sensi-
tivity assay with the identified compounds must be performed as a rescue experiment. For this, 
the protein is expressed from a plasmid in the PA14 PA4183::Tn mutant. If this returns the wt 
phenotype with the PA14 PA4183::Tn mutant, the destruction of PA4183 is solely responsible 
for the discovered changed respiration rates. Otherwise, it is possible that a spontaneous mu-
tation in other genes occurred or that the presence of the transposon itself is responsible for 
the phenotypes. Such an experiment should also be considered for the growth of the PA14 
PA4183::Tn mutant on sarcosine as sole carbon source since Willsey & Wargo, 2016 used the 
same transposon mutant from Liberati et al., 2006. This would rule out that the transposon 
insertion in the PA4183 gene has a negative impact on the expression of SouR and delivers an 
explanation if PA4183 really plays a role during sarcosine catabolism. 
The high-resolution crystal structure of the homodimeric PA418316-155 gave detailed insight into 
a further class III βαβββ-module-containing protein that has the less common back-to-back di-
merization form. The cocrystallized CHES buffer molecule, which was complexed in the con-
served putative ligand-binding site delivers a new lead towards a potential substrate of PA4183, 
since it must share chemical similarities with the natural ligand that enable the interaction with 
the protein. The chemical structure of CHES could be put into a virtual screening for natural 
compounds with similar structure and the hits could be used for a ligand screen with                 
PA418316-155 i.e. in a TSA or an MST screen to identify molecules that interact with the protein.   
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4.4 Open reading frames PA1358 – PA1359 
The crystal structure of PA1358 (Figure 56 A) was published in the PDB (ID: 1U7I, Osipiuk, J., et 
al., to be published) without functional data, structure discussion or associated publication. In 
contrast to the other class III βαβββ-module-containing proteins, the potential active site of 
PA1358 is a wide-open cleft (Figure 56 B).  
 
Figure 56: Crystal structure of the PA1358 dimer (PDB-ID: 1U7I, Osipiuk, J., et al., to be published). A) The protein chains are 
colored in green (chain A) and grey (chain B). B) The electrostatic surface of PA1358 is colored from red (-5 kT/e) to blue (5 
kT/e) as calculated by the PDB2PQR server Version 2.0.0 (Dolinsky et al., 2004). C) Overview of side chains flanking the potential 
binding cleft. D/E) Detailed insight in the potential binding cleft of PA1358 in different orientations. Side chains are represented 
as balls and sticks. Oxygen atoms are colored in red, nitrogen in blue and selenium in orange. Dashed lines refer to H-bonds 
with a maximum distance of 3.2 Å.  
It is not certain that this is also the case in solution since the loop regions on the tip of the cleft 
are involved in crystal contacts to symmetry-related molecules. This could stabilize the other-
wise flexible loops that might in solution close off the cleft. In the crystal structure, all residues 
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that potentially participate in ligand binding are solvent exposed in the cleft, which has a rather 
negatively charged electrostatic surface (Figure 56 A-C). The amino acid side chains that flank 
the potential binding cleft and might thus be important for ligand binding or catalysis are dis-
played in Figure 56 D/E. Catalytically inactive side chains from five PHE, four PRO, two MET, 
one LEU and one ILE residues dominate the cleft (Holliday et al., 2009). They might be important 
for stable interaction with the ligand or stabilize a potential reaction intermediate. However, 
there are also three HIS residues. Histidines are the most abundant catalytically active residues 
in proteins (Bartlett et al., 2002), and are candidates that could mediate an enzymatic reaction. 
Especially H62 seems promising, since it is surrounded by other residues that often participate 
in catalysis (Bartlett et al., 2002) such as K51, D83, R4 or Q34 (Figure 56 E). To derive a lead 
towards the protein function, the structure was compared against the PDB database with the 
PDBe-fold server (Krissinel & Henrick, 2004). The best among more than 100 hits came from a 
homologous Bacillus cereus protein (PDB-ID: 3OMS) with a sequence identity of 53 % and a 
similar potential active site. Since the function of this protein is also not identified, this does 
not aid functional characterization of PA1358. The rest of the hits were also inconclusive be-
cause sequence similarities, especially in binding site regions, were not detected. The gene of 
PA1358 is predicted to be transcribed in an operon with the upstream ORF PA1359 (Mao et al., 
2014). PA1359 is a 218 aa protein with an estimated MW of 23.9 kDa (Gasteiger et al., 2005).  
 
Figure 57: A) Operon organization and genomic localization of ORF PA1358 and PA1359 from P. aeruginosa strains PAO1 and 
the homologous genes in strain PA14 as derived from pseudomonas.com (Winsor et al., 2016). The locus ID of the gene ho-
mologous to PA1359 is PA14_46710 in the PA14 strain and to PA1358 it is PA14_46720. The transposon insertion sites (Tn) of 
the PAO1 PA1359::Tn mutant (left) and the PA14 PA1358::Tn mutant (right) used in this study are indicated by a grey arrow. 
The position of the insertion in the ORF is given in units of bp and the total length of the gene in brackets. B) Domain organiza-
tion of the predicted transcriptional regulator PA1359 as predicted by a Blast analysis (Altschul et al., 1997). 
A protein Blast analysis (Altschul et al., 1997) classified PA1359 as putative two domain 
transcriptional regulator of the xenobiotic response element (XRE)-family with an N-terminal 
conserved helix-turn-helix 3 (HTH) DNA-binding domain (PF01381) and a C-terminal conserved 
cupin 2 regulatory domain (PF07883). This operon was predicted to be a type II toxin-antitoxin 
(TA) system (Sevin & Barloy-Hubler, 2007). TA systems can regulate the persistence of bacterial 
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cells that allows them to survive stressful conditions, such as under exposure to antibiotics or 
in a dormant state with greatly reduced metabolism (Deter et al., 2017). In the type II TA sys-
tem, both the toxin and the antitoxin are proteins that interact with each other, to neutralize 
the harming effect of the toxin under standard conditions (Hall et al., 2017). During stress re-
sponse the antitoxin level decreases and the toxin is set free. It can then target the respective 
component of the bacterial cell (Deter et al., 2017). Most antitoxins are two domain proteins 
that are coded upstream of the toxin gene, with an N-terminal DNA-binding domain that often 
has a HTH-motif and a C-terminal domain that interacts with the toxin (Chan et al., 2016) which 
is consistent with the predicted domain organization of PA1359. Based on this, PA1358 would 
function as toxin while PA1359 would be the antitoxin in case they are a type II TA system. 
 Phenotyping  
To identify the physiological roles of PA1358 and PA1359 and to find evidence for the predicted 
TA system, the phenotypes of transposon insertion mutants in both genes (Figure 57) were 
compared to the wt in planktonic growth and motility assays. The PA1358 transposon insertion 
mutant was only verified in the PA14 background (PA14 PA1358::Tn). PA14 PA1358::Tn manu-
factured by Liberati et al., 2006 was kindly provided by Prof. S. Häußler of the HZI. PCR and 
sequencing of the PCR product confirmed the MAR2xT7 transposon in the ORF of PA1358 at 
bp 67 (Figure 57 A) as stated by the manufacturer (Liberati et al., 2006). The PA1359 mutant 
was only available in the PAO1 background (PAO1 PA1359::Tn) from Held et al., 2012 and kindly 
provided by Prof. S. Häußler of the HZI. The ISphoA/hah transposon was confirmed in the 
PA1359 ORF at the supposed bp 341 (Figure 57 A) (Held et al., 2012) by PCR and sequencing of 
the PCR product. The direct comparison of the mutants was not possible since they were not 
available in the same parental strain. PA1358 was also overexpressed in PA14 wt background 
from an arabinose inducible plasmid to demonstrate the possible toxicity of the protein. The 
behavior of the PA14 PA1358::Tn, compared to the wt, was further characterized using Pheno-
typic MicroArraysTM.  
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4.4.1.1 Planktonic growth and motility  
In this case, planktonic growth assays were performed to identify the toxicity of PA1358 in the 
absence of the potential antitoxin assuming that the PAO1 PA1359::Tn mutant shows distinct 
growth defects in comparison to the wt. However, the mutant deficient in PA1359 had compa-
rable growth to the wt under standard conditions (Figure 58 A).  
 
Figure 58: A) Planktonic growth curves of a PA14 PA1358::Tn mutant, the PA14 wt, a PAO1 PA1359::Tn mutant and the PAO1 
wt. B) Planktonic growth curves of P. aeruginosa PA14 wt transformed with pHERD30T and pHERD30T_PA1358. After 180 min 
as indicated by the arrow the cultures were split and one portion of PA14 pHERD30T and PA14 pHERD30T_PA1358 was induced 
(+I) with 0.1 % arabinose the others were not induced (pHERD30T (-I) and pHERD30T_PA1358 (-I). A/B) Displayed is the increase 
of the optical density of the cell cultures measured at 600 nm (OD600) over time (t (min)). The bacteria were incubated in LB 
medium under shaking conditions at 37 °C. C/D) The diameter of swimming and swarming colonies from PA14 PA1358::Tn 
mutants, PA14 wt and the negative controls PA14 flgK::Tn and PA14 rhlR::Tn were determined from three independent exper-
iments, after incubation for 19 (swimming) and 18 h (swarming) at 37 °C. Error bars represent the deviation calculated from 
the mean triplicates. E) Examples of the respective swimming (Figure S2) and swarming colonies (Figure S3).  
Since the PA1359 gene is located upstream in the genome, it is possible that the introduction 
of the transposon influences the transcription of PA1358 negatively and thus the level of pro-
tein in the cell, such that the toxicity of PA1358 cannot be developed. To ensure a high level of 
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PA1358 protein an arabinose inducible plasmid containing the gene for PA1358 was introduced 
to the PA14 wt strain to identify possible toxic effects caused by the accumulation of PA1358 
in the bacterium. In addition, no striking growth differences were displayed between the mu-
tant overexpressing PA1358 and the reference strain (Figure 58 B). Both results indicate that 
PA1358 has no cytotoxic effects if it is more abundant than PA1359, which does not support 
the hypothesis of PA1358 and PA1359 acting as a TA system.  
Further, the growth assays did not support the identification of the physiological function of 
PA1358, as the behavior of PA14 PA1358::Tn mutant was well comparable to the wt in plank-
tonic growth assays (Figure 58 A) as well as in the swimming and swarming motility assays (Fig-
ure 58 C/D/E). PA14 PA1358::Tn colonies had no morphological differences to the wt on LB agar 
plates and both developed the same level of greenish color after reaching high cell densities 
during planktonic and solid growth. These findings rule out that PA1358 participates in basic 
cellular functions or in the production and secretion of secondary metabolites like pyocyanin 
or pyoverdine that are responsible for the characteristic color (Pierson & Pierson, 2010).  
4.4.1.2 Characterization of PA14 PA1358::Tn with Phenotype MicroArraysTM 
To identify the physiological function of PA1358, Phenotype MicroArraysTM were conducted in 
a comparative analysis of the PA14 PA1358::Tn mutant and the PA14 wt. The PA14 PA1358::Tn 
mutant had no significant differences to the wt when 190 distinct compounds served as sole 
carbon sources (Figure S4). In contrast to this, significant phenotypic changes were spotted in 
the chemical sensitivity assay (Figure 59). The PA14 PA1358::Tn mutant was less susceptible to 
hydroxylamine, azlocillin, enoxacin and 2-phenylphenol and more susceptible to chloroxylenol, 
oxacillin, tobramycin, phenethicillin and lauryl sulfobetaine (Figure 59 A). Of these, oxacillin 
was the only compound that caused a change only in the PA14 PA1358::Tn mutant and not in 
the other class III βαβββ gene mutants in the PA14 background (Figure S4). This could indicate 
that most effects are not caused by the deficiency of PA1358 but by the presence of the trans-
poson itself.  
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Figure 59: Chemical sensitivity Phenotype MicroArraysTM of PA14 PA1358::Tn. A) Overlaid respiration curves of the wt (black) 
and the mutant (grey) that were incubated on four concentrations of substances with potential antibacterial function, which 
induced significant changes between the wt and the mutant. The values in parentheses describe the number of the respective 
Phenotype MicroarrayTM and of the wells containing the compound. The respiration curves were obtained by plotting the 
measured absorbance in arbitrary units from 0-400 detected at 490 nm (y-axes) against the incubation time from 0-48 h (x-
axes). To highlight the differences, the area between the respiration curves was colored green if the mutant respired better 
than the wt or red if the respiration of the mutant was inhibited. B) The chemical structures were obtained from the PubChem 
database (Kim et al., 2016) and visualized with ChemDraw Professional 17.0. C) Changes in thermal stability (ΔTm (K)) of PA1358 
(Tm: 62°C) as measured with a TSA. ΔTm were determined by averaging 3 independent experiments. 
Oxacillin is a β-lactam antibiotic like phenethicillin and azlocillin, which inhibit peptidoglycan 
synthesis by covalent modification of the penicillin binding protein (Kong et al., 2010). It is ra-
ther unlikely that PA1358 mediates the resistance to oxacillin only, but not to other β-lactam 
antibiotics. Since the other compounds have a variety of antimicrobial functions, it is not pos-
sible to draw simple conclusions from the PM results with respect to the physiological role of 
PA1358. If the direct interaction between one compound and PA1358 could be determined, 
the PM results could still deliver a hint towards the function of PA1358. Therefore, a TSA was 
conducted with the recombinantly expressed PA1358 protein (Figure S1) and the identified 
compounds. The melting temperature of PA1358 in buffer was 62 °C and was not significantly 
altered by any of the tested compounds (Figure 59 C). This suggests that none of them interacts 
with the protein under the tested conditions or at least that a potential interaction does not 
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stabilize the protein such that a change in Tm occurs. The latter could be investigated by the 
application of other methods like MST or ITC. 
 Interaction of PA1358 and PA1359-CTD 
To further corroborate that PA1358 and PA1359 are not a type II TA system, as indicated by the 
microbiological assays, the direct interaction of both proteins was supposed to be tested. Since, 
the full-length PA1359 protein could not be expressed in E. coli, the successfully purified regu-
latory domain PA1359-CTD (4.4.3; Figure S1), which interacts with the toxin in related systems 
(Chan et al., 2016), was used. An ITC experiment was conducted were PA1358 was titrated 
against PA1359-CTD but did not indicate any binding (Figure 60 A/B), showing that PA1358 and 
PA1359-CTD do not form a complex under the tested conditions. Further, an analytical SEC was 
conducted were a 1:1 mixture of PA1358 and PA1359-CTD and solutions with the separate pro-
teins as reference was run over the column. Since PA1358 (14.8 kDa) and PA1359-CTD 
(12.9 kDa) have similar MWs and both are dimeric in solution, their elution volume is also sim-
ilar (Figure 60 C; Ve: 14 and 14.2 ml). The same elution volume (14.1 ml) was discovered for the 
mixture of both proteins that eluted in one peak. Based on the similar MW of both proteins 
and the increased A280 of the peak, the mixture likely eluted as one peak that contained both 
proteins separately. Therefore, the analytical SEC does also not support complex formation be-
tween PA1358 and PA1359-CTD. Taken together it is rather unlikely that PA1358 and PA1359 
can form a complex. 
 
Figure 60: Possible interaction of PA1358 with PA1359-CTD. A/B) Titration of 1 mM PA1358 to 0.1 mM PA1359-CTD in an ITC-
experiment as analyzed with Origin 7 (OriginLab Corp.). A) ITC raw data, displaying the measured differential thermal power 
(DP) in µcal/sec over time. B) Injection heat in kcal/mol plotted against the molar ratio of PA1358 and PA1359-CTD C) Elution 
profiles of the analytical SEC performed with a S75 10/300GL (GE Healthcare) in SEC-buffer. 100 µM of PA1358 (dark green) 
and PA1359-CTD (light green) and an equimolar mixture (black) of 100 µM of each protein were applied separately. 
130 | R e s u l t s  a n d  D i s c u s s i o n  
 
 Construct design and purification of PA1359-CTD 
The N-terminally His6-tagged full-length protein was insoluble when expressed in E. coli. There-
fore, a construct for the mere expression of the C-terminal domain (CTD) was designed, as re-
combinantly expressed DNA-binding proteins tend to aggregate in E. coli. The domain bounda-
ries of PA1359 were set by analyzing a high-confidence 3D-structure prediction (80 % of the 
protein were modelled with 100 % confidence, no prediction for the first 40 aa) from the Phyre2 
server (Kelley et al., 2015) and a secondary structure prediction performed with PSIPRED 
(Buchan et al., 2013). The final expression construct for the PA1359-CTD ranged from aa 108 to 
218 and was soluble expressed with an N-terminal His6-tag. During a three-step purification, 
the tag was removed and the 12.9 kDa PA1359-CTD was isolated in high purity (Figure S1) and 
used for setting up crystallization screens.  
 From crystallization of PA1359-CTD to structure refinement 
A well-diffracting crystal (dmin= 1.65 Å) of PA1359-CTD grew in the initial screen in 0.1 M Tris 
pH 8.5, 8 % (w/v) PEG8000 (JCSGII well A12, Figure 61 A). The phase problem was solved by the 
molecular replacement (MR) pipeline Balbes (Long et al., 2008).  
 
 
Two molecules of PA1359-CTD were present in the ASU (Figure 62 B), which has a solvent con-
tent of roughly 53 % as derived from the Matthews coefficient of 2.56 Å/Da (Matthews, 1968). 
The electron density for the vast part of the two protein molecules were well interpretable. 
However, no electron density was observed for the nine N-terminal residues from chain A and 
for the five N-terminal residues from chain B. The remaining structure was refined to an Rcryst 
Figure 61: Crystals of PA1359-CTD grown in 0.1 M Tris pH 8.5, 8 % (w/v) PEG8000 A) Crystals 
in the crystallization drop. The asterisk marks the best diffracting crystal used for data collec-
tion. B) Crystal during data collection at SLS. 
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of 16.4 % and an Rfree of 19 %. Table 19 contains the detailed data collection, processing and 
structure refinement statistics. 
Table 19: Statistics for data collection, processing and structure refinement of PA1359-CTD  
Data collection and processing  Refinement  
Beamline†/detector X06DA, SLS/Pilatus 2M-F Resolution limit (Å) 19.96-1.65 
Wavelength (Å) 1 Completeness (%) 99.98 
Temperature (K) 100 Final Rcryst (%) 16.4 
Crystal-detector distance (mm) 150 Final Rfree (%) 19.0 
Rotation range per image (°) 0.1 No. of reflections  
Total rotation range (°) 360 Working set 33731 
Exposure time per image (s) 0.1 Test set 1588 
Space group P6122 No. of non-H atoms  
a, b, c (Å) 70.78 70.78 184.09 Protein 1724 
α, β, γ (°) 90 90 120 Solvent water/buffer 188/24 
Mosaicity (°)# 0.12 Total 1936 
Resolution range (Å) 19.96-1.65 (1.68-1.65) R.m.s. deviations  
Total No. of reflections 1267110 (63467) Bonds (Å) 0.007 
No. of unique reflections 33824 (1626) Angles (°) 0.855 
Completeness (%) 99.9 (100) Average B factors (Å2)  
Multiplicity 37.5 (39.0) Protein 40 
Mean I/σ(I) 28.8 (1.7) Solvent water/buffer 54/73 
CC1/2+ 100 (61.3) Ramachandran plot  
Rpim$ 1.3 (44.5) Favored regions (%) 98.56 
Rmeas$ 7.7 (280) Outliers (%) 0 
Wilson B-factor (Å2) 26.1 MolProbity Score‡ 1.29 
Values in parentheses are for the highest resolution shell, †SLS: Swiss Light Source (PSI, Villigen, Schweiz). #Value as reportet by AIMLESS 
(Evans & Murshudov, 2013). +CC1/2 as reported by (Karplus & Diederichs, 2012). $Rpim = Σhkl (1/(N – 1))1/2 Σi | Ii (hkl) – 〈I (hkl)〉| / Σhkl Σi Ii 
(hkl); Rmeas = Σhkl (N/(N – 1))1/2 Σi | Ii (hkl) – 〈I (hkl)〉| / Σhkl Σi Ii (hkl), where N is the number of observations of the reflection with index hkl 
and Ii is the intensity of its ith observation (Weiss, 2001). ‡MolProbity Score as reported by MolProbity (Chen et al., 2010). 
 Overall structure of PA1359-CTD  
The structure of PA1359-CTD revealed that it is a member of the RmlC-like cupin superfamily 
with one cupin domain per chain. One monomer consists of 10 β-strands (Figure 62 A). Four of 
these strands (β3, β10, β5, β8) form an antiparallel β-sheet that faces a second four-stranded (β4, 
β9, β6, β7) antiparallel β-sheet, together a small β-barrel is formed. This topology (Figure 62 A) 
represents the basic, conserved jelly roll or cupin-fold (Dunwell, 1998; Richardson, 1981). Ac-
cording to the core fold, there are two additional β-sheets, β1 and β2. These strands perform a 
domain swapping or β-strand exchange with the second protein chain in the ASU in a way that 
one of the core β-sheets is extended to a 6-stranded (β1, β2, β3, β10, β5, β8) antiparallel β-sheet 
(Figure 62 B). The resulting dimer is very likely stable in solution as this strand exchange is sta-
bilized by several H-bonds that are formed between the backbone atoms of β2- and β3-strands 
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of both monomers (Figure 62 B, right). The monomers are further connected by salt bridges 
between the sidechains of R104 (chain B) and E18 (chain A), between E18 (chain B) and R105 
(chain A) and between E44 (chain B) and the backbone of H15 (chain A) (Figure 62 A, right).  
 
A DLS experiment calculated a MW of 26.5 kDa, which matched the theoretical MW (25.7 kDa) 
of a PA1359-CTD dimer and confirmed this oligomerization state in solution. This is under-
pinned by an analysis with the 'Protein interfaces, surfaces and assemblies' service PISA (Kris-
sinel and Henrick, 2007), which suggests assembly of the ASU as being stable in solution, based 
on the calculated value of 18 kcal/mol for the free energy of assembly dissociation (ΔGdiss), as 
ΔGdiss-values above zero determine assemblies as thermodynamically stable. Furthermore, the 
Figure 62: Architecture of PA1359-CTD. A) Topology of PA1359-CTD chain A. The β-strands are numbered from N- to C-term. 
The left image shows a schematic representation of secondary structure elements edited with TopDraw (Bond, 2003). The right 
image shows one monomer of PA1359-CTD. B) Content of the ASU. Chain A is colored green. Chain B is colored grey. The right 
image displays H-bonds, and salt bridges that connect both chains in the ASU.  
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interface area of this dimer is 1625 Å2, which makes 25 % of the overall surface area of 6534 Å2 
and with this is at least twice as big as interfaces between other symmetry related chains. 
 Putative ligand binding site of PA1359-CTD 
The structure was analyzed to identify hints towards a possible regulatory molecule that alters 
the affinity of the potential transcriptional regulator PA1359 towards DNA. An analysis with the 
PDBe-fold server (Krissinel and Henrick, 2004) returned more than 300 hits that did not deliver 
new leads, as the cupin fold is highly conserved while the sequence is not. Actually, the cupins 
have been reported as being the functionally most diverse known protein superfamily with 18 
distinct functional classes (Dunwell et al., 2004). Derived from the conserved structure, the 
potential binding site of PA1359-CTD for a small molecule is proposed to lie between the two 
β-sheets facing each other (Figure 63 B). The so-formed binding cavity has a negative electro-
static surface (Figure 63) and is flanked by the amino acid side chains represented in Figure 
63 A.  
 
Figure 63: Putative ligand binding site of the PA1359-CTD dimer. The monomers are colored differently. A) Amino acid side 
chains flanking the potential ligand binding site are represented as balls and sticks. The numbering of the amino acid residues 
refers to their position in the full-length protein. Oxygen atoms are colored red and nitrogen atoms are blue. H-bonds with a 
maximum distance of 3.2 Å are displayed as dashed lines. B) The electrostatic surface of the potential ligand binding site of 
PA1359-CTD is colored from red to blue (-5 to 5 kT/e) as calculated by the PDB2PQR server Version 2.0.0 (Dolinsky et al., 2004). 
To get an idea of the potential position of the N-terminal DNA-binding domain, PA1359-CTD 
was superimposed with the two best hits that were used to make the structural prediction with 
the PHYRE2-server (Kelley et al., 2015). They were chosen as they resulted in the highest confi-
dential model (100 % confidence at 80 % sequence coverage) and had the same two-domain 
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architecture as PA1359. One was the crystal structure from a potential HTH_3 family transcrip-
tional regulator from Vibrio cholerae (PDB-ID: 1Y9Q; Kumaran, D., et al. to be published). The 
other structure is a hydroxypropylphosphonic acid epoxidase from Streptomyces wedmorenis 
with a catalytically active CTD and an HTH-fold containing NTD (PDB-ID: 2BNO, McLuskey et al., 
2005). Both structures contained the conserved C-terminal cupin fold that formed a dimer like 
PA1359-CTD. While the transcriptional regulator from V. cholerae formed a dimer in solution 
(Figure 64 A, PDB-ID: 1Y9Q, Kumaran, D., et al. to be published), the epoxidase formed a more 
complex homotetramer (Figure 64 B) (PDB-ID: 2BNO; McLuskey et al., 2005). The structural 
alignments revealed that the potential molecule binding site of PA1359 could be blocked (Fig-
ure 64 C) or influenced (Figure 64 D) by the N-terminal domain such that the structure of the 
full-length protein is required to get an impression of all amino acid residues that are necessary 
for regulator binding.    
 
Figure 64: Superposition of PA1359-CTD (green) with structurally related proteins. A) Superposition with the homodimeric 
HTH_3 family transcriptional regulator (red) from Vibrio cholerae (PDB-ID: 1Y9Q; Kumaran, D., et al. to be published). B) Su-
perposition with the homotetrameric hydroxypropylphosphonic acid epoxidase (blue) from Streptomyces wedmorenis (PDB-
ID: 2BNO; McLuskey et al., 2005). C/D) Magnification of the potential ligand-binding site of the respective cupin domain. The 
triangles indicate the potential ligand-binding site. Monomers of multimeric proteins are shown in different shades of green 
(PA1359-CTD), red (PDB-ID: 1Y9Q) or blue (PDB-ID: 2BNO). 
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 Conclusion and Outlook 
The ORF coding for the class III βαβββ-module-containing protein PA1358 and the probable 
transcriptional regulator PA1359 was predicted to be a type II TA-system with PA1358 as toxin 
and PA1359 as the antitoxin. However, there was no evidence to confirm the toxicity of PA1358 
in the absence of PA1359 in the microbiological assays. Further, it was not possible to confirm 
the formation of a complex between PA1358 and the regulatory domain of PA1359, which 
would be expected from type II TA-system proteins. These results indicate that the prediction 
was not accurate and that PA1358 and PA1359 most probably fulfill another function.     
The phenotypic characterization of the PA14 PA1358::Tn mutant provided no evidence that 
PA1358 plays a major role in the central metabolism of the bacterium and in the tested motility 
forms. Since the PA14 PA1358::Tn mutant had an altered metabolic rate in the chemical sensi-
tivity assay, the protein might, as expected, participate in the mediation of resistance towards 
compounds with antimicrobial activity. Since no interaction was discovered between PA1358 
and the identified compounds, further experiments must be conducted to suggest a precise 
function of PA1358. At first, the phenotypes from the chemical sensitivity assays should be 
confirmed by repeating the experiment and by determination of MICs, since the manufacturer 
does not provide the concentration of the compounds in the PM. Further, it must be clarified 
if the phenotypes are only caused by the lack of the functional PA1358 protein, if a spontaneous 
mutation in other genes occurred, or if the presence of the transposon itself is responsible for 
the phenotypes. As described for the other proteins investigated here, the chemical sensitivity 
assay with the identified compounds must be repeated as a rescue experiment in which the 
protein is expressed from a plasmid in the PA14 PA1358::Tn. If the phenotype of the PA14 
PA1358::Tn mutant is reversed by the introduction of functional protein, the loss of PA1358 is 
confirmed to be responsible for a detected change in respiration rates.  
The purification of the regulatory domain of PA1359 was first described in this study. The crys-
tal structure of PA1359-CTD gave new insights in an undiscovered protein from the very diverse 
cupin fold superfamily. However, no hypothesis about the nature of a regulatory molecule can 
be made from the crystal structure, since the potential binding site is probably also built up by 
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the missing DNA binding domain. Therefore, more effort should be put in the soluble expres-
sion of the full-length PA1359 protein. The solubility could be enhanced if the full-length pro-
tein is expressed with different purification tags, such as MBP- or T7-lysozyme at the N- and/or 
at the C-termini.   
4.5 PA4518 
The ORF of PA4518 in the P. aeruginosa genome is alone expressed in a single-gene transcrip-
tional unit (Wurtzel et al., 2012), and the crystal structure of the homodimeric class III βαββββ-
module protein PA4518 (15.3 kDa, 141 aa) was determined in an earlier study (Vit, 2015). The 
precise analysis of the 3D arrangement of amino acids flanking the potential ligand-binding site 
did not provide any indications concerning a potential function or molecule interacting with 
PA4518 (Vit, 2015). Therefore, the physiological role of PA4518 was investigated by compara-
tive analysis of the PA4518 transposon insertion mutant (PA14 PA4518::Tn) with the wt. The 
PA14 PA4518::Tn was manufactured by Liberati et al., 2006 and kindly provided by Prof. S. Häu-
ßler from the HZI. PCR and sequencing of the PCR product confirmed the MAR2xT7 transposon 
in the ORF of PA4518 at bp 63 (Figure 65 A) as stated by the manufacturer (Liberati et al., 2006). 
The phenotype of PA14 PA4518::Tn was characterized with motility and planktonic growth as-
says and with Phenotype MicroArraysTM.  
 
Figure 65: ORF of PA4518 in the P. aeruginosa PA14 strain. The actual locus ID of the PA4518 homologue in the PA14 strain is 
PA14_58620. The genomic localization given in bp of the gene was derived from pseudomonas.com (Winsor et al., 2016). The 
transposon insertion site (Tn) of the PA14 PA4518::Tn mutant used in this study is indicated by a grey arrow. The position of 
the insertion in the ORF is given in units of bp and the total length of the gene in brackets. 
 Motility and planktonic growth of PA14 PA4518::Tn 
Swimming, swarming (Figure 66 B-E) and planktonic growth (Figure 66 A) assays with PA14 
PA4518::Tn pointed out that the mutant had comparable features as the wt. In addition to this, 
both strains developed the same characteristic green color when reaching high cell densities 
during planktonic growth and during solid growth on LB plates, indicating that they can produce 
comparable amounts of pyocyanin and pyoverdine. There were also no obvious morphological 
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differences between the colonies on agar plates. These findings indicated that the protein does 
not interfere in basic cellular functions and the production of the most abundant secondary 
metabolites, pyocyanin and pyoverdine under the tested conditions. 
 
Figure 66: Phenotypic characterization of a P. aeruginosa PA14 PA4518 transposon insertion mutant (PA14 PA4518::Tn) in 
comparison to the respective wild type (PA14 wt) and a swimming (PA14 flgK::Tn) and swarming (PA14 rhlR::Tn) deficient 
mutant. A) Planktonic growth curves of the mutant and the wt. Displayed is the increase of the optical density of the cell 
cultures measured at 600 nm (OD600) over time (t (min)). The bacteria were incubated in LB-medium under shaking conditions 
at 37 °C. B/C) The diameter of swimming and swarming colonies was determined from three independent experiments, after 
incubating for 19 (swimming) and 18 h (swarming) at 37 °C. Error bars represent the deviation calculated from the mean trip-
licates. D/E) Examples of the respective swimming and swarming colonies.  
 Characterization of PA14 PA4518::Tn with Phenotype MicroArraysTM 
The identification of the physiological role of PA4518 was further investigated with Phenotype 
MicroArraysTM. The PA14 PA4518::Tn was incubated on 190 different carbon sources and on 
240 distinct compounds with antimicrobial activity. The comparison of the respiration curves 
between the mutant and the wt (Figure S4) revealed no significant changes in the carbon source 
utilization assay, but some differences occurred in the chemical sensitivity assay. Four com-
pounds induced an increased and six compounds induced a reduced respiration phenotype 
(Figure 67). Most of the compounds were also discovered in the PMs with the other PA14 mu-
tants where their antimicrobial activity was already discussed. Polymyxin B (Evans et al., 1999), 
compound 48/80 (Hall et al., 1983; Lenney et al., 1977; Nakao et al., 2011) and chloroxylenol 
(McDonnell and Russell, 1999) target the membrane and increase its permeability. Azlocillin 
and phenethicillin are β-lactam antibiotics that inhibit the cell wall synthesis (Kong et al., 2010). 
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Chlorodinitrobenzene (Habig et al., 1974; Vuilleumier, 1997) and dichlofluanid (Schuphan et 
al., 1981) are suggested to deplete the glutathione pool and thus increase the oxidative stress 
(Masip et al., 2006). The aminoglycoside antibiotic tobramycin inhibits protein synthesis 
(Bendush & Weber, 1976; Brogden et al., 1976). Ruthenium red and 5-fluoroorotic acid exclu-
sively alter the respiration rate in the PA14 PA4518::Tn mutant (Figure 67 A, Figure S4).  
 
 
Ruthenium red is a histological stain that can interact with several Ca2+-binding proteins in eu-
karyotes (Charuk et al., 1990; Yamada et al., 2000). The antimicrobial mechanism is not under-
stood but ruthenium red was identified to bind to the bacterial Ca2+-binding protein FtsZ and 
induce its bundling to protofilaments (Santra et al., 2004). FtsZ bundling plays an important 
role during cell division (Koppelman et al., 2004; Margolin, 2003) and therefore, ruthenium red 
Figure 67: Chemical sensitivity Phenotype MicroArraysTM of PA14 PA4518::Tn. A) Displayed are the overlaid respiration curves 
of the wt (black) and the mutant (grey) that were incubated on four concentrations of substances with potential antibacterial 
function that induced significant changes between the wt and the mutant. The values in parentheses describe the number of 
the respective Phenotype MicroarrayTM and of the wells containing the compound. The respiration curves were obtained by 
plotting the measured absorbance in arbitrary units from 0-400 detected at 490 nm (y-axes) against the incubation time from 
0-48 h (x-axes). To highlight the differences, the area between the respiration curves was colored green if the mutant respired 
better than the wt or red if the respiration of the mutant was inhibited. B) The chemical structures were obtained from the 
PubChem database (Kim et al., 2016) and visualized with ChemDraw Professional 17.0. C) TSA results: changes in thermal 
stability (ΔTm (K)) of PA4518 (Tm: 59°C) that were determined by averaging 3 independent experiments. 
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might interfere with proper proliferation of bacteria. 5-fluoroorotic acid is an analog of orotic 
acid and inhibits the enzymes of the pyrimidine synthesis pathway that use orotic acid as nat-
ural substrate, explaining the toxic effect towards bacteria (Krungkrai et al., 1992). The PM 
identified compounds with antimicrobial activity mediated by various mechanisms. They could 
not be connected to suggest a physiological role for PA4518 that explains the observed pheno-
types introduced by all compounds. Since it cannot be ruled out that PA4518 directly interacts 
with one of the compounds, the possible binding of the isolated PA4518 with the available 
compounds was investigated by a TSA and MST experiments. For this, the recombinantly ex-
pressed protein was purified by Vanessa Hering as described before (Vit, 2015) (Figure S1). In 
the TSA, dichlofluanid was the only compound that significantly affected the Tm of PA4518, 
which is 59 °C in SEC buffer by -6.3 K (Figure 67 C). The following MST experiment with di-
chlofluanid did not result in a binding curve, indicating that the compound does not interact 
with PA4518 under the tested conditions. 
 Conclusion and Outlook 
The comparative analysis of the PA14 PA4518::Tn mutant phenotype with the PA14 wt revealed 
that the protein plays no role during central metabolism and during swimming and swarming 
motility. The higher susceptibility of the PA14 PA4518::Tn mutant to antibacterial compounds 
suggests that the class III βαβββ-module protein plays a role during the mediation of resistance 
towards toxic compounds as shown for other βαβββ-module proteins. However, no further 
hypotheses about a potential mechanism can be derived since the direct interaction with the 
compounds was not detectable and PA4518 might participate in a more common resistance 
mechanism. Before a reliable statement about the function of PA4518 can be made, the results 
from the chemical sensitivity assay have to be confirmed by repeating the experiment and by 
determination of MICs. Further, it must be demonstrated that the phenotype is only caused by 
the disruption of the PA4518 gene and the resulting lack of the PA4518 protein and not by 
spontaneous mutations in other genes or by the presence of the transposon. This can be done 
in a rescue experiment in which a protein expression plasmid containing the PA4518 ORF is 
introduced in the PA14 PA4518::Tn mutant and the phenotype of the change inducing com-
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pounds is investigated. If the phenotype of the complemented PA14 PA4518::Tn mutant re-
flects the phenotype of the wt, the loss of PA4518 is responsible for a detected change in res-
piration rates. 
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5 Supplement 
5.1 Protein purification 
 
 
 
 
 
 
 
 
 
 
 
 
5.2 Phenotyping 
 
 
 
 
A C B 
Figure S1: Final purities of proteins isolated during this study. Displayed is a 18 % SDS-gel. 4 µg protein were loaded on each 
lane and stained with InstantBlueTM (expedeon). The marker was PageRulerTM Plus Prestained Protein Ladder, #26620 
(Thermo Fisher Scientific). A) Protein constructs that were first isolated during this study. B) Purity of PA418316-155 MSE pro-
duced for phasing the crystal structure and His6-PA418316-155 utilized in MST experiments. C) Purity of proteins used and 
purified during this study, with before described purification protocols. PA4518 was purified by Vanessa Hering under su-
pervision of the author.   
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 Swimming and swarming motility assays 
 
Figure S2: Swimming motility assays. Displayed are three independent biological replicates of the βαβββ transposon mutants 
in comparison with the respective wt and swimming deficient transposon mutant. 
 
 
 
Figure S3: Swarming motility assays. Displayed are three independent biological replicates of the βαβββ transposon mutants 
in comparison with the respective wt and swimming deficient transposon mutant. 
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 Phenotype MicroArraysTM (PM) 
 
Figure S4: Phenotype MicroArraysTM of PA14 mutants PA1358::Tn (green), PA1672::Tn (grey), PA4183::Tn (red), PA4518::Tn 
(purple) in comparison to the PA14 WT (black). The respiration curves were obtained by plotting the measured absorbance 
(490 nm) in arbitrary units from 0-400 (y-axes) against the incubation time from 0-48 h (x-axes). Plates PM1 and PM2 con-
tained different carbon sources and PM11-PM20 contained chemical compounds with antimicrobial activity in four different 
concentrations that are increasing from left to right (wells 1-4, 5-8 and 9-12 contain the same compound. 
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Figure S5: Phenotype MicorArraysTM of PAO1 WT (black) and PA2721::Tn mutant (grey). The respiration curves were ob-
tained by plotting the measured absorbance (490 nm) in arbitrary units from 0-400 (y-axes) against the incubation time from 
0-48 h (x-axes). Plates PM1 and PM2 contained different carbon sources and PM11-PM20 contained chemical compounds 
with antimicrobial activity in four different concentrations that are increasing from left to right (wells 1-4, 5-8 and 9-12 
contain the same compound.  
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5.3 Supporting information for open reading frame PA2721-PA2723 
 Supporting information for PA2723 
 
Figure S6: Secondary structure prediction of PA2723 by PSIPRED server (Buchan et al., 2013). 
 
 
Figure S7: Determination of the oligomerization state of PA2723 by analytical SEC with a SuperdexTM 75 10/300 GL (GE 
Healthcare) in SEC-buffer. A) Calibration curve calculated after equation 2 using the elution volumes (Ve) from the LMW stand-
ard. B) Elution profiles of the LMW standard proteins and Blue dextran. The void volume (V0) correspond to the Ve of Blue 
dextran 7.7 ml. The other Ve that were used for calculating the calibration curve are 9.48 ml for conalbumin, 11.62 ml for 
carbonic anhydrase, 13.46 ml for RNase A and 16.09 ml for aprotinin. C) Elution profile of PA2723. Ve is 13.5ml, which corre-
sponds to a MW of 15.1 kDa.  
 
 
 
 
Figure S8: TSA of PA2723. Displayed is the negative derivative curve. The melting 
temperature of PA2723 is defined at the minimum of the derivative curve and is 
59 °C in SEC buffer. 
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 Supporting information for PA2722 
 
Figure S9: Fluorescence scan with the PA2722 crystal from BESSY II, BL14.2 to confirm the presence of Zn2+-ions and to identify 
the peak wavelength for SAD-data collection. 
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 Statistics of PA2721 crystals soaked with dichlofluanid and captan 
Table S1: Full data collection, processing and refinement statistics of PA2721 crystals soaked with each 1.5 mM dichlofluanid & captan for 24 h.  
Data collection & processing Dichlofluanid Captan Refinement  Dichlofluanid Captan 
Beamline BL14.2, BESSY II home source Space group P21 P21 
Detector Pilatus 2M Saturn944+ Resolution limits (Å) 42.65-1.46 39.27-2.1 
Wavelength (Å) 0.9184 1.54187 Completeness (%) 98.8 94.5 
Temperature (K) 100 100 Final Rcryst (%) 15.59 23.29 
Exposure time per image (s) 0.3 10 Final Rfree (%) 17.6 26.59 
Rotation range per image (°) 0.1 0.5 No. of reflections   
Total rotation range (°) 360 100 Working set 46921 14411 
Crystal-detector distance (mm) 127 50 Test set 2301 738 
Space group P21 P21 No. of non-H atoms   
a,b,c (Å) 42.88 55.09 58.98 42.57 54.78 56.57 Protein 2470 2364 
α,β,γ (°) 90.00 95.87 90.00 90.00 95.31 90.00 Solvens 387 125 
Resolution range (Å) 42.65-1.46 (1.48-1.46) 39.27 - 2.1 (2.16-2.1) Total 2857 2489 
Mosaicity (°)# 0.33 0.36 R.m.s. deviations   
Total No. of reflections 315008 (15711) 31243 (2411) Bonds (Å) 0.007 0.002 
No. of unique reflections 47017 (2254) 14431 (1122) Angles (°) 0.844 0.435 
Multiplicity 6.7 2.1 Average B factors (Å2)   
Completeness (%) 99.1 (97.2) 90.6 (57.6) Protein 25.36 34.78 
Mean I/σ(I) 20.2 (2.1) 7.3 (1.7) Solvens 38.89 36.34 
CC1/2+ 99.9 (85.6) 99.7 (70) Ramachandran plot   
Rmeas (%)¥ 4.5 (106.4) 8.3 (58.7) Favoured regions (%) 97.8 96.1 
Rpim (%)$ 1.7 (39.8) 5.5 (39.0) Outliers (%) 0 0.32 
Wilson B-factor (Å2) 16.2 25.7 MolProbity score‡ 1.03 1.38 
Matthews coefficient 2 1.9   
Solvent content (%) 38 34   
 
Molecules per ASU 2 2   
 
Values in parentheses are for the highest resolution shell, † BESSYII (HZB, Berlin, Germany), home source: MicroMaxTM 007 HF rotating Cu-anode X-ray generator with a Saturn 944+ CCD detector (Rigaku, 
Tokyo, Japan), # Value as reported by AIMLESS (Evans and Murshudov, 2013). + CC1/2 as reported by (Karplus and Diederichs, 2012), $ Rpim = Σhkl (1/(N – 1))1/2 Σi | Ii (hkl) – < I (hkl) > | / Σhkl Σi Ii (hkl) (Weiss, 
2001); ¥Rmeas = Σhkl (N/(N – 1))1/2 Σi | Ii (hkl) – < I (hkl) > | / Σhkl Σi Ii (hkl), where N is the number of observations of the reflection with index hkl and Ii is the intensity of its ith observation (Weiss, 2001). ‡ 
MolProbity score as reported by MolProbity (Chen et al., 2010). 
 
148 | S u p p l e m e n t  
 
 Crystallographic fragment screening with PA2721 
Table S2: Summary of processing and refinement statistics¥ of fragment screening data sets processed in SG P1. 
Data            
set ID§ 
Completeness 
(%) 
ISa 
Res.       
(Å) 
Rwork          
(%) 
Rfree    
(%) 
R.m.s. deviations 
bonds (Å) angles (°) 
1 93.8 (91.0) 33.4 1.5 15.34 19.48 0.009 1.218 
3 95.8 (93.3) 32.5 1.53 16.78 22.17 0.010 1.228 
4 74.8 (75.2) 38.7 1.6 19.49 27.22 0.011 1.265 
5 85.0 (85.4) 37.7 1.7 18.14 23.01 0.011 1.317 
7 77.6 (79.4) 36.6 1.26 20.36 25.53 0.011 1.274 
9 93.5 (90.7) 32.4 1.31 18.1 21.83 0.009 1.242 
12 94.2 (92.0) 23.2 1.69 26.33 34.16 0.015 1.554 
15 86.2 (84.9) 26.3 1.34 22.61 25.61 0.011 1.323 
16 93.3 (91.9) 38.1 1.63 16.6 20.11 0.010 1.270 
18 92.6 (88.6) 18.0 1.68 28.25 37.33 0.016 1.604 
19 93.5 (91.6) 35.6 1.45 14.33 18.29 0.009 1.205 
20 85.5 (87.6) 42.7 1.51 15.61 21.15 0.009 1.195 
25 93.1 (90.8) 25.3 1.45 23.12 26.6 0.011 1.362 
26 92.7 (87.4) 19.6 1.5 23.26 27.71 0.012 1.345 
28 94.6 (93.8) 38.5 1.59 14.54 19.69 0.009 1.178 
32 92.4 (91.2) 36.8 1.35 21.04 26.28 0.010 1.271 
34 93.1 (92.3) 30.5 1.52 19.87 23.78 0.011 1.285 
37 94.1 (91.8) 28.8 1.45 20.41 26.22 0.011 1.319 
40 95.1 (92.0) 31.9 1.35 20.08 24.51 0.010 1.236 
46 92.4 (90.7) 35.7 1.33 19.09 23.8 0.010 1.253 
47 93.6 (91.5) 37.8 1.37 17.83 23.25 0.010 1.230 
49 94.9 (93.2) 25.9 1.67 20.64 25.55 0.012 1.361 
50 75.6 (77.2) 31.3 1.69 20.22 26.89 0.012 1.304 
51 93.7 (91.2) 31.6 1.36 17.46 22.09 0.009 1.204 
52 94.2 (92.3) 31.1 1.49 16.34 20.93 0.009 1.219 
55 84.2 (86.5) 45.1 1.76 21.13 28.1 0.012 1.353 
58 86.0 (86.4) 26.2 1.48 23.78 28.84 0.013 1.391 
59 93.8 (90.9) 33.2 1.55 16.74 22.55 0.011 1.237 
62 92.0 (90.8) 29.8 1.3 22.74 26.97 0.010 1.316 
63 93.5 (90.6) 32.8 1.43 23.76 28.83 0.012 1.393 
64 94.6 (90.3) 28.8 1.61 20.98 26.01 0.012 1.374 
65 92.4 (88.8) 31.8 1.47 25.74 30.09 0.013 1.444 
66 78.5 (79.2) 37.5 1.28 23.21 28.76 0.010 1.235 
67 93.3 (90.3) 29.7 1.37 25.13 31.5 0.012 1.366 
71 93.9 (89.8) 34.3 1.6 18.72 22.82 0.012 1.326 
73 92.5 (87.3) 27.7 1.59 24.11 31.4 0.013 1.404 
75 77.9 (79.8) 43.7 1.29 18.78 23.72 0.009 1.242 
77 94.1 (89.8) 26.7 1.57 15.37 20.07 0.010 1.209 
86 93.9 (92.5) 32.8 1.5 14.29 19.11 0.009 1.181 
87 84.3 (83.1) 37.4 1.6 22.53 29.92 0.013 1.362 
88 76.6 (78.9) 40.1 1.48 25.78 34.7 0.013 1.399 
91 93.0 (88.6) 29.6 1.8 21.12 27.75 0.013 1.399 
94 90.5 (87.6) 24.8 1.8 23.49 30.85 0.014 1.470 
96 90.3 (87.5) 36.8 1.38 18.92 24.59 0.010 1.268 
98 94.5 (93.3) 31.0 1.89 16.52 22.35 0.012 1.293 
120 92.5 (90.7) 36.0 1.39 18.31 22.98 0.009 1.261 
123¤ 94.7 (92.0) 15.2 2.0 19.88 27.06 0.008 0.977 
§The data set ID refers to the ID of the soaked fragments. Data sets 1-120 were collected at beamline 14.2, BESSYII (HZB). ¥Processing 
statistics (Completeness (%), Isa value and Resolution (Res. (Å)) as calculated by XDSAPPv2.99 or v2.0 (Krug et al., 2012; Sparta et al., 2016). 
Refinement statistics as calculated by phenix.refine (Adams et al., 2010) through the HZB automated refinement pipeline. ¤Data set 123 was 
measured at the home source. Processing statistics as calculated by XDS (Kabsch, 2010) and Aimless (Winn et al., 2011). Refinement statistics 
as calculated by phenix.refine (Adams et al., 2010). 
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Table S3: Summary of processing¥ and reﬁnement† stabsbcs of fragment screening data sets processed in space group P21.  
Data            
set ID§ 
Completeness 
(%) 
ISa 
Res.       
(Å) 
Rwork          
(%) 
Rfree    
(%) 
R.m.s. deviations 
bonds (Å) angles (°) 
2 94.3 (92.5) 44.1 1.5 20.55 24.21 0.011 1.324 
6 95.0 (94.0) 42.9 1.38 17.33 21.68 0.008 1.189 
8 92.2 (68.9) 13.6 1.41 24.36 30.94 0.011 1.320 
10 94.4 (93.8) 50.9 1.47 16.0 20.17 0.009 1.171 
11 96.8 (96.9) 35.8 1.5 17.74 22.25 0.009 1.168 
14 96.1 (96.4) 45.2 1.77 19.07 24.02 0.010 1.251 
17 93.9 (92.6) 35.2 1.38 16.85 21.87 0.008 1.180 
21 95.4 (95.3) 39.6 1.46 18.12 22.93 0.009 1.155 
30 96.6 (94.3) 29.6 1.56 14.42 20.47 0.008 1.154 
31 98.9 (98.4) 27.4 1.44 21.1 24.03 0.010 1.313 
33 95.0 (93.2) 20.7 2.13 18.31 26.5 0.013 1.330 
35 94.2 (93.3) 38.6 1.28 17.2 20.61 0.008 1.206 
36 97.2 (96.8) 28.9 1.54 18.72 23.81 0.010 1.139 
39 96.4 (94.5) 37.4 1.29 19.1 23.75 0.009 1.211 
41 99.2 (97.5) 35.8 1.2 21.82 24.34 0.009 1.236 
44 91.7 (90.2) 37.1 1.4 16.64 20.1 0.008 1.201 
45 91.8 (89.1) 40.6 1.51 15.44 21.67 0.009 1.119 
53 94.0 (92.1) 40.6 1.42 16.16 20.5 0.008 1.196 
54 98.8 (97.7) 37.9 1.4 18.45 22.61 0.009 1.167 
57 96.5 (95.3) 38.1 1.49 17.44 22.31 0.009 1.204 
60 94.7 (93.6) 46.6 1.48 16.2 21.69 0.009 1.207 
61 95.6 (94.0) 33.1 1.25 18.83 21.02 0.008 1.212 
69 95.3 (91.9) 44.4 1.43 18.79 22.29 0.009 1.242 
70 96.0 (92.8) 21.1 1.48 20.06 25.88 0.011 1.241 
72 96.3 (96.3) 50.7 1.44 17.78 22.67 0.008 1.131 
76 95.3 (94.7) 48.8 1.72 24.39 30.86 0.014 1.447 
78 94.0 (74.6) 31.7 1.04 20.85 23.84 0.008 1.177 
79 95.2 (94.6) 43.7 1.4 16.95 21.27 0.008 1.165 
80 96.1 (94.5) 37.3 1.34 18.1 21.96 0.009 1.230 
85 94.4 (94.2) 26.8 1.56 15.95 22.77 0.009 1.158 
89 95.5 (95.6) 41.5 1.55 21.43 25.07 0.011 1.231 
90 96.5 (94.1) 36.9 1.31 17.73 21.72 0.008 1.161 
93 95.8 (94.3) 41.4 1.27 19.23 24.7 0.009 1.170 
99 98.6 (96.9) 23.2 1.51 18.22 24.14 0.010 1.221 
101 95.1 (93.6) 37.9 1.33 16.99 20.16 0.008 1.164 
102 94.6 (92.6) 29.7 1.3 19.64 23.34 0.008 1.174 
122 96.7 (96.3) 34.9 1.28 15.65 18.27 0.008 1.201 
124 96.4 (95.7) 41.1 1.45 17.53 21.68 0.008 1.128 
125 96.5 (95.3) 19.2 1.6 18.56 24.66 0.010 1.183 
13¤ 96.0 (93.0) 17.4 2.0 25.94 34.01 0.015 1.281 
29 95.8 (92.4) 49.6 1.9 17.90 22.55 0.005 0.747 
43 94.2 (69.2) 47.7 2.0 19.37 23.70 0.005 0.836 
56 91.5 (59.3) 31.7 2.0 19.53 23.05 0.005 1.243 
68 97.7 (81.2) 28.3 2.0 20.09 24.02 0.010 1.128 
82 97.4 (95.8) 39.2 2.1 20.20 23.99 0.015 1.868 
97 92.2 (65.8) 54.5 1.8 19.95 24.41 0.014 1.359 
100 100 (100) 20.4 2.0 18.32 23.62 0.007 0.942 
121 96.9 (93.8) 30.4 1.9 21.04 22.49 0.006 0.974 
§The data set ID refers to the ID of the fragments soaked into the crystal. Data sets 2-125 were collected at beamline BL14.2, BESSY II (HZB). 
¥Processing statistics (Completeness (%), Isa value and Resolution (Res., (Å)) as calculated by XDSAPP v2.99 or v2.0 (Krug et al., 2012; Sparta et 
al., 2016). Refinement statistics as calculated by phenix.refine (Adams et al., 2010) through the HZB automated refinement pipeline. ¤Data sets 
13-121 were measured at the home source. Processing statistics as calculated by XDS (Kabsch, 2010) and Aimless (Winn et al., 2011). Refine-
ment statistics as calculated by phenix.refine (Adams et al., 2010). Data sets with fragment screening hits are marked green.
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Table S4: Data collection and processing statistics of PA2721 fragment screening hits (8, 10, 61 & 100) and of input models for HZB phasing and refinement pipeline (90, 19). 
Data set ID 8 10 61 90 19 100 
Beamline/detector† BL14.2, BESSY II/Pilatus 2M home source 
Wavelength (Å) 0.9184 1.54187 
Temperature (K) 100 100 
Exposure time per image (s) 0.2   10 
Rotation range per image (°) 0.1   0.5 
Total rotation range (°) 160 120 120 160 220 360 
Crystal-detector distance (mm) 115 127 144 136 115 40 
Space group P21 P21 P21 P21 P1 P21 
a,b,c (Å) 42.75 55.18 56.65 42.42 55.01 56.27 42.83 54.59 57.22 42.41 54.88 56.35 56.51 69.06 69.64 42.20 54.96 56.17 
α,β,γ (°) 90.0 93.69 90.0 90 95.68 90 90 93.97 90 90.0 95.72 90.0 104.31 93.1 93.37 90 95.41 90 
Resolution range (Å) 
42.66-1.30          
(1.38-1.30) 
42.21-1.47                
(1.56-1.47) 
39.45-1.25            
(1.33-1.25) 
42.2-1.31              
(1.39-1.31) 
44.77-1.45           
(1.54-1.45) 
42.01-2.0              
(2.05-2.00) 
Mosaicity (°)# 0.102 0.174 0.064 0.155 0.153 0.19 
Total No. of reflections 192660 96044 160205 180982 370918 127492 
No. of unique reflections 63991 41696 69630 59727 169345 17448 
Multiplicity 3.0 2.3 2.3 3.0 2.2 7.1 
Completeness (%) 98.6 (97.9) 94.4 (93.8) 95.6 (94.0) 96.5 (94.1) 93.5 (91.6) 100.0 (100.0) 
Mean I/σ(I) 11.74 (2.45) 18.09 (2.40) 11.00 (1.61) 12.64 (0.84) 13.08 (2.41) 7.2 (1.8) 
CC1/2+ 99.8 (79.1) 100.0 (83.7) 99.9 (63.5) 99.9 (44.8) 99.9 (80.3) 98.4 (58.6) 
Rmeas (%)¥ 6.6 (54.3) 3.5 (49.1) 5.8 (72.9) 5.2 (147.4) 5.6 (47.2) 31.7 (149.3) 
Wilson B-factor (Å2) 16.97 24.99 18.2 23.6 19.84 11.8 
Isa 24.06 50.93 33.12 36.89 35.59 20.41 
Matthews coefficient 1.9 1.9 1.9 1.9 1.9 1.9 
Solvent content (%) 35 35 35 35 34 34 
Molecules per ASU 2 2 2 2 8 2 
Values in parentheses are for the highest resolution shell, †BESSYII (HZB, Berlin, Germany), home source: MicroMaxTM 007 HF rotating Cu-anode X-ray generator with a Saturn 944+ CCD detector (Rigaku, 
Tokyo, Japan), # Value as reported by AIMLESS (Evans and Murshudov, 2013). +CC1/2 as reported by (Karplus and Diederichs, 2012), ¥Rmeas = Σhkl (N/(N – 1))1/2 Σi | Ii (hkl) – < I (hkl) > | / Σhkl Σi Ii (hkl), where 
N is the number of observations of the reflection with index hkl and Ii is the intensity of its ith observation (Weiss, 2001).
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Table S5: Refinement statistics of PA2721 fragment screening hits (8, 10, 61&100) and of input models for HZB phasing and 
refinement pipeline (90 & 19). 
Data set ID 8 10 61 90 100 19 
Space group P21 P21 P21 P21 P21 P1 
Resolution limits (Å) 39.49-1.30 39.24-1.47 39.45-1.25 35.46-1.31 27.96-2.0 39.32-1.45 
Completeness (%) 98.6 94.44 95.57 96.51 99.99 93.50 
Final Rcryst (%) 13.98 16.62 14.80 23.18 18.02 18.27 
Final Rfree (%) 15.41 18.69 16.93 26.19 23.12 20.61 
No. of reflections       
Working set 63984 41683 69614 59696 17432 169271 
Test set 2101 2084 2100 2100 793 2099 
No. of non-H atoms       
Protein 2508 2544 2516 2335 2447 9727 
Fragment 38 36 11 - 9 - 
Solvens 462 297 419 139 244 1152 
Total 3008 2877 2946 2474 2700 10879 
R.m.s. deviations       
Bonds (Å) 0.005 0.003 0.007 0.004 0.005 0.008 
Angles (°) 0.953 0.697 0.951 0.651 0.842 1.164 
Average B factors (Å2)       
Protein 14.0 26.96 17.18 22.17 19.09 15.05 
Fragment 17.22 41.63 17.12 - 14.92 - 
Solvens 31.67 39.78 33.62 29.18 28.56 23.85 
Ramachandran plot       
Favoured regions (%) 96.5 97.1 95.9 96.41 95.2 97.8 
Outliers (%) 0 0 0 0 0 0.08 
MolProbity score‡ 1.23 1.24 1.22 1.06 1.43 1.15 
‡ MolProbity score as reported by MolProbity (Chen et al., 2010). 
 
Table S6: Gene names of homologs in P. aeruginosa strains PAO1 and PA14 
PAO1 PA14 
PA1358 PA14_46720 
PA1359 PA14_46710 
PA1672 PA14_42870 
PA2721 PA14_28960 
PA2722 PA14_28950 
PA2723 PA14_28940 
PA4183 PA14_09780 
PA4184 PA14_09770 
PA4518 PA14_58620 
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